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Errata 
p. 37, line 10: for (57,62,63) read (92,135,167) 
p. 40, line 20: for (102,210 ,202) read (102, 201,202) 
p. 65, line 2: for (64) read (65) 
p. 89, regel 36: lees "bijdrage" in plaats van "bijdragen" 
p. 90, regel 11: lees "produceren" in plaats van "te 
produceren" 
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CHAPTER 1. INTRODUCTION AND STATEMENT OF PROBLEMS 
The testicular gland is the main site of androgen pro-
duction in the male. Androgens (e.g. testosterone, andros-
tenedione and dihydrotestosterone) secreted by the testis 
and transported by the bloodstream to their target organs, 
influence several important physiological processes, such 
as maintenance of sex accessory glands 1 muscle development, 
hair growth, etc. (75). Inside the testis androgens are 
involved in the maintenance and regulation of spermatoge-
nesis (195). 
The testicular gland contains two main tissue compart-
ments: the seminiferous tubules and the interstitial tissue. 
The interstitial tissue is composed of Leydig cells, macro-
phages, connective tissue, blood and lymph vessels and con-
tributes approximately 10% to the total weight of the 
testis of the rat. Myoid cells, endothelial cells, Sertoli 
cells and cells in various stages of the spermatogenic 
cycle are the main constituents of the seminiferous tubules. 
It is generally accepted that the Leydig cell in the inter-
stitial compartment is the main steroid producing cell type 
in the testis (58,84). However, studies with tracer amounts 
of radioactive precursors indicate that seminiferous tubules 
can metabolize steroid precursors to androgens (10,16,37, 
214). In this regard it has been suggested that Sertoli 
cells might produce androgens in almost equal amounts as 
the Leydig cells (12-14,122). This notion might have impor-
tant biological implications if steroids produced by the 
Sertoli cells would be involved in the maintenance of sper-
matogenesis, and if androgens produced by the Leydig cells 
would be secreted only into the bloodstream for transport 
to their extratesticular target organs. 
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The first aim of the present thesis was to investigate 
the steroidogenic capacities of isolated interstitial 
tissue and seminiferous tubules (chapter 3). The testis of 
the rat was chosen for these studies because the two tissue 
compartments are morphologically and histochemically easily 
discernable {21) and can be separated from the testis using 
simple dissection techniques (37,89,174). For species other 
than the rat the separation of the different types of 
tissue is difficult. The mass production of steroids from 
endogenous precursors in cell-free systems has been esti-
mated, rather than measuring the conversion rate of exoge-
nous labelled substrates. Therefore, the possible diffi-
culty was prevented that added radioactive substrates may 
not completely mix with endogenous substrates and will not 
reflect true production rates. The present approach has 
permitted to compare the amounts of steroids produced in 
vivo with production rates in whole testis tissue, in iso-
lated interstitial tissue and in seminiferous tubules. 
Testicular steroid production is regulated and main-
tained by LH released from the pituitary gland (57,84,85). 
Surgical removal of this part of the brain (hypophysectomy) 
results in a rapid decrease of steroid production and ulti-
mately the testes become atrophic. 
To understand the hormonal regulation of steroidogenesis 
in molecular terms, knowledge of the cellular architecture 
and subcellular distribution of enzymes, substrates and 
cofactors, involved in steroid production, is indispensable. 
From incubation studies with radioactive precursors it was 
known that the enzymes required for one of the first steps 
in steroidogenesis, i.e. the conversion of cholesterol to 
pregnenolone occur in mitochondria {210) , whereas the 
enzymes responsible for the conversion of pregnenolone to 
testosterone are localized in the endoplasmic reticulum 
(207). Incubation techniques with tracer amounts of radio-
active cholesterol are complicated by the possibility that 
the results may not reflect true endogenous production. In 
addition, in previous studies the isolated subcellular 
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fractions have not always been characterized by proper mar-
ker enzymes. Consequently, the above mentioned localization 
of steroidogenic enzymes may be a simplification of the 
real cellular situation. 
The second aim of this thesis was to study the subcel-
lular production site of pregnenolone in rat testis tissue 
(chapter 3}. The rates of pregnenolone formation from endo-
genous substrates have been estimated and the rates of pro-
duction of pregnenolone in isolated subcellular fractions 
were compared with testosterone production from endogenous 
precursors in whole tissue homogenates. 
The subcellular fractions were characterized with the 
use of specific marker enzymes in order to correct for 
mutual contamination. In addition, the subcellular locali-
zation of 38-hydroxysteroid dehydrogenase, required for the 
conversion of pregnenolone to progesterone has been inves-
tigated. 
The stimulating effect of LH on rat testicular steroid 
production has been clearly established both in vivo and 
in vitro (59,85}. The conversion of cholesterol to pregne-
nolone appears to be rate-limiting in the metabolic steps 
resulting in androgen production (85}. LH is thought to 
stimulate steroid production via cyclic AMP as intracel-
lular messenger which ultimately has an indirect effect on 
the production rate of pregnenolone (59,85). Recently, the 
involvement of cyclic AMP dependent protein kinase activity 
and the synthesis or activation of a "labile" protein com-
pound (41} in the regulation of testicular testosterone 
production has been proposed. However, the mechanism of 
action of cytoplasmic factors on pregnenolone formation in 
mitochondria is still unknown. 
Therefore, the third aim of the work presented in this 
thesis was to investigate the effects of trophic hormones 
administered in vivo on testicular steroid production in 
isolated mitochondrial fractions (chapter 4 and 5). The 
mitochondrial production rates of pregnenolone have been 
compared with the amount of testosterone produced in vivo. 
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The results in section 4.2. and appendix paper III show the 
effect of long-term treatment with HCG on testicular steroid 
production and enzyme concentrations in rat testis prepara-
tions. In section 4.3. and 5.2. and appendix paper IV the 
results are given of the acute effect of LH on production 
rates of pregnenolone in isolated mitochondrial fractions 
compared with testost.;rone production rates in vitro and 
in vivo. The effect of variation of incubation conditions 
was studied on pregnenolone production rates in mitochon-
drial fractions from control and LH treated testes. 
Finally, an attempt has been made to elucidate a possible 
role of ca2+ ions in the mechanism of action of trophic 
hormones on the rate-limiting step in testicular steroid 
production {chapter 5). 
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CHAPTER 2. MATERIALS AND METHODS 
2.1. Animals and preparation of biological material 
2.1.1. Animals 
Male Wistar rats (8-14 weeks old) were used for experi-
ments described in appendix papers I and II and Wistar rats 
substrain R-Arnsterdam (14-16 weeks old) for the experimen-
tal work, presented in appendix papers III and IV. The 
animals were kept under controlled light (14 h light and 
10 h darkness) and temperature (20-22°C) conditions. Animals 
were killed by decapitation. 
2.1.2. Hormone treatment 
In appendix paper III the effect of long-term treatment 
with HCG is described. Daily subcutaneous injections of 
100 i.u. HCG dissolved in 0.2 rnl 0.9% NaCl were given for 
5 consecutive days. Control animals received 0.2 ml 0.9% 
NaCl only. The rats were killed by decapitation 24 h after 
the last injection and testis tissue preparations were 
analyzed for steroids. 
Results of short-term effects of LH on testicular steroid 
production are described in appendix paper IV and in 
section 5.2. Rats were anaesthetized by intraperitoneal 
injection of 0.3 ml sodium pentobarbital (60 mg/ml). Either 
LH dissolved in 0.2 ml 0.9% NaCl, containing 0.2% bovine 
serum albumin (LH treated rats) or 0.2 ml 0.9% NaCl, con-
taining 0.2% bovine serum albumin (control animals) was 
administered into the Vena Iliaca. Blood from the testi-
cular vein was collected in heparinized tubes during 20 min 
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after hormone injection. Blood samples were centrifuged 
after collection and the plasma was stored at -20°C until 
analyzed. When the effect of LH treatment on steroid pro-
duction rates in vitro was studied, one testis was removed 
and immediately chilled at 0°C in 0.25 M sucrose containing 
1 mM EDTA (zero control testis). Subsequently the animals 
received via injection into the Vena Iliaca either a LH 
solution or a NaCl-albumin solution only. The second testis 
was removed 5-30 min after injection with LH (LH treated 
testis) or NaCl-albumin solution (control testis). No dif-
ferences could be observed for in vitro production rates 
between preparations of 11 zero control testis 11 and "control 
testis 11 • Therefore, for the experiments described in sec-
tion 5.2. both testes were removed 20 min after injection. 
2.1.3. Dissection and homogenization of testis tissue and 
isolation of subcellular fractions from testis 
tissue 
After removal from the scrotum, testes were chilled in 
ice-cold 0.25 M sucrose, containing l mM EDTA. Then the 
tunica albuginea and the main blood vessels were removed 
and the remaining testis tissue was used for further prepa-
rations. 
When testis tissue was dissected into interstitial 
tissue and seminiferous tubules, a modification of the 
technique of Christensen and Mason (37) \Vas used. 
Whole testis tissue was covered in a petri disk with a 
small volume of ice-cold 0.25 M sucrose, containing 
1 mM EDTA and was dissected with stainless steel forceps 
into interstitial tissue and seminiferous tubules. The iso-
lated seminiferous tubules were washed 2 times with 10 ml 
of dissection medium. The purity of the isolated tissue 
fractions was checked by microscopic examination. 
Tissues were homogenized at 0°C in 0.25 M sucrose, con-
taining 1 mM EDTA, with an automatic Potter homogenizer 
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(Braun Melsungen, Germany) (3 times 15 sec at 1100 rpm). The 
volume of homogenization medium was adjusted, so that 
10-15% homogenates (gram wet weight tissue/ml volume medium 
x 100%) were obtained. 
In appendix paper I, tissue homogenates were separated 
at 4°C in a nuclear fraction N(500xg for 10 min pellet), a 
nuclei-free fraction E(SOOxg for 10 min supernatant), a 
heavy mitochondrial fraction M(3500xg for 10 min pellet), 
a light mitochondrial fraction L(10,000xg for 10 min 
pellet), a microsomal fraction P(105,000xg for 60 min 
pellet) and a particle-free supernatant S(105,000xg for 
60 min supernatant). Fractions N, MandL were spun down in 
a SE-12 rotor using a Sorvall RC2-B superspeed centrifuge. 
The pellets obtained were washed twice with isolation 
medium. Fractions P and S were obtained using a Beckman 
50 Ti rotor in a Beckman L2-65B ultracentrifuge. In appen-
dix papers II-IV and section 5.2. a combined heavy and 
light mitochondrial fraction M(15,000xg for 10 min pellet) 
was isolated using a Sorvall HB-4 swing out rotor in a 
Sorvall RC-2B superspeed centrifuge. Fraction M was washed 
two times with isolation medium. 
2.2. Incubation conditions 
As a rule 6-8 mg protein of whole testis homogenates, 
1-2 mg protein of interstitial tissue homogenates and 
3-6 mg protein of seminiferous tubules homogenates were 
incubated at 33°C in an o 2;co 2 {95:5, v/v) atmosphere in 
2 ml medium (pH 7.3), containing sucrose (0.125 M), EDTA 
(0.5 mM), sodium succinate (20 mM), NAD+ (1.0 mM), NADPH 
(1.0 mM), glucose-6-phosphate (10 mM), glucose-6-phosphate 
dehydrogenase (0.3 unit), cacl 2 (0.7 mM), Mgcl 2 (5.0 mM), 
Tris-HCl (25 mM). Production of testosterone from endoge-
nous precursors was determined as described in section 
2.3.1. 
Aliquots of mitochondrial fractions isolated from whole 
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testis tissue (1-2 mg protein/incubation), from intersti-
tial tissue (0.3-0.6 mg/incubation) as well as from semini-
ferous tubules (2-6 mg/incubation) were rountinely incu-
bated at 33°C in an o 2;co 2 (95:5, v/v) atmosphere in l-2 ml 
medium, pH 7.3, containing sucrose (0.125 M), EDTA (0.5 mM), 
sodium succinate (20 mM), NADPH {1.0 mM), glucose-6-phos-
phate dehydrogenase (0.3 unit), glucose-6-phosphate (10 mM), 
CaCl 2 (0.7 mM), Mgcl 2 (5.0 mM), Tris-HCl (25 mM). Produc-
tion rates of pregnenolone from endogenous substrates were 
estimated as described in section 2.3.2. Cyanoketone was 
present in the incubation medium to prevent further conver-
sion of pregnenolone to progesterone and androgens (appen-
dix paper II). In section 5.2. the effect of variations in 
the isolation medium and incubation conditions on mitochon-
drial pregnenolone production rates was investigated (for 
details see: Legends to figures of section 5.2.). 
2.3. Estimation of steroids in biological samples 
For the experiments presented in this thesis it was 
necessary to measure routinely small amounts of testoste-
rone and of pregnenolone in rat testis tissue homogenates 
and subcellular fractions and, in addition, to dAtermine 
changes in concentrations during in vitro incubation 
studies. Therefore, a technique appeared to be required 
which would permit the estimation of testosterone as well 
as of pregnenolone in the range of 1-100 ng. At the start 
of the experimental work in 1971 a variety of analytical 
methods for estimation of testosterone in biological 
samples had been described (see for review ref. 139). A 
gas-chromatographic technique with a satisfactory reliabi-
lity (section 2.3.1.1.) was readily available for mea-
surements of testosterone. For estimation of pregnenolone 
a modification of a gas-liquid chromatographic technique 
with electron capture detection of dehydroepiandrosterone 
was developed (section 2.3.2.1.). During recent years, 
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after the wide-scale introduction of radioimmunoassay tech-
niques, a rapid development has taken place of analytical 
methods for estimation of steroids. Radioimmunoassay 
methods for estimating steroids are now present with high 
sensitivity and great practicability. During the progress 
of the experimental work described in this thesis, the more 
time-consuming and laborious gas-liquid chromatography was 
replaced by radioimmunoassay methods to determine testoste-
rone and pregnenolone respectively (section 2.3.1.2. and 
2. 3. 2. 2.) • 
2.3.1. Estimation of testosterone 
2.3.1.1. Gas-liquid chromatography 
The estimation of testosterone in tissue samples was 
essentially as described by Brownie et al. (28). After iso-
lation and purification of the testosterone containing 
samples gas-liquid chromatography was performed on a Pye 
Unicam 104, model 84, equipped with a 63 Ni electron capture 
detector or on a F and M gaschromatograph equipped with a 
3H electron capture detector. The 90 em coiled column was 
packed with a stationary phase of 1% QF-1 on gaschrom Q. 
Nitrogen was used as carrier and as purge gas. The mono-
chloroacetate derivative of 208-hydroxy-4-pregnen-3-one was 
used as internal standard for gas-liquid chromatography. 
The reliability of the method has been previously described 
{108,139). The sensitivity of detection of testosterone 
using gas-liquid chromatography with electron capture de-
tection of the chloroacetate derivative of testosterone is 
1-2 ng. The precision of the assay method in the range of 
1-100 ng testosterone is 10-20%, when expressed as the 
coefficient of variation, calculated from the results of 
multiple estimations of the same sample (108,139). 
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2.3.1.2. Radioimmunoassay 
Testosterone in plasma and testis tissue samples was 
estimated using the radioimmunoassay technique described by 
Verjans et al. (213), which was essentially a modification 
of the method first presented by Furuyama et al. (71). 
Testosterone in plasma samples was extracted with 
hexane-ether (4:1, v/v) after addition of 25,000 dpm 
[ 1,2,5,6 3H]-testosterone as internal standard. Extracts 
were purified using alumina-columns. Testosterone in homo-
genates or subcellular fractions of rat testis tissue was 
extracted with ethyl acetate after addition of 20,000 dprn 
[ 1,2,5,6 3H]-testosterone as internal standard. Extracts 
were either purified using chromatography in a Bush A II 
system (150) or were used for radioimmunoassay directly 
after extraction. After incubation of aliquots of testoste-
rone samples with antiserum, dextran-coated charcoal sus-
pension was added to the incubation mixture for separation 
of free and bound testosterone (method b of Verjans et al. 
(213)). The precision of the radioimmunoassay technique 
when expressed as coefficient of variation was in the order 
of 5-20%, calculated from multiple estimation of amounts of 
testosterone in the range of 50-300 pg. The specificity of 
the radioimmunoassay of testosterone was investigated by 
comparing the ability of various steroids to displace [ 3H]-
testosterone from the antibody. Of the steroids investigated 
only 5~-dihydrotestosterone showed an appreciable cross-
reactivity with the antiserum for testosterone. However, 
since the amounts of 5~-dihydrotestosterone present in 
adult rat testis tissue are low compared with testosterone 
levels, the specificity of the method described (213) is 
high enough for the type of study presented in this thesis. 
Estimates obtained by radioimmunoassay and by the gas-
liquid chromatography technique of testosterone concentra-
tions in homogenates and subcellular fractions from testis 
tissue showed a good correlation (r=0.98, n=26). 
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2. 3. 2. Estimation of pregnenolone 
2.3.2.1. Gas-liquid chromatography 
Pregnenolone in homogenates and subcellular fractions 
from testis tissue was initially estimated by gas-liquid 
chromatography. This technique was essentially similar to a 
method described by de Jong and van der Molen for estima-
ting dehydroepiandrosterone in plasma {110). These authors 
suqgested that the assay technique could be applied for 
other 3-hydroxy-5-ene steroids as well, since steroidal 
3-hydroxy-5-ene can generally be oxidized to electron cap-
turing 3,6-dioxo-4-ene compounds. 
Pregnenolone was extracted from hornogenates and subcel-
lular fractions of rat testis tissue by ethyl acetate after 
addition of 100,000 dpm [16-3H]-pregnenolone as internal 
standard to correct for losses during extraction and chro-
matography. After purification with paper chromatography, 
using a Bush A II system pregnenolone was oxidized to 
4-pregnene-3,6,20-trione with cro3 (110). 4-Pregnene-3,6, 
20-trione was purified with thin-layer chromatography before 
estimation with electron capture detection after gas-liquid 
chromatography, essentially as described by de Jong and 
van der Molen (110). 4-Androstene-3,6,17-trione was used as 
internal standard for gas-liquid chromatography. The 
overall recovery of pregnenolone after oxidation and puri-
fication was 16 ± 4% (mean values± S.D., n=68). 
The accuracy and precision in the estimation of pregne-
nolone are summarized in table 2.I. In the order of 3-5 ng 
4-pregnene-3,6,20-trione could still be estimated by this 
gas-liquid chromatographic method with acceptable accuracy 
and precision. However, smallest amounts of pregnenolone 
that could be detected in the biological samples were in 
the order of 20-30 ng because of the loss of pregnenolone 
during oxidation and purification. 
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Table 2.I Accuracy and precision in the estimation of pregnenolone added to 
water using gas-liquid chromatography with electron capture 
detection of 4-pregnene-3,6,20-trione 
ng pregnenolone ng pregnenolone n c.v. 
known found ~ S.D. ( %} 
0 0. 9 ~ 0.6 15 66.6 
10 13.9 + 1.5 6 10.8 
50 55.7 + 11 . 2 21 20.1 
100 104.5 ~ 15.9 16 15. 3 
2.3.2.2. Radioimmunoassay 
A radioimmunoassay technique for estimating pregnenolone 
was developed in collaboration with H.L. Verjans. New 
Zealand white rabbits were immunized against pregnenolone-
3-hemisuccinate/bovine serum albumin and three months after 
the initial immunization an antiserum was obtained, which 
was suitable for use in the radioimmunoassay. Pretreatment 
of this antiserum before use was exactly as described for 
the antiserum against testosterone (213). Pregnenolone was 
extracted from hornogenates and subcellular fractions with 
ethyl acetate after addition of 20,000 dpm (16- 3H]-pregne-
nolone as an internal standard. Extracts either were puri-
fied with paper chromatography using a Bush A II system or 
were directly used for radioimmunoassay. For the radioimmu-
noassay suitable aliquots of the pregnenolone containing 
extracts were added to 10 ml glass tubes {10-250 ~1 were 
added plus 20,000 dprn [ 16- 3H}-pregnenolone as a second 
internal standard) in addition to 250 ~1 of a buffer con-
sisting of 8 rnM sodium phosphate, pH 7.2, 140 rnM NaCl, 
0.05% human y-globuline and 0.06% bovine serum albumin and 
containing 1 in 10,000 diluted antiserum. The contents of 
the tubes were incubated for 16 h at 4°C. Four tubes con-
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taining buffer and internal standard, but no antiserum, were 
assayed to determine non-specific binding. Bound and free 
pregnenolone were separated by a dextran-coated charcoal 
adsorption technique (213). Calibration curves were obtained 
with known amounts of pregnenolone in the range of 192 to 
960 pg. Non-specific binding in the absence of antiserum 
was 0.62% + 0.21 (mean value~ S.D., n=30). Data on the 
precision of estimation of known amounts of pregnenolone 
using radioimmunoassay without extraction and chromatogra-
phy of the pregnenolone are summarized in table 2.II. 
Table 2.!1 Precision of the calibration curve of radioimmunoassay obtained 
with known amounts of pregnenolone 
pg pregnenolone [3H] -pregnenolone c.v. 
added bound in 
' 
(n=l2} I >I 
mean S.D. 
0 40.5 2. l 5. l 
192 24.9 0. 9 3.6 
384 17.7 0. 8 4 . 5 
600 13.7 1.2 8. 7 
720 11.8 0. 8 6.7 
960 9. 3 0. 9 9.6 
Accuracy of the method was assessed by replicate estima-
tions of known amounts of pregnenolone extracted from a 
sucrose (0.25 M) - EDTA (1 mM) mixture. Table 2.III shows 
mean values and coefficients of variations. The data show 
a good correlation between the amounts of pregnenolone 
added and amounts estimated. 
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Table 2.III Accuracy and precision of radioimmunoassay of pregnenolone 
extracted from 0.25 M sucrose, containing 1 mM EDTA 
ng pregnenolone ng pregnenolone S.D. c.v. 
added to n found (mean} (ng} I%) 
sucrose 
-
EDTA 
0 20 0.03 o.os 166 
4.8 6 4,4 0. 7 15 
9. 6 18 8.0 1.1 13 
24 18 22.3 2. 2 10 
48 17 45.2 3.6 8 
96 17 89.6 7.0 8 
Recovery of pregnenolone after extraction from biological 
samples was 102% + 2% (mean values~ S.D., n=30). The pre-
cision of the radioimmunoassay was estimated by measuring 
pregnenolone in the same biological samples at 5-8 diffe-
rent days (see table 2.IV). The interassay coefficient of 
variation was in the order of 5 to 11%. 
Table 2.IV Precision of the radioimmunoassay of pregnenolone in biological 
samples. Each sample was analyzed at 5-8 different days. 
Interassay mean~ S.D. and interassay coefficient of variation 
are given 
sample 
number 
4 
6 
amount of 
pregnenolone 
estimated (ng} 
4 7. 0 
4 7. 2 
71.9 
144.3 
149.9 
156 . 1 
number 
of 
assays 
5 
5 
7 
8 
8 
8 
S.D. c.v. 
(ng) I %1 
3. 7 8 
3. 6 8 
3. 8 5 
15. 2 11 
16. 2 11 
8. 3 5 
27 
Table 2.V shows data on the intra-assay precision. The 
amount of pregnenolone in each biological sample was esti-
mated in sixfold. The coefficient of variation of the mean 
values was 4 to 17%. 
Table 2.V Precision of the radioimmunoassay for estimation of pregnenolone in 
biological samples. Replicate assays of each sample were performed 
'" 
the same series of assays on the same day. Intra-assay mean 
:': S.D. and intra-assay coefficient of variation are given 
sample amount of number of S.D. intra-assay c.v. 
number pregnenolone replicate (ng) (%) 
estimated {ng) assays 
I 30.3 6 5 .1 16 . 8 
II 4 6. 8 6 5. 3 11. 4 
III 78.3 6 5. 6 7 .l 
IV 81.6 6 12. 3 15. 1 
v 155.8 6 6. 6 4. 2 
VI 355.7 18.3 5 .1 
The specificity of the antiserum was tested by comparing 
the ability of various steroids to displace [ 3H]-pregneno-
lone from the antibody and was expressed as percentage 
cross-reaction i.e. the amount of a certain steroid that 
displaces 50% of [ 3H)-pregnenolone relative to the amount 
of pregnenolone that displaces 50% of the { 3HJ-pregnenolone. 
The following data were obtained: pregnenolone, 100%; 
cortisol, 29%; estradiol-176, 21%; progesterone, 12%; 
dehydroepiandrosterone, testosterone, cholesterol, 5a-
dihydrotestosteronei l7a-hydroxyprogesterone, llS-hydroxy-
progesterone, corticosterone and cyanoketone1 <1%. 
For actual samples# specificity was also evaluated by 
comparison of the estimates of pregnenolone concentrations 
measured by the radioimmunoassay technique with results 
obtained with gas-liquid chromatography for estimation of 
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pregnenolone. The results of radioimmunoassay and gas-liquid 
chromatographic estimations showed a good correlation 
(r~0.96, n~29). 
In studies with isolated mitochondrial fractions, cyano-
ketone was added to the incubation medium to prevent 
further conversion of pregnenolone. Under such conditions 
the main steroid produced is pregnenolone and interfering 
steroids are almost completely absent. 
The use of a radioimmunoassay technique for estimation 
of pregnenolone has two important advantages, when compared 
with a gas-liquid chromatographic technique: 
1. almost no loss of pregnenolone occurs during preparation 
of the samples for radioimmunoassay, whereas at least 85% 
of pregnenolone is lost during purification and oxidation 
to 4-pregnene-3,6,20-trione for gas-liquid chromatography. 
Therefore,the overall sensitivity of detection of pregneno-
lone using radioimmunoassay technique is 10-20 times higher 
than the sensitivity of gas-liquid chromatography. 
2. the radioimmunoassay is much less laborious and time-
consuming than the gas-liquid chromatographic technique. 
Previously DiPietro and coworkers (47) and Abraham 
et al. (1) have described radioirnmunoassays for estimation 
of pregnenolone. Sensitivity and precision of the described 
assays are comparable with the assay employed in this 
thesis. The specificity of the antisera used by these 
authors appeared, however, higher. 
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CHAPTER 3. LOCALIZATION OF STEROID PRODUCTION IN RAT TESTIS 
3.1. Introduction 
The early observations of Berthold in 1849 (19) and 
Bouin and Ancel in 1903 (24) indicated the production of a 
compound with 11 androgenic activity" in the testicular 
gland. However, it was not until 1935 before David and co-
workers (46) isolated this hormonal "principle" from testis 
tissue and identified the structure of the compound as tes-
tosterone. It is now generally accepted that testicular 
testosterone production is controlled by LH secreted by the 
pituitary gland (chapter 4). 
In order to restrict the discussion of the site of 
steroid formation in the testis,steroidogenesis in testicu-
lar cells might be defined as the net production of testos-
terone from sterol precursors. This implies the occurrence 
of cholesterol, of the cholesterol side-chain cleaving 
enzyme system and of steroid metabolizing enzymes related 
to the conversion of pregnenolone to testosterone in that 
particular cell type. In figure 1 a scheme for testosterone 
production from cholesterol precursors is depicted. In rat 
testis pregnenolone is converted to testosterone via pro-
gesterone, 17~-hydroxyprogesterone and androstenedione, the 
so-called 64-route (14,187,188,193,208,209). In contrast, 
the 65-pathway via 17a-hydroxypregnenolone and dehydro-
epiandrosterone appears to be an important route besides 
the 64 -pathway for androgen formation in testis of rabbit, 
dog and man (13,30,60,141,176,223). 
Initial observations on the localization of testosterone 
and its production site in the testis were restricted to 
the study of the correlation between hormone levels and 
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biological effects with microscopic examination of testis 
tissues obtained under different physiological conditions. 
From such studies it was suggested that Leydig cells in 
the interstitial compartment of the testis are the main 
source of testosterone. On the other hand, no conclusive 
data were available to definitely exclude the possibility 
that cell types in the seminiferous tubules are involved in 
steroidogenesis. In this regard, Lacy and coworkers (123) 
have suggested that the androgens required for spermatoge-
nesis are not supplied by the Leydig cells. 
The first aim of this thesis was to investigat.e the 
cellular distribution of testicular steroid production. 
Therefore, production rates from endogenous precursors by 
preparations of both testicular tissue compartments were 
determined (appendix papers I and III). In addition, the 
distribution of 38-hydroxysteroid dehydrogenase was mea-
sured between interstitial tissue and seminiferous tubules 
(appendix papers II and III). 
For a proper understanding in molecular terms of the 
hormonal regulation of testosterone formation in the testi-
cular gland, knowledge of the cellular architecture in re-
lation to subcellular localization of substrate pools, 
enzyme systems and cofactors is indispensable. Therefore, 
the second aim of the present work was to investigate the 
subcellular localization of steroid production from endo-
genous precursors. In addition, the subcellular localiza-
tion of 3S-hydroxysteroid dehydrogenase was investigated 
(appendix papers I and II). 
In sections 3.2. and 3.3. the available data on cellular 
and subcellular localization of steroid production in rat 
testis have been reviewed. 
3.2. Cellular localization of testicular steroid production 
Several authors have shown that intact interstitial tis-
sue will readily convert radioactive cholesterol to andre-
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gens (10,89). However, the conversion rate of radioactive 
cholesterol by seminiferous tubules is very low or undetec-
table (10,89,220). The selectively restricted uptake of 
cholesterol by seminiferous tubules can explain this vir-
tual lack of conversion of exogenous cholesterol (155,156). 
Irusta and Wasserman (100) have reported that a mitochon-
drial fraction from seminiferous tubules converts [ 3H]-
cholesterol to [ 3H]-pregnenolone, but no quantitative com-
parison with an interstitial mitochondrial fraction was 
made. Bass et al. (10) and Wisner and Gomes (76,220) mea-
sured the cleavage of [ 14c]-isocaproic acid from [ 26- 14c]-
cholesterol, as an estimate for side-chain cleavage acti-
vity in mitochondrial fractions obtained from interstitial 
tissue and seminiferous tubules. Since mitochondria iso-
lated from interstitial tissue are 100-1000 times more 
active {on protein basis) in cleaving the side-chain of 
{26- 14c]-cholesterol than the corresponding tubular frac-
tion, Wisner and Gomes (220) concluded that mitochondria in 
seminiferous tubules are lacking in cholesterol side-chain 
cleaving enzyme complex and that the small conversion rate 
in vitro can readily be caused by contaminating material 
from the interstitial tissue. 
Incubation studies with tracer amounts of radioactive 
cholesterol are complicated by the possibility that the 
radioactive precursor is not taken up or does not comple-
tely mix with the endogenous cholesterol pool and therefore 
the results obtained might not reflect true production 
rates. This objection does not apply if androgen production 
from endogenous substrate pools is estimated. Endogenous 
testosterone production by intact interstitial tissue {42, 
44), isolated Leydig cells (103,144) and hornogenates of 
isolated interstitial tissue {108,218 and appendix paper 
III) has been clearly established. In contrast, data on 
testosterone production by analogous preparations of semi-
niferous tubules are contradictory. Cooke et al. {42,44) 
found no androgen production by isolated intact seminife-
rous tubules, whereas de Jong (108) estimated a small, but 
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significant production of testosterone. Lacy and coworkers 
(123) have claimed that seminiferous tubules produce tes-
tosterone from endogenous substrate in at least equal 
amounts as the interstitial compartments. However 1 these 
authors only estimated testosterone concentrations after 
2 hours incubation and did not correct for zero time con-
centrations of this steroid, so that conclusions about the 
actual production of androgens by isolated seminiferous 
tubules are not possible. The production rate of testoste-
rone in homogenates of seminiferous tubules in the presence 
of cofactors is about 500 times lower than the production 
rate in homogenates of interstitial tissue (appendix paper 
III). Seminiferous tubules would contribute only 2% to the 
testosterone production of total testis tissue in vitro 1 if 
it is assumed that the interstitial compartment contains 
10% of the total testis protein (37,174). 
The first step in androgen formation from sterol precur-
sors is the conversion of cholesterol to pregnenolone. This 
step is catalyzed by the cholesterol side-chain cleaving 
enzyme complex, which, in rat testis, is localized in the 
mitochondrial fraction (see section 3.3.). The production 
of pregnenolone by isolated mitochondrial fractions 
obtained from interstitial tissue can be easily shown. The 
production rate of pregnenolone by mitochondrial fractions 
isolated from seminiferous tubules was 100-500 times lower 
(on protein basis) when compared with similar mitochondrial 
fractions from interstitial tissue (appendix papers I, II 
and III). Table 3.1 summarizes data from appendix paper III. 
In vitro production rates in homogenates and mitochondrial 
fractions from whole testis tissue, interstiti~l tissue 
and seminiferous tubules are compared with the in vivo pro-
duction rate of testosterone in rat testis as calculated by 
de Jong and coworkers (109). These data permit the conclu-
sion/ that the amount of steroids produced in vitro in pre-
parations of rat interstitial tissue is quantitatively com-
parable with the amount of testosterone produced and secre-
ted into the blood by the testicular gland in vivo. 
34 
Table 3.! Steroid production rates in vitro and in vivo 
production rate 
(nmol steroid/2 testes, hr) 1 
Whole testis tissue 
homogenate 23.7 ~ 9.6 
mitochondrial fraction 16. 0 ~ 4 • 5 
Interstitial tissue 2 
homogenate 13.6 ~ 3 .1 
mitochondrial fraction 6 .1 ~ 3. 5 
Seminiferous tubules 2 
homogenate 0.20 ~ 0.18 
mitochondrial fraction 0. 16 + 0.13 
Testosterone production 
in vivo 3 10.7 + 7. 3 
In homogenates production rate of testosterone was measured. 
In isolated mitochondrial fractions the amount of pregnenolone 
produced has been estimated. 
2 Data not corrected for losses of tissue during dissection. 
de Jong, F.H., Hey, A. H. and van der Molen, H.J. (1973) (ref. 109). 
Indirect evidence for the occurrence of enzymes cataly-
zing the conversion of pregnenolone to testosterone (3s-
hydroxysteroid dehydrogenase, 17a-hydroxylase, 17a,20-lyase 
and 176-hydroxysteroid dehydrogenase) in the interstitial 
compartment can be derived from the patterns of radioactive 
products in incubation studies with tracer amounts of 
steroid precursors ( 14,15, 37,61, 72,89, 98,167,197). From 
results obtained with the same incubation technique applied 
to seminiferous tubules, several authors have concluded 
that 3S-hydroxysteroid dehydrogenase, 17a-hydroxylase, 
17a,2Q-lyase and 176-hydroxysteroid dehydrogenase are also 
present in the spermatogenic compartment of rat testis 
(15,16,37 ,55,89,214). The poor kinetic conditions of those 
studies permit only a qualitative interpretation of the 
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results obtained and do not permit the calculation of the 
quantitative distribution of the enzymes related to andro-
gen formation in the different tissue compartments. 
In appendix paper II the quantitative distribution of 
3S-hydroxysteroid dehydrogenase was calculated, by estima-
ting the specific activity of this steroid dehydrogenase in 
both tissue compartments. At least 95-98% of the enzyme 
activity could be isolated in the interstitial tissue frac-
tion. Recently 1 Menard and coworkers {135) reported that 
70-80% of the cytochrome P450 dependent enzymes 17a-hydro-
xylase and 17a,20-lyase are present in the interstitial 
tissue compartment. Richards and Neville (167) and Henry 
and Gomes (92) found a relatively high 17s-hydroxysteroid 
dehydrogenase activity in isolated seminiferous tubules. 
Conclusions on the capability of isolated seminiferous 
tubules to produce biological active steroids depend on 
the degree of purity of the preparations of seminiferous 
tubules or cell types of this tissue compartment used in 
studies in vitro. In most studies the degree of purity or 
lack of contaminating material from interstitial tissue has 
been evaluated by histological or electron-microscopic exa-
minations. 
Early histochemical studies revealed that 3S-hydroxy-
steroid dehydrogenase was predominantly localized in the 
interstitial cells of rat testis (22). In a recent publi-
cation Hovatta and coworkers (95) established that a cer-
tain number of cells, showing positive histochemical reac-
tion for 3S-hydroxysteroid dehydrogenase can always be 
found at the peritubular tissue of seminiferous tubules 1 
separated from total testis by the wet dissection technique 
as described by Christensen and Mason (37). Those cells 
were always located outside the basement membrane and 
seemed to be identical with Leydig cells. The number of 
3S-hydroxysteroid dehydrogenase positive cells attached to 
the isolated seminiferous tubules was large enough to 
account for a significant steroid production by prepara-
tions of seminiferous tubules in vitro. From this observa-
36 
tion, the very low activities in isolated seminiferous 
tubules of both the cholesterol side-chain cleaving enzyme 
complex and the 3~-hydroxysteroid dehydrogenase can easily 
be explained by interstitial contamination. Therefore, an-
drogen formation from sterol precursors and from pregneno-
lone in the spermatogenic compartment is not very likely. 
On the other hand, the occurrence of 17a-hydroxylase, 
17a,20-lyase and 17S-hydroxysteroid dehydrogenase in some 
cell types in the seminiferous tubules cannot be ruled out 
(57,62,63). 
On basis of our present knowledge two different possibi-
lities for the sites of androgen formation in rat testis 
can be proposed. Cholesterol is converted to pregnenolone 
and progesterone in the Leydig cells of the interstitial 
tissue. Most of the progesterone is probably metabolized to 
testosterone in the same cell type. Testosterone can then 
be secreted into the blood stream and via the testicular 
lymph into the seminiferous tubules. Uptake of radioactive 
progesterone and other steroids by seminiferous tubules in 
vivo has been shown by Parvinen et al. (155,156) and 
van Doorn et al. (49). Therefore, part of the progesterone 
and/or 17a-hydroxyprogesterone and androstenedione may be 
directly secreted into the seminiferous tubules and there 
metabolized to testosterone. Both alternatives imply that 
the concentration of testosterone in the seminiferous tubu-
les is dependent on the steroidogenic activity of the in-
terstitial tissue. According to the first theory tubular 
testosterone is directly derived from interstitial testos-
terone, whereas the second theory implies an indirect 
supply of androgens via conversion of steroid precursors. 
In order to prove the validity of the second theory it will 
be necessary to show that the production rate of androgens 
inside the tubules is high enough to meet the tubular re-
quirements. Maximal production rates of testosterone in 
preparations of seminiferous tubules, free from contamina-
ting interstitial material, have to be measured and compared 
with the level of testosterone required for maintaining 
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spermatogenesis, taking into consideration the turnover of 
testosterone by catabolizing enzymes and an efflux via the 
testicular efferent duct to the epididymis. 
In conclusion, data at hand support the concept that the 
interstitial tissue compartment is the main site of andro-
gen production in rat testis. It cannot definitively be 
excluded that the small production rate of testosterone and 
low level of 3s-hydroxysteroid dehydrogenase related to the 
conversion of pregnenolone to progesterone in preparations 
of seminiferous tubules in vitro reflect contaminating 
material from the interstitial tissue. In order to solve 
this problem iso-enzyme patterns of steroidogenic enzymes 
and the presence of specific marker enzymes for both inter-
stitial tissue and seminiferous tubules have to be studied. 
3.3. Subcellular localization of steroidogenesis in rat 
testis 
Toren and coworkers (210) concluded that the cholesterol 
side-chain cleaving enzyme complex in whole testis could be 
isolated in the mitochondrial fraction. The enzyme activity 
was assayed by measuring the rate of cleavage of [ 14c]-
isocaproic acid from [ 26- 1.4c) -cholesterol. This enzyme 
system has an absolute requirement for NADPH and molecular 
oxygen (52,136,137,210). The mitochondrial localization of 
cholesterol side-chain cleaving enzyme complex is compatable 
with the results presented in appendix paper I. After isola-
tion of subcellular fractions from whole testis tissue or 
interstitial tissue, it appears that endogenous steroid pro-
duction occurs only in the isolated mitochondrial fractions. 
Therefore both the steroidogenic cholesterol pool (or at 
least an essential part of this pool) and the cholesterol 
side-chain cleaving enzyme complex must be localized in 
this subcellular fraction. 
The mitochondrial localization of this enzyme complex 
has also been reported for the adrenal gland (82) and human 
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placental tissue (131). In contrast 1 the cholesterol side-
chain cleaving enzyme complex in rat ovarian tissue appears 
to be localized in mitochondrial, microsomal as well as 
particle-free supernatant fractions (39 1 66 1 67,97). Yago and 
coworkers (221) have reported that this enzyme complex in 
bovine corpora lutea is predominantly localized in the mi-
tochondria. 
Submitochondrial localization of the testicular choles-
terol side-chain cleavage enzyme has been studied in mito-
chondria obtained from a mouse Leydig cell tumour. Moyle 
et al. (145) have reported that the enzyme complex was 
located in the mitochondrial inner membrane fraction, as 
characterized by cytochrome £ oxidase. Although complete 
separation of mitochondrial inner and outer membranes was 
not obtained, the same authors (145) concluded from the 
distribution pattern of monoamine oxidase, a specific mar-
ker for the outer membrane (181) 1 that the bulk of mito-
chondrial cholesterol was present in the outer membrane. 
Parsons and Yamo (154) obtained similar results for choles-
terol localization in guinea-pig liver mitochondria. 
Evidence derived from studies using distribution patterns 
of marker enzymes supports the conclusion that cholesterol 
side-chain cleaving enzyme complex in the adrenal gland is 
localized in the mitochondrial inner membrane (222). 
However, it was observed by Billiar et al. (20) by control-
led digestion of adrenal mitochondria by phospholipase A 
that a difference between the distribution of cholesterol 
side-chain cleaving enzyme complex and specific marker 
enzymes for mitochondrial inner membranes and the inter-
membrane space could be demonstrated. Therefore 1 these 
authors questioned the generally accepted submitochondrial 
distribution of this enzyme complex and proposed a locali-
zation in the outer membrane. 
Tarnaoki (207) states in a recent review that the conver-
sion of pregnenolone to testosterone involving 3s-hydroxy-
steroid dehydrogenase, 17a-hydroxylase 1 17a,20-lyase and 
17s-hydroxysteroid dehydrogenase occurs in the endoplasmic 
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reticulum of the testis Leydig cells. His conclusion is 
based on results with subcellular fractions not characte-
rized by specific marker enzymes in order to correct for 
mutual contamination. Since routinely 20-35% of each of 
these steroid metabolizing enzymes has been found in the 
isolated mitochondrial fraction and 65-80% in the micro-
somal fraction (188,207,209,217), it seems inaccurate to 
conclude that these enzymes are solely present in or 
attached to the endoplasmic reticulum. Results on the sub-
cellular localization of 3S-hydroxysteroid dehydrogenase 
are described in more detail in appendix paper II. From 
differences between the distribution patterns of 3S-
hydroxysteroid dehydrogenase and of carboxyl esterase, and 
from a difference in susceptibility of mitochondrial and 
microsomal 3S-hydroxysteroid dehydrogenase activity to the 
proteinase nagarse it was concluded that at least 7-15% of 
this steroid dehydrogenase is present in mitochondria. 
A bimodal localization of this enzyme has also been pro-
posed for the adrenal gland {9,45,117,133), human term pla-
centa {114} and for ovarian tissue (102,210,202). 
Sulimovici and coworkers (199) have further fractiona-
ted mitochondria obtained from whole testis tissue accor-
ding the method described by Parsons et al. (153). The 
inner membrane fraction was identified with the aid of 
succinate dehydrogenase and cytochrome c oxidase and the 
corresponding outer membrane fraction with monoamine oxi-
dase. At least 85% of mitochondrial 3S-hydroxysteroid de-
hydrogenase appeared to be localized in the inner membrane 
fraction. A point of criticism may be that most marker en-
zymes used in this study are 70-80% localized in the semi-
niferous tubules {appendix paper III) , whereas 95-98% of 
the steroid dehydrogenase investigated is present in the 
interstitial compartment. Therefore results obtained with 
mitochondrial preparations from whole testis tissue are 
difficult to interpret. 
Indirect evidence for the occurrence of 3S-hydroxy-
steroid dehydrogenase in the inner mitochondrial membrane 
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of rat adrenal cortex was obtained by Kream and Sauer (117). 
Microsomal 38-hydroxysteroid dehydrogenase showed an abso-
+ lute dependency for exogenous NAD to convert pregnenolone 
into progesterone. Mitochondria, however, converted pregne-
nolone into progesterone in the absence of added NAD+. 
Since the mitochondrial matrix space contains endogenous 
NAD+ the authors concluded that this steroid dehydrogenase 
was localized in the inner membrane and had access to the 
matrix space. Moreover, progesterone formation from preg-
nenolone in mitochondria was almost completely inhibited by 
the addition of citric acid cycle substrates, most likely 
by reducing the intramitochondrial NAD+, since these sub-
strates had no effect on microsomal 38-hydroxysteroid de-
hydrogenase. Depending on the intrarnitochondrial adenine-
dinucleotide redox potential, the end product of the mito-
chondrial cholesterol side-chain cleaving that leaves the 
mitochondrion could be either pregnenolone or progesterone. 
Considering that the formation of pregnenolone by mitochon-
drial side-chain cleaving of cholesterol depends on the 
level of reduced NADPH in the matrix space and is stimula-
ted by various citric acid cycle intermediates (203), it 
seems likely therefore that under conditions when mitochon-
drial pregnenolone synthesis is stimulated, most of this 
steroid is converted to progesterone outside the mitochon~ 
dria. 
A possible bimodal localization of 17a-hydroxylase, 
l7a,20-lyase and 178-steroid dehydrogenase remains to be 
elucidated. 
The submicrosomal localization of· 38-hydroxysteroid de-
hydrogenase, 17a-hydroxylase, l7a,20-lyase and 178-hydroxy-
steroid dehydrogenase has been extensively investigated by 
Inano and coworkers (207}. Electron-microscopic examination 
of submicrosomal fractions obtained after sucrose-CsCl gra-
dient centrifugation revealed the presence of a fraction 
with a smooth-surface membrane structure and a second frac-
tion with membrane structures with ribosomal particles on 
the outer surface. Biochemical analysis showed that the 
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bulk of RNA was localized in the rough-surfaced microsomal 
subfraction whereas cytochrome P450 enzymes related to the 
conversion of pregnenolone to testosterone were predomi-
nantly present in the smooth-surfaced microsomal subfrac-
tion (99,207). 
Shikita and colleagues (99,187,188,207,209) have repor-
ted the presence of an unknown factor in the particle-free 
supernatant that stimulated the activities of the enzymes 
related to the conversion of pregnenolone to testosterone. 
This factor is heat-stable (99) and is not involved in 
regeneration of respectively NAD+ and NADPH (187,188), co-
factors for respectively 36-hydroxysteroid dehydrogenase 
and !?a-hydroxylase, 17a,20-lyase and 176-hydroxysteroid 
dehydrogenase. The chemical nature and the physiological 
significance of this factor remains unknown. In appendix 
paper II no evidence could be obtained for the existence of 
such a cytoplasmic factor, neither from the total recovery 
of this steroid dehydrogenase activity estimated in subcel-
lular fractionation studies, nor from recombination of a 
particle-free fraction with aliquots of a microsomal frac-
tion. 
In summary it appears well established that the rate-
limiting step in androgen formation, that is the conversion 
of cholesterol to pregnenolone, is mitochondrially locali-
zed. Data in appendix papers I-IV show that both the meta-
bolic active precursor pool and the cholesterol side-chain 
cleaving enzyme complex are present in this subcellular 
fraction. Although isolated mitochondrial fractions in vitro 
produce in addition to pregnenolone significant amounts of 
testosterone, it is not possible to conclude that mitochon-
dria in vivo synthetize androgens without cooperation of 
enzymes localized in the endoplasmic reticulum required for 
the conversion of pregnenolone to testo~terone. For 
example, data in appendix paper II show that a small part 
(7-15~) of 36-hydroxysteroid dehydrogenase in rat testis 
is present in mitochondria. Therefore, statements (207) 
that the endoplasmic reticulum is the only site for the 
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conversion of pregnenolone to testosterone must be con-
sidered with caution. 
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CHAPTER 4. HORMONAL REGULATION OF RAT TESTICULAR 
STEROIDOGENESIS 
4.1. Introduction 
Specific peptide hormones from the pituitary gland ini-
tiate, maintain and stimulate testicular steroidogenesis 
(58,59,84,85). LH (or ICSH) stimulates the production of 
androgens in the testis in vivo as well as in vitro. In 
addition, a supplementary role of follicle stimulating hor-
mone and prolactin in the control of testicular steroid 
production and secretion has been suggested (7,62,78-80, 
104,136). 
Investigations concerning the hormonal regulation of 
testicular steroidogenesis have dealt with two main aspects 
of trophic stimulation of the testicular gland: short-term 
and long-term effects of trophic hormones. According to 
Hall (85) 11 short-term" effects are limited to effects on 
steroid production within 1 hour after addition of the 
trophic hormone to the animal or to the incubation medium. 
Effects observed after 1 hour arc considered "long-term" 
effects. 
In general, the acute effect of gonadotrophins may be 
restricted to intracellular changes in enzyme activities, 
in supply of cofactors and of substrates for the enzyme 
system responsible for the production of testosterone. 
Long-term effects of trophic hormones are a significant 
increase in testicular protein and in activities of enzymes 
related to steroidogenesis, and in tissue growth. 
Investigation of the effect of long-term treatment with 
trophic hormones on testicular steroidogenesis was one of 
the aims of the present thesis. Adult rats with intact 
pituitaries were injected with HCG daily for 5 days. In 
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this way, the effects of superimposing exogenous trophic 
hormones over a long time on endogenous circulating LH 
were investigated. Most data presented in the literature on 
long-term administration of trophic hormones on testicular 
growth and on steroid production have been derived from 
studies with immature or hypophysectomized animals. Chronic 
treatment of immature rats with trophic hormones results in 
an increased androgen production and in increased levels of 
cholesterol side-chain cleaving enzyme complex and of 
enzymes related to the conversion of pregnenolone to tes-
tosterone {50,70,136,182,186). In essence, the acceleration 
of the development of testicular steroidogenesis during 
maturation has been compared with the experimental results 
obtained after long-term treatment of immature rats with 
qonadotrophins. 
Administration of LH or HCG to hypophysectomized adult 
rats stimulates testosterone secretion in vivo, as well as 
testosterone production in vitro and elevates the amount of 
enzymes related to steroidogenesis {2,50,62 1 78-80,87,136, 
164,165,177 ,196). This type of study has clearly established 
that the maintenance of testicular steroid production 
depends on the presence of a specific pituitary hormone 
{i.e. LH) in the blood and that exogenous gonadotrophins 
are able to replace endogenous hormones in their trophic 
action on the testicular gland. 
The effect of chronic administration of trophic hormones 
on steroidogenesis in testis from adult rats with intact 
pituitaries is discussed in section 4.2. 
The scheme for the molecular mechanism of the acute 
action of LH on testosterone production in the testis is 
mainly based on data obtained in studies on the adrenal 
gland. It is generally accepted that receptor sites for 
trophic hormones are present at the plasma membrane of 
target cells. Binding of the hormone by the receptor 
results in an activation of adenylate cyclase activity, 
localized in the cell membrane 1 which in turn will increase 
intracellular cyclic AMP concentrations. This cyclic nucleo-
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tide can activate protein kinase activity, after binding to 
a specific receptor. It has been suggested that enhanced 
protein kinase activity may cause an increased phosphoryla-
tion of a ribosomal compound resulting in the formation of 
a labile protein. On the other hand activation of a newly 
synthetized protein cannot be excluded. This hypothetical 
labile protein factor may stimulate the transfer of choles-
terol accumulated in the cytoplasma to the enzyme system, 
localized in mitochondria catalizing the conversion of 
cholesterol to pregnenolone (see ref. 183 for an extensive 
review). The significance of this concept for the hormonal 
stimulation of testicular steroidogenesis is discussed in 
section 4.3. 
In the present thesis the acute effect of LH on testicu-
lar androgen formation has been investigated. Special atten-
tion has been given to the role of mitochondrial pregneno-
lone formation as the rate-limiting step in testicular tes-
tosterone production. The estimation of endogenous steroid 
production rates in homogenates and in subcellular frac-
tions offered the possibility to compare steroid production 
rates from endogenous substrates in vitro and in vivo after 
acute trophic hormone stimulation. In addition, the rapidity 
of the increase of production rates in vitro after hormonal 
stimulation in vivo was compared with the increase observed 
in vivo (see appendix paper IV). Finally, a possible role 
of ca 2+ in the regulatory mechanism of the acute effect of 
trophic hormones on steroid formation has been investigated 
(chapter 5). 
4.2. Long-term effects of trophic stimulation 
It has been reported that the conversion of [ 14c]-acetate 
to [ 14c]-testosterone in slices of rabbit testis was stimu-
lated after administration of ICSH for 3 days (86), but no 
effect on the conversion of labelled cholesterol to testos-
terone in rabbit testis homogenates was observed (87). 
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Long-term administration of HCG had only a stimulatory 
effect on the enzymic activity of 3S-hydroxysteroid dehy-
drogenase, 17a,20-lyase and Sa-steroid reductase, estimated 
in testicular microsomal fractions of rats younger than 
22 days (186). Shikita and Hall (186) therefore proposed 
that testes of rats older than 22 days are under the in-
fluence of high levels of endogenous gonadotrophins, which 
maintain a maximally stimulated enzyme activity. De Jong 
and coworkers (108,109) have 1 however 1 shown that treatment 
with HCG for 5 consecutive days increased the testosterone 
concentration in rat testicular venous plasma, although it 
has also been reported that testosterone levels in periphe-
ral plasma were not elevated after 3.5 days of LH admini-
stration (62). These results might have been caused by dif-
ferences in the turnover or clearance of circulating tes-
tosterone and/or injected trophic hormone. Long-term HCG 
treatment in vivo caused a decreased testosterone produc-
tion by decapsulated rat testis in vitro (108). In con-
trast1 it was shown in appendix paper III that the same 
prolonged treatment with HCG stimulated testosterone pro-
duction in homogenates of whole testis tissue 1 incubated in 
the presence of cofactors. From the increased pregnenolone 
production in isolated mitochondrial fractions, it was con-
cluded that HCG stimulates testicular androgen formation by 
activating the mitochondrial processes involved in steroid 
production. Purvis et al. (165) have reported that prolon-
ged HCG treatment of intact adult rats will increase the 
amount of mitochondrial cytochrome P450 , an essential com-
ponent of the cholesterol side-chain cleaving enzyme com-
plex. Long-term HCG administration will specifically stimu-
late steroid production in the interstitial compartment of 
the testis (appendix paper III). Although the total amount 
of interstitial tissue protein was not elevated after hor-
mone treatment 1 a 40% increase in mitochondrial protein was 
observed. 
Nussdorfer and colleagues (152) investigated with stero-
logic techniques the effect of chronic administration of 
a 
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ACTH on the mitochondria of the zona fasciculata of the rat 
adrenal cortex. Up to the 9th day of hormone treatment the 
volume of the mitochondria significantly increased, whereas 
the number of mitochondria per cell was only slightly ele-
vated. After 12 days of ACTH treatment they observed a 
large increase in the number of mitochondria per cell, with 
a concomittant decrease in their average volume. Unfortuna-
tely, no data are available that allow extrapolation of 
these phenomena observed in the adrenal gland to the tes-
tis. For that reason, it cannot be concluded that the in-
crease of interstitial mitochondrial protein,cytochrome 
P450 and pregnenolone synthesis reflects the effect of HCG 
treatment either on the size of the mitochondria in the 
interstitial compartment or on the total number of mito-
chondria involved in steroidogenesis. 
In contrast with the earlier mentioned results of 
Shikita and Hall (186), prolonged HCG treatment for 5 days 
caused an increase in specific activity of 3s-hydroxysteroid 
dehydrogenase (appendix paper III) o It has been shown that 
microsomal cytochrome P450 decreased to one third of the 
level in control animals after 2 days of HCG administration 
{164) o After 4 days of HCG injections cytochrome P450 levels 
were restored to control values, and further HCG treatment 
caused a rapid increase in microsomal cytochrome P450 con-
tent. A similar pattern was observed when cytochrome P450 
dependent 17a-hydroxylase and 17a,20-lyase activities were 
determined. In contrast, the specific activity of 178-
hydroxysteroid dehydrogenase decreased slowly but consistent 
during chronic HCG treatment of intact adult rats (164) o 
Limited information is available on the effect of long-
term trophic hormone treatment on cholesterol metabolism in 
rat testis. The incorporation of radioactive acetate into 
cholesterol has been found to be increased after chronic 
HCG administration {224). Prolonged HCG treatment in combi-
nation with aminoglutethimide, a specific inhibitor of the 
cholesterol side-chain cleaving enzyme complex, resulted in 
histochemical evidence for the accumulation of lipid 
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material in the Leydig cell of puberal rat testis {151). 
The chemical nature of the accumulated material remains to 
be established, although it has been suggested that these 
lipid droplets might consist of cholesterol {esters). How-
ever, van der Molen et al. (140) could not observe any ef-
fect of HCG treatment on concentrations of free and of es-
terified cholesterol levels in homogenates of whole testis 
and isolated interstitial tissue. This may indicate that 
the accelerated cholesterol biosynthesis (224) keeps pace 
with the stimulated conversion of this compound to andro-
gens. 
To summarize, chronic treatment of adult rats for several 
days with HCG resulted in an increased testosterone produc-
tion in vivo {108,109) as well as in vitro (appendix paper 
III). The increase in androgen formation may be explained 
by an elevated pregnenolone production in mitochondrial 
fractions from the interstitial compartment. In addition, 
levels of 3s-hydroxysteroid dehydrogenase (appendix paper 
III), 17a-hydroxylase and 17a,20-lyase were increased after 
prolonged hormone treatment (164). In contrast a small 
decrease of 176-hydroxysteroid dehydrogenase activity was 
observed (164). It is shown in appendix paper III that the 
same prolonged HCG treatment did not elevate the specific 
activities of interstitial mitochondrial and interstitial 
microsomal enzymes which are not directly related to andro-
gen formation. It is concluded that chronic treatment with 
HCG results in a specific increase of enzyme levels respon-
sible for the formation of androgens in the testicular 
gland. 
4.3. Short-term effects of trophic stimulation 
4.3.1. General aspects 
Infusion of HCG via the spermatic artery of the dog 
testis resulted in an almost instantaneous increase of tes-
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tosterone secretion (57,58). Intravenous administration of 
HCG or LH to normal adult rats increased the testosterone 
concentration both in testis tissue and in testicular 
venous plasma within 20 min after injection (108,109 and 
appendix paper IV). Trophic hormone in vitro stimulates the 
conversion of labelled cholesterol to testosterone by 
slices of rabbit testis (83,88) as well as the production 
of androgens from endogenous precursors by intact testis 
tissue and isolated cells within 30 to 60 min after addi-
tion of the hormone (41,54,103,120,146,147,171,172). Rapid 
responses of steroid production to trophic hormones have 
also been observed in studies with preparations of the 
adrenal gland (11,147,168,183) and of ovarian tissue (3,4, 
170) • 
In recent years more experimental evidence has been ob-
tained about the intracellular mechanism of action of LH in 
the testicular gland. Therefore, an attempt can now be made 
to discuss the validity of the general working hypothesis 
given in section 4.2. for the action of trophic hormones on 
steroidogenesis in the testicular gland. 
4.3.1.1. Receptors for gonadotrophic hormones 
The occurrence of receptor sites for HCG and LH in rat 
testis have been described (34,35,53). Binding of labelled 
LH and HCG occurs mainly in the interstitial compartment of 
the testis (68,118,126). According to the working hypothe-
sis trophic hormone receptors should be present at the 
plasma membrane and functionally related to the adenylate 
cyclase, localized at the inner side of the Leydig cell 
membrane. However, Pulsinelli and Eik-Nes (163), Hollinger 
(94) and Sulimovici and coworkers (200,206) have reported 
the presence of adenylate cyclase activity in isolated 
mitochondrial fractions obtained from dog (94,163) and rat 
testes ( 200,206) • 
50 
4.3.1.2. Cyclic AMP as second messenger 
HCG and LH can increase intracellular cyclic AMP concen-
tration in whole testis, in dissected interstitial tissue 
and in isolated partially purified Leydig cells (40,103, 
172,173,174,178). Since the increase of intracellular 
cyclic AM_P concentration precedes the elevation of steroid 
production (171,173) and since cyclic AMP and dibutyryl 
cyclic AMP have shown to stimulate testosterone production 
in vitro (38,178), it has been suggested that this cyclic 
nucleotide is the intracellular ("second") messenger in 
trophic hormone stimulation of testosterone production 
(see for review ref. 173). 
Recent publications have cast a doubt on the obligatory 
and unique role of cyclic AMP as the second messenger in 
the sequence of intracellular events provoked by trophic 
hormones. A large discrepancy was observed between the 
amount of LH required to stimulate testosterone production 
and to elevate the intracellular concentration of cyclic 
AMP (44,146,161). Low amounts of LH stimulated testosterone 
production whereas no significant effect on cyclic AMP con-
centration was observed. This may indicate that hormonal 
control of steroidogenesis under certain conditions is not 
mediated by cyclic AMP, but by other unknown cellular fac-
tor(s). Beall and Sayers (11) have reported a similar ob-
servation during stimulation of corticosteroid production 
in isolated adrenal cells by low doses of ACTH. However, 
failure to demonstrate an increase in the concentration of 
cyclic AMP may simply reflect the inadequacy of the assay 
techniques used for the estimation of the cyclic nucleotide. 
Moreover, a multiple intracellular compartmentation of 
cyclic AMP may exist, whereas only one of those compart-
ments, comprising a small fraction of total cellular cyclic 
AMP, may be involved in the activation of steroid produc-
tion. Recently, Schulster and coworkers (130,184) and 
Nakamura et al. (149) have shown that stimulation of corti-
costeroid production by low amounts of ACTH is always pre-
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ceded by a small, but significant increase in cyclic AMP 
concentration. In their opinion, there is no strong evidence 
that cyclic AMP does not act as second messenger in hormonal 
stimulation of steroidogenesis. 
A direct in vitro effect of cyclic AMP on 3B- and 176-
hydroxysteroid dehydrogenases in rat testis has been repor-
ted (27,204). The concentration of cyclic AMP used in these 
studies were in the millimolar range, whereas cyclic AMP in 
interstitial tissue after LH stimulation is present in 
micrornolar concentrations (172). Although an accumulation 
of cyclic AMP at the enzymatic site cannot be excluded it 
does not appear very likely that these inhibitory effects 
have a physiological meaning. Data of Catt and coworkers 
(36) do not favour the possibility that cyclic AMP will 
inhibit steroid metabolizing enzymes because most of cyclic 
AMP produced by trophic stimulation is extruded from the 
cell and can be recovered in the incubation medium. 
4.3.1.3. Protein kinase activity 
The presence of cyclic AMP dependent protein kinase ac-
tivity in rat testicular interstitial tissue has been es-
tablished {18,43,161). Exogenous histone is generally used 
as a substrate for estimation of protein kinase activity. 
In order to elucidate an obligatory role of protein kinase 
in the stimulating action of LH on androgen production, 
phosphorylation of specific endogenous protein(s) in the 
Leydig cell has to be shown. Murakami and Ichii (148) have 
reported that ACTH treatment in vivo activates the incorpo-
ration of radioactively labelled phosphate into mitochon-
drial, microsomal as well as cytosol protein in the adrenal 
gland. The nature of the phosphorylated compounds has not 
been further investigated. However, no data are available 
which demonstrate that LH activates the phosphorylation of 
endogenous proteins in rat testis, resulting in a drastic 
change in either biological or enzymatic activity of the 
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phosphorylated protein factor. 
4.3.1.4. Synthesis of ''labile'' proteins 
Studies carried out with inhibitors of protein synthesis 
have provided indirect evidence that newly synthetized pro-
teins play an important role in trophic stimulation of 
steroid production in rat testis {41,86 and appendix paper 
IV). It was found that cycloheximide and puromicine, speci-
fic inhibitors of ribosomal protein synthesis in the endo-
plasmic reticulum (158), prevented the trophic stimulation 
of androgen production. Chloramphenicol, an inhibitor of 
mitochondrial protein synthesis, seemed to be without ef-
fect on testosterone production in isolated Leydig cells 
(103), although Hall and Eik-Nes (86) have reported that 
chloramphenicol inhibited the incorporation of labelled 
acetate into testosterone in slices of rabbit testis. 
Until now, attempts to show a stimulating effect of LH 
on protein synthesis in various preparations of intact 
adult rats have been unsuccessful. This experimental result 
may support the theory that LH acts by activating newly 
synthetized protein(s) although it cannot be ruled out that 
the present assay methods are not adequate enough to detect 
the increased synthesis of a particular protein. 
Cooke et al. (41) have calculated that the decay half-
life of the newly synthetized protein involved in stimula-
ted testosterone formation is less than 13 minutes. A pro-
tein factor with a rapid turnover rate involved in hormone 
stimulated steroidogenesis has also been postulated for 
ovarian tissue (5) and adrenal cells (183). 
4.3.2. Role of mitochondria in testicular steroidogenesis 
It is generally accepted that the conversion of choles-
terol to pregnenolone, which is restricted to mitochondria, 
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is rate-limiting in overall testosterone production (85). 
The ultimate locus of hormonal stimulation of androgen pro-
duction may therefore be present in this particular subcel-
lular fraction. The results reported in appendix paper IV 
have clearly established that stimulated testosterone pro-
duction after LH treatment is caused by increased pregneno-
lone formation from endogenous precursors in the mitochon-
dria. Experimental data concerning the essential link be-
tween hormonal stimulated events in the cytosol of the Ley-
dig cell and the increased conversion of cholesterol into 
pregnenolone are still limited. 
The production of pregnenolone in the mitochondrion is a 
result of the activity of a highly integrated system, in-
volving an enzyme complex in the inner mitochondrial mem-
brane, a steroidogenic cholesterol pool, molecular oxygen 
and NADPH. The enzyme system, (the so-called cholesterol 
side-chain cleaving enzyme complex) has been shown to con-
tain cytochrome P450 and an iron-sulfur protein: "testo-
doxin" (analogous to adrenodoxin in adrenal mitochondria 
{96,203)) as well as an FAD-containing protein: NADPH-
''testodoxin'' reductase (132) . 
No experimental evidence exists to conclude that short-
term treatment with trophic hormones increases the concen-
tration of one of those components of the cholesterol side-
chain cleaving enzyme complex. In contrast, prolonged hor-
monal treatment for 5 consecutive days was necessary to 
show an elevated content of mitochondrial cytochrome P450 
(132,165). 
The biochemical mechanism of cleaving the side-chain of 
cholesterol, resulting in the formation of pregnenolone and 
isocaproic acid, is not completely elucidated (31,183,204) 
Hydroxylation of the carbon atoms at 20- and at 22-posi-
tions (32,33,48,169,189), formation of 20a.-peroxide (128) 
or a direct desaturation of 20-22 carbon bond, resulting in 
a ~20-22 cholesterol (116) has been proposed as the first 
step in splitting the side-chain in adrenal mitochondria. 
Independent of the exact mechanism involved, investigations 
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with adrenal mitochondria have revealed that the rate of 
association of cholesterol with cytochrome P450 may be 
rate-limiting in overall pregnenolone formation (29,111, 
191). Since all these factors are required for the biosyn-
thesis of pregnenolone, LH can theoretically exert its 
stimulating effect via one or a combination of the follo-
wing factors: 
1. enhancement of the supply of molecular oxygen for the 
enzyme system. 
2. net change in intramitochondrial NADPH/NADP+ ratio. 
3. release of pregnenolone from the mitochondria to prevent 
feed back inhibition by this steroid of cholesterol 
side-chain cleaving enzyme activity (115). 
4. an increase of rate of association of cholesterol with 
cytochrome P450 , through a stimulation of the intrami-
tochondrial transfer of cholesterol from a metabolically 
inert pool to a steroidogenic pool as well as by an in-
crease of the supply of cholesterol from extramitochon-
drial sources. 
ad 1: The increased blood flow through the testicular gland 
under influence of gonadotrophins resulting in an elevated 
o 2 supply to the hydroxylation chain has been proposed as a 
possible explanation of hormonal stimulated androgen forma-
tion (85). Hamberger and Steward (90) reported that LH 
stimulated oxygen consumption by interstitial cells. Since 
the increase in oxygen consumption has not been stoechio-
metrically correlated with an increase in testosterone for-
mation, the observed phenomenon may reflect more a positive 
effect of trophic hormones on the total metabolic state of 
the interstitial cells than a driving force for the conver-
sion of cholesterol into pregnenolone. 
ad 2: The concept that trophic hormone action is mediated 
by changes in NADPH/NADP+ in cytosol and matrix space of 
the mitochondria of the steroid producing cell has been 
considered for a long time. According to the original 
55 
scheme of Haynes and Berthet (91) the metabolism of glucose-
6-phosphate via the pentose phosphate pathway enhanced the 
availability of NADPH for steroidogenesis. Since cyclic AMP 
is involved in the activation of phosphorylase activity 
(91) it was suggested that trophic hormones can stimulate 
steroid production by elevating the amount of glucose-6-
phosphate originating from the breakdown of glycogen. The 
inner mitochondrial membrane is impermeable for NAD(P)H 
(77). However, it is now known, that reducing equivalents 
of cytoplasmic NAD(P)H can be transported across the inner 
mitochondrial membrane via shuttle mechanisms {see review 
138). Moreover, the presence of "malic" enzyme in mitochon-
dria of various steroidogenic cell types (143,159,160,190, 
198) provides a second mechanism to raise intramitochon-
drial NADPH/NADP+ ratios. Although data concerning the 
involvement of NADPH in trophic stimulation of testicular 
steroid production are limited compared with the adrenal 
gland, some experimental evidence has been provided that 
glycolysis and Krebs cycle activity may be related to 
gonadotrophic stimulated androgen production. The increase 
in testosterone production from endogenous substrates by 
interstitial tissue in the presence of LH was greater when 
glucose was added to the incubation medium (172). Isolated 
mitochondrial fractions convert more labelled cholesterol 
to pregnenolone and produce more pregnenolone from endoge-
nous substrates in the presence of Krebs cycle intermedia-
tes (23, and section 5.2.), most probably through an ele-
vation of the intramitochondrial NADPH/NADP+ ratio. For 
testis no data are available which allow the conclusion 
that the stimulating effect of trophic hormones on steroid 
production can be explained solely by an increase of reduced 
NADPH at the rate-limiting step in androgen formation. 
ad 3: Pregnenolone can inhibit the conversion of radioac-
tive cholesterol to pregnenolone by mitochondrial prepara-
tions from bovine adrenal cortex {115), bovine corpus 
luteum (97) anO rat testis (51). Koritz and Hall {115) have 
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suggested that trophic hormones might stimulate the conver-
sion of cholesterol into pregnenolone, by increasing the 
rate of removal of pregnenolone from mitochondria. Trophic 
hormone action may induce a modification in mitochondrial 
membrane structure, causing mitochondrial swelling and con-
comittant increase of permeability for pregnenolone. There 
is, however, little experimental evidence to support this 
hypothesis. Incubation of quartered adrenal glands (64) as 
well as isolated mitochondrial fractions from the adrenal 
gland {191), from ovarian tissue (5) and from testicular 
interstitial tissue {appendix paper II) in the presence of 
cyanoketone (a specific inhibitor of 3S-hydroxysteroid 
dehydrogenase activity (74)), resulted in an accumulation 
of pregnenolone. Under these conditions no inhibition of 
pregnenolone formation was observed. Johnson and Nelson 
(105) have reported that addition of albumin to the incuba-
tion medium caused a transfer of endogenous pregnenolone 
from adrenal mitochondria to the medium, without affecting 
the production rate of pregnenolone. In appendix paper IV 
it was shown that LH treatment in vivo of normal adult 
rats caused a five times increase in pregnenolone concen-
trations in isolated testicular mitochondrial fractions. 
Despite the mitochondrial accumulation of pregnenolone, in 
vitro production rates of pregnenolone by mitochondrial 
fractions isolated from hormone stimulated testis were 
increased when compared with relevant control samples. 
Therefore, it is not very likely that release of pregneno-
lone from the mitochondria is an important factor in con-
trol mechanism of steroidogenesis. 
ad 4: Metabolism of cholesterol as related to steroid pro-
duction has been extensively explored in the adrenal gland 
and ovarian tissue. The generally accepted hypothesis con-
cerning the role of cholesterol dynamics in regulating 
steroid- production has been formulated in great detail by 
Garren and coworkers (73) and by Boyd and Trzeciak (26). 
ACTH stimulates the hydrolysis of esterified cholesterol, 
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accumulated in lipid storage particles in the cytosol (26, 
73). Activation of cholesterol esterase activity by ACTH 
treatment has been established (26,211). Trzeciak and Boyd 
(211) have presented strong evidence that cholesterol este-
rase activity can be regulated by cyclic AMP. Hormonal ac-
tivation of the hydrolysis of esterified cholesterol in the 
lipid droplets appears to be a cycloheximide-insensitive 
process (73). This may indicate that the hypothetical pro-
tein compound is not involved in this particular step of 
cholesterol metabolism. The accumulation of free choleste-
rol in the lipid droplets which results after cycloheximide 
administration (73) indicates that the transport of free 
cholesterol from the storage particles to the mitochondria 
requires a newly synthetized protein factor. Farese (63) 
was able to isolate from supernatant fractions of ACTH 
stimulated adrenal quarters a protein moiety that showed a 
small, but significant stimulation of steroid production by 
mitochondrial fractions isolated from control adrenal 
quarters. However, there is no information about possible 
cholesterol binding properties of this protein factor. Kan 
et al. (112,113,212) have reported about a cholesterol bin-
ding protein in preparations of adrenal mitochondria, 
which was capable to enhance the conversion of cholesterol 
to pregnenolone in incubations of acetone powders of adre-
nal mitochondrial fractions. However, no change in the 
level of this protein compound after ACTH treatment of 
intact or hypophysectomized rats was observed (113). Elec-
tron microscopic studies (73,119,185) have revealed that 
mitochondria and the abundant lipid droplets in adrenal 
cells are in close contact with each other and ACTH treat-
ment resulted in a fusion of these subcellular particles 
(119,185). A possible role of a labile newly synthetized 
protein factor in this fusion process remained unclear. 
On the other hand, an intramitochondrial shift of choles-
terol from a metabolically inert cholesterol pool to cyto-
chrome P450 , an essential component of cholesterol side-
chain cleaving enzyme system, may occur by trophic stimula-
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tion (29,111,191). Since no change in total mitochondrial 
cholesterol concentration after in vivo ACTH treatment was 
observed (191), cholesterol supply from extramitochondrial 
sources must be in equilibrium with the trophic hormone in-
duced intramitochondrial substrate shift and subsequent 
increased conversion to pregnenolone. It is doubtful 
whether this scheme for activation of adrenal steroid pro-
duction can be applied integrally to the mechanism of ac-
tion of LH on androgen formation in the testis of the rat. 
In striking contrast with the adrenal gland and ovarian 
tissue, very few lipid droplets and esterified cholesterol 
are present in the steroidogenic compartment of rat 
testis (see table 4.I). The concentration of free choleste-
rol, however, is comparable (73,140,157). Free cholesterol 
is predominantly localized in the mitochondrial and micro-
somal fractions (140,215). No acute effect of LH adminis-
tered in vivo on free cholesterol as well as on esterified 
cholesterol in isolated interstitial tissue could be obser-
ved (140), although under such conditions testosterone 
levels in testicular venous plasma (109 and appendix paper 
IV) and in testicular tissue are elevated and rates of mi-
tochondrial pregnenolone production are increased (appendix 
paper IV). This discrepancy can be explained by the fact 
that the theoretical amount of cholesterol required for 
steroid production is rather small (table 4.I). Therefore, 
in contrast with the adrenal gland dramatic changes in 
cholesterol levels in rat testis tissue cannot be expected. 
No experimental data are available, which allow the defini-
tive conclusion that LH stimulates testicular steroid pro-
duction either by an increased transport or supply from 
extramitochondrial sources to the mitochondrion, or by an 
intramitochondrial shift of a large inert cholesterol pool 
to the cholesterol side-chain cleaving enzyme complex. 
With respect to the cholesterol ester content of testis 
tissue, it is of interest that differences exist between 
rats and mice which are normally used for laboratory work. 
In mouse testes the cholesterol esters account for 10-40% 
59 
"' 0 
Table 4.1 Concentrations of free and esterified cholesterol in rat adrenal cortex and rat testis interstitial 
tissue and pregnenolone production rates from endogenous substrate by isolated mitochondrial 
fractions 
Homogenate 
free cholesterol (nmol/mg protein} 
esterified cholesterol (nrnol/mg protein} 
% esterified cholesterol 
~itochondrial fraction 
free cholesterol {nmoljmg mitochondrial 
protein) 
pregnenolone production (nmol/mg 
mitochondrial protein, 10 min) 
Adrenal cortex 
50 
400 - 450 
90 
10 - 15 
2 - 5 
Tissue 
(73) 
( 26 1 7 3) 
(26,191) 
(26,191} 
Interstitial tissue 
20 
0.3 
l. 5 
25 - 100 
o.3 - o.sX: 
( 14 0) 
( 14 0) 
(215) 
( 215) 
incubation was performed at 27°C in a medium containing 0.250 H sucrose, 20 roN KCl, 10 mM potassium 
phosphate, 5.0 mM MgC1 2 , 15 mM Tris HCl (pH 7.3), 6.0 mM isocitrate and 4 ~M cyanoketone. 
lt incubation was performed at 33°C in a medi'Jm containing 0.125 _~\sucrose, 35 mM Tris HCl (pH 7.3), 
5.0 mM 1-1gc1 2 , 20 mM sodium Succinate and 0.1 ~~1 cyanoketone. 
Numbers between brackets are references. 
of the total cholesterol (6,8,162). LH treatment in vivo 
caused a significant decrease in total esterified choleste-
rol content of the mouse testis (6,8). In addition, LH may 
stimulate steroid production in isolated Leydig cell tumours 
in part by increasing the concentration of free cholesterol 
within the cell, released from esterified cholesterol (162). 
This indicates that hormonal control of mouse testis 
steroid production in this respect is consistent with the 
model of Garren et al. (73) postulated for the adrenal 
gland. 
4.3.3. Conclusions 
An increase in the blood concentration of LH of adult 
male rats with intact pituitaries results in a rapid in-
crease of testicular testosterone secretion (108,109 and 
appendix paper IV). A concomittant increase in testicular 
testosterone concentration takes place, indicating an ele-
vated production of androgens in vivo by trophic hormone 
action. Testosterone production rates in whole testis tis-
sue homogenates are markedly increased when testes are re-
moved from the animal 20 min after intravenous injection 
of LH (appendix paper IV) . The increase in pregnenolone 
production estimated in isolated mitochondrial fractions is 
most probably the cause of increased testosterone forma-
tion. Increased pregnenolone production rates support the 
generally accepted theory that the mitochondrial conversion 
of cholesterol to pregnenolone is rate-limiting in steroid 
biosynthesis and that this step is the locus of acute 
trophic action. 
Table 4.II summarizes in quantitative terms data from 
appendix paper IV, reflecting the effect of intravenous in-
jection of LH on testicular testosterone production in vivo 
as well as on steroid production in vitro. Table 4.II 
clearly shows that a good correlation exists between the 
increase in amounts of testosterone synthetized in vivo 
61 
Table 4.II Acute effect of LH in vivo on testosterone production in vivo 
and steroid production in vitro 
control LH treated 
in vivo 
testosterone secretion rate 1 
(nmol testosterone/testis, 
20 min) 
testosterone concentration 2 
(nmol testosterone/testis) 
1.3 
0.35 
3. 1 
3. 5 
in vitro 
testosterone production rate 3 
(nmol testosterone/testis 
equivalent, 20 min) 
pregnenolone production rate4 
(nmol pregnenolone/testis 
equivalent, 20 min) 
1.6 
1.3 
6. 6 
4. 5 
Calculated from data in Table I, appendix paper IV, assuming that 10% of 
testosterone is bound to erythrocytes and that the.haematocrit value is 
45% (109). Values of 0.25 ml/gram testis, min for testicular blood flow 
were obtained from Jones (107) and Free and Tillson (69)·. 
Data from Table II, appendix paper IV, assuming that one rat testis 
contained 110 mg protein (appendix paper III). 
Data from Fig. 3A, appendix paper IV. Testes were removed 20 min after 
hormone injection. Testosterone production rates estimated in whole 
testis tissue homogenates. 
Data from Fig. 3B, appendix paper IV. Testes •,.;ere removed 20 min after 
hormone inJeCtion. Pregnenolone production rates were estimated in 
isolated mitochondrial fractions. 
during the first 20 min after LH injection, and steroid 
production rates in vitro estimated in preparations of 
testis, removed 20 min after injection of the trophic hor-
mane. 
Injection of cycloheximide prior to LH prevents the 
stimulating effect of LH treatment on steroid production 
estimated in vivo as well as in vitro (appendix paper IV) 
This observation may offer indirect evidence that synthesis 
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of a protein compound is involved in the hormonal regula-
tion of testicular steroidogenesis. Cooke et al. (41) cal-
culated from data obtained from superfusion experiments 
that this hypothetical protein will have a half-life of 
13 min or shorter. 
Data presented in appendix paper IV and section 5.2. may 
suggest that stimulation of mitochondrial pregnenolone pro-
duction by trophic hormones is caused by an increase in 
availability of sterol substrate for the conversion to 
pregnenolone by cholesterol side-chain cleaving activity. 
Information on the molecular mechanism of hormone stimula-
tion of mitochondrial pregnenolone synthesis in rat testis 
is still limited. 
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2+ CHAPTER 5. THE ROLE OF Ca IN HORMONAL REGULATION OF 
TESTICULAR STEROIDOGENESIS 
5.1. Introduction 
Recent experimental evidence, mainly from adrenal prepa-
rations, indicates that ca2+ ions may play a key role in 
the hormonal regulation of production and secretion of 
steroids. A possible interaction between cyclic AMP and 
ca
2
+ ions in hormonal control mechanisms of a variety of 
tissues has been reviewed by Rasmussen (166). 
2+ Extracellular Ca appears to be required for the in-
crease in steroid production by rat adrenal gland in res-
ponse to ACTH (21,81). Sayers and coworkers (180) have 
suggested that the magnitude of the signal generated by 
binding of ACTH to the membrane receptor site and the 
transmission of this signal through the membrane to the 
adenylate cyclase compartment is related to the extracellu-
lar ca2+ concentration. Since the stimulation of cortico-
steroid synthesis by dibutyryl cyclic AMP was hardly affec-
2+ ted by extracellular Ca , Haksar and Peron (81) concluded 
that ca2+ has a larger effect on the events prior to the 
formation of the second messenger cyclic AMP, than on the 
events resulting from increased cyclic AMP production. In 
contrast, Bowyer and Kitabchi (25) concluded that the 
action of ca 2+ may occur both before and after the stimula-
tion of cyclic AMP. Dufau et al. (56) have reported that 
binding of gonadotrophic hormones to isolated Leydig cells 
is not influenced by ca2+ ions. The production of cyclic 
AMP and testosterone in response to gonadotrophic stimula-
tion was, however, reduced in the absence of extracellular 
ca2+ ions. 
Several important observations have been reported about 
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intracellular effects of ca2+ in steroidogenic tissue. 
Farese (64) observed that low concentrations of ca2+ ions 
can stimulate the transfer of amino acid from the amino acyl 
transfer-RNA complex to protein in cell-free preparations 
of adrenal glands. With soluble fractions from ACTH stimu-
lated adrenal cells (which contain an increased transfer 
enzyme activity) no effect of ca 2+ was observed. Moreover, 
ca 2+ can activate malic enzyme in adrenal mitochondria 
(160), but it is not clear whether ca2+ increases the avai-
lability of cytosol NADP+ for the intramitochondrially 
localized cholesterol side-chain cleaving enzyme complex 
via this mechanism. 
Mitochondria can readily concentrate ca 2+ from the sur-
rounding medium (125). Therefore, mitochondria can play a 
role in modifying the cellular ionic environment. The 
intramitochondrial ca 2+ concentration is not necessarily 
constant, but can be influenced by changes in the rate of 
ca
2+ uptake and in extramitochondrial ca2+ concentrations. 
It has been found that high extramitochondrial concentra-
tions of ca 2+ can cause a swelling of adrenal mitochondria 
in vitro with a concomittant increase in pregnenolone pro-
duction rate when NADPH is present in the incubation medium 
(93,192). Studies with isolated mitochondria from adrenal 
cortex suggest that the association of cholesterol with 
cytochrome P450 is rate-limiting in overall pregnenolone 
production rate and that ACTH increases the association 
rate of substrate and enzyme complex (29,111,192). In this 
respect Simpson et al. {192) have reported that ca2+ ions 
in vitro induce changes in cytochrome P450 difference spec-
tra similar to the changes that occur after ACTH stimula-
tion in vivo. These authors suggest that ca2+ is involved 
in a shift of intramitochondrial cholesterol from a meta-
bolic inert pool to the cholesterol side-chain cleaving 
enzyme complex. The low concentrations of cytochrome P450 
in testicular mitochondrial fractions (132), however, do 
not permit a similar type of study with testicular mito-
chondria. 
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ACTH can influence the distribution of ca2+ in the adre-
nal gland (101,127). It has been reported, that ACTH and 
dibutyryl cyclic AMP cause a significant stimulation of 
45 2+ Ca uptake by rat adrenal glands in vitro (127). Within 
5 minutes after hormone treatment a marked accumulation of 
45ca 2+ was observed in mitochondrial and microsomal frac-
tions (127). Jaanus and Rubin (101) have suggested that 
increased ca2+ levels in subcellular fractions are the 
result of a translocation and redistribution of ca2+ between 
the intracellular components, without significant uptake of 
extracellular ca2+. 
Addition of ca2+ ions will also stimulate the conversion 
of labelled cholesterol to steroids by isolated mitochon-
drial fractions of rat testis (52). In appendix paper IV it 
was concluded that LH administration to intact, adult rats 
caused a difference in mitochondrial sensitivity to ca2+. 
These preliminary observations have been extended in sec-
tion 5.2. 
5.2. Experimental results 
Adult intact rats were anaesthetized with nembutal and 
were then intravenously injected with 25 ug LH (LH treated 
testes) or with 0.2 ml 0.9% NaCl- 0.2% serum bovine albu-
min solution only (control testes). Testes were removed 
from the animal 20 min after injection. Mitochondrial 
fractions were isolated as previously described {appendix 
paper III). 
Influence of incubation time on pregnenolone production 
rates. 
Figures 1 and 2 summarize the influence of incubation 
time on pregnenolone production rates in mitochondrial 
fractions from control and LH treated testes. Figure 1 
shows a biphasic pattern of pregnenolone formation by mito-
chondrial fractions isolated in sucrose-EDTA from both con-
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Figure l Time course of the concentrations of pregnen<)lone in mitochondrial 
fractions isolated in 0.25 M sucrose, containing 1 mM EDTA,from luteinizing 
hormone treated and control testes. 
The incubation medium contained 0.125 ~1 sucrose, o.S mM EDTA, 20 mM sodium 
succinate, 5.0 m"'! Mgcl 2 , 30 rn.NI Tris-HCl {pH 7.3), 0.1 1.-M cyanoketone and 
0.7 mM Cacl 2 . &, aliquots of mitochondrial protein incubated in 2 ml incu-
bation medium only. 0, aliquots of mitochondrial protein in incubation medium 
plus 1.0 mM NADPH, 10 rn.NI glucose 6-phosphate and 0.3 unit glucose 6-phosphate 
dehydrogenase. ( --- ) solid line, 0.95 mg mitochondrial protein from control 
testes. ( --- ) broken line, 1.0 mg mitochondrial protein from luteinizing 
hormone treated testes. 
trol and LH treated testes, when incubated in the presence 
of 20 mM succinate and 0.7 mM ca2+ ions. An initial phase 
(10-20 minutes) of high pregnenolone production was followed 
by a very slow rate of production up to 120 min incubation 
time. In mitochondrial fractions obtained from LH treated 
testes production rates during the first 10 min were in-
creased when compared to relevant control samples. Produc-
tion rates after 30 min incubation were almost zero. Addi-
tion of NADPH to the incubation mixture containing succi-
nate and ca2+ ions resulted in a triphasic pattern. An ini-
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tial phase lasting 10 min of high pregnenolone production 
was followed by a slower production rate during about 20 
minutes. Thereafter a rapid increase in production rates 
by mitochondrial fractions isolated from control testes as 
well as from LH treated testes took place. The stimulating 
effect of NADPH on pregnenolone production after longer 
incubation times may result from an increased permeability 
of mitochondrial membranes for NADPH. During incubations 
lasting 10-30 min an unexpected phenomenon has been obser-
ved when NADPH was present in the incubation medium. The 
presence of NADPH resulted in lower succinate supported 
production rates of pregnenolone during short incubation 
times (figure 1). This might reflect a lower production of 
pregnenolone as well as an increased catabolism. Therefore, 
studies were performed with tracer amounts of [16- 3H]-
pregnenolone added to the incubation mixture at time zero. 
After incubation the steroid products were analyzed using 
silicagel thin-layer chromatography with trichloromethane: 
diethyl ether (85:15, v/v) as eluent fluid, and it appeared 
that during incubation in the presence of added NADPH a 
part of the radioactive steroid was metabolized to a more 
polar compound. In the absence of added NADPH little or no 
conversion of labelled pregnenolone took place (data not 
shown) . 
Figure 2 shows the effect of duration of incubation on 
pregnenolone concentrations in control and LH stimulated 
testicular mitochondrial fractions isolated in sucrose 
without EDTA. In the absence of extramitochondrial succi-
nate and ca 2+ ions control mitochondrial fractions produced 
pregnenolone only during the first 10 min of incubation. 
Thereafter production rates were almost negligible. Addi-
tion of 0.5 mM ca2+ to the incubation medium at time zero 
increased the initial production rate but had no effect on 
the production rates observed after 10 min incubation. 
Addition of 20 rnM succinate hardly influenced production 
rates during the first 10 min, but prevented the decrease 
of pregnenolone production rates, probably by preventing 
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Figure 2 Time course of the pregnenolone concentrations in mitochondrial 
fractions isolated in 0.25 M sucrose in the absence of EDTA,from control and 
luteinizing hormone treated testes. 
The composition of the incubation medium was 0.125 M sucrose, 5.0 mM MgC1 2 , 
30 mM Tris-HCl (pH 7 .3) and 0.1 ~~~ cyanoketone. Aliquots of mitochondrial 
fractions were incubated in: I, 2 ml incubation medium only. i, incubation 
medium containing 0.5 mM C?.Cl2. G, incubation medium containing 
20 ITL'I! sodium succinate. incubat!.on medium containing 20 mM sodium succinate 
as '"ell as 0.5 mt1 ::acl2. ( --) solid lines, mitochondrial protein 
from control testes. ( --- ) broken lines, mitochondrial protein from 
luteinizing hormone treated testes. Each point reflects mean values of 
2-3 incubations. 
the depletion of intramitochondrial donors of reducing 
equivalents. Addition of both succinate and ca2+ ions re-
sulted in an increase in the production of pregnenolone 
during the first 30 min. This initial phase was followed 
by a slower rate of production for 60 min. Pregnenolone 
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production in mitochondrial fractions from LH treated tes-
tes was maintained during the first 20 min. Thereafter pro-
duction rates were almost negligible. Addition of 0.5 mM 
ca
2
+ had no stimulating effect on the initial production of 
pregnenolone. However, during 90 min incubation 20 mM suc-
cinate maintained production of pregnenolone in mitochon-
drial fractions from LH treated testes. The presence of 
0.5 mM ca2+ in addition to succinate caused a small stimu-
lation of initial production rates. Mitochondrial fractions 
from control and LH stimulated testes gave almost similar 
production rates when ca2+ and succinate were present in 
the incubation mixture. These data strongly suggest that 
ca2+ in vitro can mimic the stimulatory effect of LH in 
vivo on succinate supported pregnenolone production. 
The results in figure 2 may indicate that after LH 
treatment in vivo a metabolically active cholesterol pool 
has been built up and that ca2+ in vitro does not stimulate 
further accumulation of cholesterol into this active pool. 
Information on the mechanism of the intrarnitochondrial 
cholesterol shift is still limited. Studies on fractiona-
tion of mitochondria obtained from Leydig cell tumors (145) 
have shown that cholesterol side-chain cleaving enzyme is 
predominantly located in the inner mitochondrial membrane, 
whereas the bulk of cholesterol was present in the outer 
membrane fractions. ca2+ might activate cholesterol trans-
port from an inactive pool to the enzyme complex; 
at the other hand changes in the conformation of mitochon-
2+ drial membrane structures, provoked by Ca , may facilitate 
the contact between enzyme complex and the substrate. Expe-
riments with aged mitochondria (figures 3A and B) may sup-
port this theoretical explanation. 
Effect of ageing of mitochondrial protein on pregnenolone 
production rates. 
Figures 3A and 3B summarize the effect of ageing of mi-
tochondrial preparations, isolated in sucrose without EDTA. 
Pregnenolone production rates in the presence of either 
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Figure 3 Influence of age·ing of mitochondrial fractions isolated in 0. 25 M 
sucrose in the absence of EDTA from luteinizing hormone treated and control 
testes on the time course of the pregnenolone concentrations. 
The incubation medium contained 0.125 mM sucrose, 5.0 mM MgC1 2 , 30 mM 
Tris-HCl (pH 7.3), 20 mM sodium succinate and 0.1 uM cyanoketone. Figure 3A: 
freshly prepared mitochondrial fractions incubated in: A, 2 ml incubation 
medium only. 8, incubation medium containing 1.0 mM NADPH, 10 mM glucose 
6-phosphate dehydrogenase. ( --) solid line, 0.91 mg mitochondrial protein 
from control testes. ( --- ) broken line, 0.93 mg mitochondrial protein from 
luteinizing hormone treated testes. Figure 3B: aliquots of mitochondrial 
fractions from control and luteinizing hormone treated testes were aged by 
pre-incubation for 60 min at 33°C in 0.25 M sucrose. Incubation conditions 
were identical to those as described in the legend to Figure 3A. 
succinate or succinate plus NADPH were higher in freshly 
prepared mitochondrial fractions from LH treated rats than 
in control preparations (figure 3A). After ageing for 60 
min at 33°C in 0.25 M sucrose the rates of pregnenolone 
production by control mitochondrial fractions in the pre-
sence of succinate or succinate plus NADPH increased and 
equalled production rates by relevant LH treated mitochon-
drial fractions (figure 3B). It is well known that ageing 
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of mitochondria involves changes in the ultrastructure. The 
effect of ageing of steroidogenic mitochondria on pregneno-
lone production rates may reflect, therefore, the loss of 
a distinct compartmentalized localization of enzyme complex 
and substrate pool in freshly prepared mitochondria from 
control testes. In this regard Kahnt and coworkers (111) 
and Johnson et al. (106) observed that pregnenolone produc-
tion rates of rat adrenal cortex mitochondria increased 
after disruption (either by swelling in distilled water or 
by sonication) of the mitochondria whereas production rates 
in sonicated mitochondria obtained from control and ACTH 
treated adrenal glands became similar (106). 
Effect of ruthenium red on ca 2+ stimulated pregnenolone 
production rates. 
The involvement of binding of ca2+ by testicular mito-
chondria in ca2+ stimulated pregnenolone production was 
investigated with ruthenium red. Ruthenium red is a speci-
fic inhibitor of mitochondrial ca 2+ binding and prevents 
the accumulation of ca2+ inside the mitochondria (175,194). 
Figure 4 shows that ruthenium red inhibited ca 2+ stimulated 
pregnenolone production in isolated mitochondrial fractions 
by almost 70%. Production rates in the absence of ca 2+ were 
not affected by ruthenium red. These results may indicate 
that testicular mitochondria can accumulate Ca 2+ from the 
surrounding medium by a specific ca2+ binding and uptake 
mechanism. It is not known if the 30% stimulation of preg-
nenolone production in the presence of ca2+ and ruthenium 
red was caused by ca 2+ accumulation in the mitochondria by 
a ruthenium red insensitive transport mechanism, or is 
merely reflecting improper incubation conditions. 
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Figure 4 Effect of ruthenium red on ca2+ stimulated pregnenolone production 
rates by mitochondrial fractions isolated in 0.25 M sucrose, containing 
l rnM EDTA,from luteinizing hormone treated and control testes. 
Aliquots of mitochondrial fractions were incubated in 1 ml medium, 
containing 0.125 M sucrose, 0.5 mM EDTA, 20 rnM sodium succinate, 5.0 rnM Mgcl 2 , 
30 rnM Tris-HCl (pH 7.3), 0.1 ~M cyanoketone, 10 mM NADPH, 10 mM glucose 
6-phosphate and 0.3 units glucose 6-phosphate dehydrogenase for 15 min at 
33°C. e, incubation medium alone. 6, incubation medium containing 0.7 mM CaC1 2 . 
I - ) , solid line, 1.25 mg mitochondrial protein from control testes. 
( --- ), brcken line, 1.3 ~g mitocho;-;drial protein from luteinizing hormone 
treated testes. 
5.3. Conclusions 
From experimental data presented in appendix paper IV 
and section 5.2. it is concluded that ca2+ can stimulate 
testosterone production in vitro, via a stimulation of the 
mitochondrial pregnenolone production. ca 2+ fulfills the 
criterium for a potential obligatory factor involved in the 
trophic stimulation of steroid production, since ca 2+ had a 
greater effect on succinate supported pregnenolone produc-
tion rates in control mitochondrial fractions than on pro-
duction rates in mitochondrial fractions isolated from LH 
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treated testes (section 5.2.). Ca 2+ may stimulate the for-
mation of pregnenolone via an effect on the rate of asso-
ciation of cholesterol and cytochrome P450 through an 
intramitochondrial cholesterol shift or changes in mito-
chondrial membrane conformations. At the other hand, it 
cannot be excluded that ca 2+ also increases the availability 
of reducing equivalents for cholesterol side-chain cleaving 
enzyme activity. 
The experiments with ruthenium red, a specific inhibitor 
of ca2+ uptake by mitochondria (175,194), indicate that 
specific mitochondrial ca2+ binding and uptake were invol-
ved in stimulation of pregnenolone production rates by ca 2+ 
ions added to the incubation mixture (section 5.2.). 
Information on the possible role of ca2+ in testicular 
steroidogenesis in vivo or in intact cells in vitro is 
limited at this moment. Therefore, it is not possible to 
postulate a detailed mechanism of action of LH on androgen 
formation involving ca2+ ions. 
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SUMMARY 
The testicular gland is the main androgen producing 
organ in male animals. The production of androgens is regu-
lated by LH, secreted by the pituitary. The experimental 
work described in this thesis concerns the role of the 
rate-limiting step in overall testosterone formation in rat 
testis, that is the rnitochondrially localized production of 
pregnenolone. 
In order to properly characterize cellular and subcel-
lular fractions used in this study, the presence and dis-
tribution of specific marker enzymes had to be established 
in these fractions. Carboxyl esterase has been used to 
characterize testicular interstitial tissue. Cytochrome £ 
oxidase and monoamine oxidase have been applied to identify 
mitochondrial fractions, whereas carboxyl esterase, 
rotenone-insensitive NADPH-cytochrome £ reductase and 
steroid sulfatase have been used as marker enzymes for 
microsomal fractions. Glucose-6-phosphate dehydrogenase and 
lactate dehydrogenase were assayed as reference enzymes for 
the particle-free supernatant fraction. In appendix paper 
I, however, it has been suggested that a small part of lac-
tate dehydrogenase activity is localized in mitochondria of 
specific cell types in the seminiferous tubules. 
As a measure for steroid production, the production 
rates of endogenous testosterone in tissue homogenates and 
of endogenous pregnenolone in isolated mitochondrial frac-
tions have been determined rather than the formation of 
steroids from exogenous labelled precursors. In this way 
the possibility was avoided that exogenous substrates may 
not completely mix with endogenous substrate pools and that 
the conversion rates may not reflect true production rates 
of endogenous steroids. In addition, estimation of the rate 
of steroid production from endogenous precursors offered 
the possibility to compare endogenous production rates in 
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vitro with the production of steroids in vivo. 
The mass of testosterone and of pregnenolone was ini-
tially estimated using gas-liquid chromatography with elec-
tron capture detection technique (chapter 2 and appendix 
papers I, II and III). This technique was in the course of 
these investigations replaced by more sensitive and less 
time-consuming radioimmunoassay techniques (chapter 2 and 
appendix papers III and IV). 
Five main aspects has been studied: 
1. The cellular localization of the endogenous production 
of androgens and of enzyme systems related to androgen 
formation (chapter 3, appendix papers I, II and III). 
From the experiments on the cellular localization of 
steroidogenesis in rat testis, in interstitial tissue and 
in seminiferous tubules, it was concluded that interstitial 
tissue contributes at least 97% to total testicular 
steroid production in vitro. Similar conclusion can be 
drawn from a comparison of pregnenolone production rates in 
mitochondrial fractions isolated from those tissue compart-
ments. It was also concluded that at least 95% of the 3s-
hydroxysteroid dehydrogenase activity was located in the 
interstitial compartment of the testicular gland. The 
results presented (chapter 3 and appendix papers I, II and 
III) do not provide sufficient evidence to exclude the 
possibility that seminiferous tubules are producing pregne-
nolone and progesterone from endogenous precursors. However, 
the quantitative contribution of t.hese steroids produced in 
cell types in the seminiferous tubules to the production in 
total testis would be very small, and the low production 
rates measured in isolated seminiferous tubules may well 
reflect contamination of material from the interstitial 
tissue. 
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2. The subcellular localization of the production of andro-
gens (chapter 3 and appendix papers I, II and III). 
From the experiments on the localization of steroid pro-
duction in isolated subcellular fractions from rat testis 
it was concluded that only isolated mitochondrial fractions 
synthetize steroids from endogenous substrates. Both the 
cholesterol side-chain cleaving enzyme system and a choles-
terol substrate pool are present in this particular frac-
tion. Testosterone and pregnenolone were the main steroids 
produced in the absence of cyanoketone. The production of 
testosterone in isolated mitochondrial fractions may have 
been caused by contamination with microsomal enzymes requi-
red for the conversion of pregnenolone to testosterone. In 
this regard the difference in distribution pattern of 36-
hydroxysteroid dehydrogenase indicated that 7-15% of this 
steroid dehydrogenase is located in the mitochondria. 
3. The effect of long-term treatment with HCG in vivo on 
endogenous steroid production and on enzyme activities 
in testis of adult male rats (chapter 4 and appendix 
paper III) . 
Intact adult rats who had received daily subcutaneous 
injections of 100 i.u. HCG for 5 days showed increased 
testosterone concentrations in total homogenates of all 
testis tissues investigated. The production of testosterone 
from endogenous precursors was markedly elevated in homage-
nates of whole testis tissue and this increase in steroid 
formation after long-term HCG treatment could be explained 
by an increased production in the interstitial compartment. 
Long-term treatment with HCG increased pregnenolone produc-
tion in mitochondrial fractions isolated from interstitial 
tissue. This observation confirms the generally accepted 
theory that enhanced androgen production is caused by an 
increase in mitochondrial pregnenolone formation. 
The specific activity of 3S-hydroxysteroid dehydrogenase 
was increased in homogenates of whole testis tissue, 
isolated interstitial tissue and seminiferous tubules. 
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Long-term HCG treatment had no effect on the specific acti-
vities of marker enzymes such as cytochrome £ oxidase, 
monoamine oxidase, steroid sulfatase and lactate dehydroge-
nase. In contrast, the specific activity of carboxyl este-
rase was decreased. 
4. The acute effect of LH on testicular steroid production 
(section 4.3. and appendix paper IV). 
Within 20 min after LH injection concentrations of tes-
tosterone in testicular venous plasma and in testicular 
tissue were 3, respectively 10 times higher than in rele-
vant samples of control rats. Pregnenolone concentrations 
in isolated mitochondrial fractions from testes removed 
from the animal 20 min after LH treatment were 5 times 
increased. 
The production rates of testosterone in homogenates of 
whole testis tissue and of pregnenolone in isolated mito-
chondrial fractions were significantly elevated within 5 to 
10 min after intravenous LH injection. The stimulating 
effect of LH on testosterone production in vivo as well as 
on testosterone production in testicular homogenates and on 
pregnenolone production in isolated mitochondrial fractions 
was abolished, when cycloheximide was administered intra-
venously 10 min prior to LH. 
5. A possible role of ca2+ ions in the cellular mechanism 
of hormonal regulation of steroid production (chapter 5 
and appendix paper IV) . 
Addition of Ca + ions to the incubation medium stimula-
ted both testosterone production rates in whole testis 
tissue homogenates and the rates of pregnenolone production 
in mitochondrial fractions. Addition of ca2+ had a greater 
effect on pregnenolone production rates in control mito-
chondrial fractions than in LH stimulated fractions 
2+ (section 5.2.). In this respect, Ca in vitro can mimic 
the effect of LH in vivo on mitochondrial steroid produc-
tion. 
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After ageing of mitochondrial protein, rates of pregne-
nolone formation in control mitochondrial fractions were 
increased and were almost similar to production rates in 
comparable fractions from LH stimulated testes. 
The presence of ruthenium red, a specific inhibitor of 
binding and transport of mitochondrial ca2+, resulted in a 
70% reduction of the ca 2+ stimulated pregnenolone produc-
tion rates in mitochondrial fractions from control and LH 
treated testes. Production rates in the absence of ca2+ 
were not affected by ruthenium red. 
In chapter 5 a possible role of ca 2+ ions in the hormonal 
regulation of steroid production has been discussed. 
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SAME NVA TTING 
Bij rnanlijke dieren vindt de produktie van androgene 
steroiden voornamelijk plaats in de testikel. Luteiniserend 
hormoon (LH), dat uitgescheiden wordt door de hypofyse, 
reguleert de testikulaire steroidproduktie. In dit proef-
schrift zijn de resultaten beschreven van onderzoekingen 
over de snelheidsbeperkende stap bij de produktie van tes-
tosteron in de testikel van de rat: de produktie van preg-
nenolon, gelokaliseerd in de mitochondria. 
Voor de karakterisering van de cellulaire en subcellu-
laire frakties die gebruikt zijn, is de aanwezigheid en 
verdeling van specifieke "marker"enzymen in deze frakties 
bepaald. carboxyl esterase werd gebruikt om het intersti-
tiele weefsel van de testikel te karakteriseren. Met behulp 
van cytochroom £ oxidase en monoamine oxidase werden mito-
chondriale frakties geldentificeerd. Carboxyl esterase, 
rotenon-ongevoelige NADPH-cytochroom c reduktase en steroid 
sulfatase werden gebruikt als "marker"enzymen voor de 
mikrosomale frakties. Glucose-6-fosfaat dehydrogenase en 
lactaat dehydrogenase werden bepaald als enzymen die karak-
teristiek zijn voor de oplosbare fraktie van de testikel. 
Uit appendix publikatie I blijkt tevens dat een klein ge-
deelte van de testikulaire lactaat dehydrogenase aktiviteit 
is gelokaliseerd in mitochondria van specifieke celtypen in 
de seminifere tubuli. 
De produktiesnelheden van endogeen testosteron in 
weefselhomogenaten en van endogeen pregnenolon in geiso-
leerde mitochondriale frakties werden bepaald als maat voor 
de produktie van steroidhormonen in vitro. Deze methode 
biedt twee voordelen boven de techniek waarbij de omzet-
tingssnelheid van toegevoegd radioaktief substraat bestu-
deerd wordt. De mogelijkheid wordt vermeden dat exogeen 
substraat niet volledig mengt met het reeds aanwezige endo-
gene substraat zodat de omzettingssnelheid van radioaktieve 
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prehormonen niet de ware produktiesnelheden van de endogene 
steroiden reflekteert. Ten tweede kan men met behulp van de 
hoeveelheden steroiden, die geproduceerd worden uit endo-
geen substraat, een reelere vergelijking maken tussen de 
produktiesnelheden in vitro en in vivo. 
De massa van testosteron en pregnenolon in biologische 
monsters werd aanvankelijk bepaald met behulp van gaschro-
matografie (hoofdstuk 2 en appendix publikaties I, II en 
III). Deze techniek werd in de loop van het onderzoek ver-
vangen door gevoeliger en minder tijdrovende radioimmunolo-
gische bepalingsmethoden (hoofdstuk 2 en appendix publika-
ties III en IV). Met behulp van deze bepalingstechniek was 
het mogelijk om de invloed en het effekt van veranderingen 
in de inkubatiekondities op de initiele produktiesnelheden 
van pregnenolon na kortdurende inkubaties van mitochondria-
le frakties te onderzoeken. 
Vijf aspekten werden bestudeerd: 
1. De cellulaire lokalisatie van de produktie van androge-
nen uit endogeen aanwezig substraat en van enzymen, die 
betrokken zijn bij de synthese van androgenen (hoofd-
stuk 3, appendix publikaties I, II en III). 
Uit de resultaten van de experimenten betreffende de 
cellulaire lokalisatie van de steroidproduktie in de testi-
kel van de rat werd gekonkludeerd, dat interstitieel weef-
sel minstens 97% bijdraagt aan de totale produktie van tes-
tosteron in vitro. Inkubatiestudies met mitochondriale 
frakties, geisoleerd uit interstitieel weefsel en semini-
fere tubuli 1 leidden tot dezelfde konklusie. 
Van de totale aktiviteit van het enzym 3s-hydroxysteroid 
dehydrogenase 1 dat de omzetting van pregnenolon in proges-
teron katalyseert, is tenminste 95% aanwezig in het inter-
stitiele kompartiment. Op grand van de resultaten, vermeld 
in hoofdstuk 3 en appendix publikaties I, II en III, kan 
niet worden uitgesloten dat de seminifere tubuli pregneno-
lon en progesteron uit endogeen aanwezig substraat kunnen 
produceren. De kwantitatieve bijdragen van de steroidpro-
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duktie in de seminifere tubuli tot de totale steroidproduk-
tie in de testikel is evenwel gering. De geringe produktie-
snelheid van steroiden in geisoleerde seminifere tubuli in 
vitro zou het gevolg kunnen zijn van verontreiniging met 
kleine hoeveelheden rnateriaal afkornstig uit interstitieel 
weefsel. 
2. De subcellulaire lokalisatie van de steroidproduktie 
(hoofdstuk 3 en appendix publikaties I, II en III). 
Uit experirnenten met geisoleerde subcellulaire frakties 
uit testisweefsel bleek dat alleen mitochondriale frakties 
signifikante hoeveelheden endogene steroiden te produceren. 
Uit deze resultaten kan worden gekonkludeerd dat in de 
rnitochondriale fraktie zowel het enzymkornplex noodzakelijk 
voor de afsplitsing van een gedeelte van de zijketen van 
cholesterol aanwezig is, als ook het substraat voor dit 
enzyrnkomplex. In afwezigheid van cyanoketon, een remmer van 
3S-hydroxysteroid dehydrogenase aktiviteit, werd voornarne-
lijk pregnenolon en testosteron gesynthetiseerd. De produk-
tie van testosteron in geisoleerde mitochondriale frakties 
kan mogelijk veroorzaakt zijn door verontreiniging van deze 
fraktie met mikrosomaal gelokaliseerde enzymen, welke nood-
zakelijk zijn voor de ornzetting van pregnenolon tot tes-
tosteron. In appendix publikatie II werd gekonkludeerd dat 
ongeveer 7-15% van 38-hydroxysteroid dehydrogenase mito-
chondriaal gelokaliseerd is. 
3. Het effekt van langdurige behandeling van volwassen rnan-
lijke ratten met gonadotropinen in vivo op de testiku-
laire produktie van endogene steroiden (sektie 4.2. en 
appendix publikatie III) . 
Dagelijkse subcutane toediening van 100 i.u. HCG aan 
intakte volwassen ratten, resulteerde in een toename in de 
koncentratie van testosteron in homogenaten van zowel 
totaal testisweefsel als interstitieel weefsel en serninifere 
tubuli. Na de horrnoonbehandeling was ook de produktie van 
testosteron in hornogenaten van totaal testisweefsel ver-
90 
hoogd. De gestirnuleerde produktie van testosteron in horno-
genaten van interstitieel weefsel kan de verhoogde produk-
tie van endogeen testosteron in totaal testisweefsel valle-
dig verklaren. Tevens werd een verhoogde produktie van 
pregnenolon waargenornen in mitochondriale frakties gelso-
leerd uit totaal testisweefsel en interstitieel weefsel. 
Deze resultaten bevestigden de theorie dat horrnonaal gesti-
muleerde produktie van androgenen veroorzaakt wordt door 
een toename in de rnitochondriale pregnenolonsynthese. 
Na langdurige behandeling met HCG was de specifieke ak-
tiviteit van 38-hydroxysteroid dehydrogenase in homogenaten 
van totaal testisweefsel, interstitieel weefsel en semini-
fere tubuli verhoogd, maar er was geen effekt op de speci-
fieke aktiviteiten van "marker"enzymen als cytochroorn £ 
oxidase, monoamine oxidase, steroid sulfatase en lactaat 
dehydrogenase aantoonbaar. De specifieke aktiviteit van 
carboxyl esterase nam af. 
4. Het akute effekt van gonadotropinen op de testikulaire 
steroidproduktie (sektie 4.3. en appendix publikatie IV}. 
Binnen 20 min na intraveneuze toediening van LH aan in-
takte volwassen ratten steeg de koncentratie van testoste-
ron in testikulair veneus plasma en in testikulair weefsel 
met een faktor 3, respektievelijk 10. De koncentratie van 
pregnenolon in mitochondriale frakties uit testikels welke 
20 min na toediening van LH uit de rat verwijderd werden 
was 5 rnaal hoger dan in vergelijkbare kontrole rnitochon-
driale frakties. 
Binnen 5 min na intraveneuze injektie van LH was de pro-
duktiesnelheid van testosteron in weefselhomogenaten en 
van pregnenolon in mitochondriale frakties verhoogd. Het 
stirnulerende effekt van LH op de testosteronproduktie in 
vivo en in vitro en op de produktie van pregnenolon in ge-
isoleerde mitochondriale frakties werd geblokkeerd, wanneer 
10 min voor de toediening van LH in vivo cycloheximide 
intraveneus werd toegediend. 
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5. De mogelijke rol die ca 2+ ionen spelen in het cellulaire 
mechanisme van de hormonaal gereguleerde produktie van 
steroiden (hoofdstuk 5 en appendix publikatie IV) . 
Toevoeging van Ca + ionen stimuleerde de produktie van 
testosteron in weefselhomogenaten en van pregnenolon in 
mitochondriale frakties. Toevoeging van ca 2+ aan het inku-
batiemedium kan het stimulerende effekt van LH in vivo op 
de mitochondriale pregnenolonproduktie nabootsen, aangezien 
2+ Ca een groter stimulerend effekt had op de produktie van 
pregnenolon in kontrole mitochondriale frakties dan in 
mitochondriale frakties gelsoleerd uit LH gestimuleerde 
testikels (sektie 5.2.). 
Veroudering van mitochondriaal eiwit verhoogde de pro-
duktiesnelheid van pregnenolon in mitochondriale frakties 
van kontrole testikels. Na veroudering waren de mitochon-
driale produktiesnelheden van pregnenolon in kontrole en 
LH gestimuleerde testikels vrijwel gelijk. 
2+ Het stimulerend effekt van Ca op de pregnenolonproduk-
tie in mitochondriale frakties (zowel voor kontrole als LH 
gestimuleerde testikels) was ongeveer 70% lager in aanwe-
zigheid van ruthenium red, een specifieke rernrner van bin-
ding en transport van ca2+ in mitochondria. 
De rnogelijke rol van ca2+ ionen in de horrnonale regula-
tie van de testikulaire steroidproduktie is uitvoeriger 
beschreven in hoofdstuk 5. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd in 1945 te 
Amsterdam geboren. In 1964 werd het getuigschrift 
gymnasium B behaald aan het Cartesius Lyceum te Amsterdam. 
Aan de Gemeentelijke Universiteit van deze stad begon hij 
in hetzelfde jaar met de scheikundestudie. Hij behaalde het 
kandidaatsexamen in de wiskunde en natuurwetenschappen 
{kode 52) in 1968 en het doctoraalexarnen met hoofdvak bio-
chemie en bijvakken fysisch en synthetisch organische 
chernie in 1971. Sinds september 1971 is hij verbonden als 
wetenschappelijk medewerker aan de afdeling Chemische 
Endocrinologie (Biochemie II) van de Erasmus Universiteit 
te Rotterdam. 
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NAWOORD 
In het voor u liggende proefschrift zijn de resultaten 
verwerkt van het experimentele onderzoek dat van september 
1971 tot juni 1975 door rnij verricht is op de afdeling 
Chernische Endocrinologie (Biochernie II) van de Erasmus 
Universiteit te Rotterdam. 
Velen hebben op theoretische en praktische wijze 
bijgedragen tot het verschijnen van dit proefschrift: 
Henk van der Molen als organisator en promotor, 
Dr. G.S. Boyd en Jasper Scholte als coreferenten, Brian 
Cooke als kritisch lezer van de manuskripten en de overige 
medewerkers van de afdelingen Biochernie I en II als 
kommentatoren tijdens werkbesprekingen op dinsdagmiddagen 
en/of donderdagavonden. 
Het praktische werk werd mede verricht door Ienke Kalkman, 
Mary van der Planck en, als stagiaires van de Delftse 
Analistenschool, Anneke Moespot en Hans Goedemans. Inge 
van Dop heeft als keuze-praktikante enige maanden aan het 
onderzoek meegewerkt. Pim Clotscher droeg zorg voor het 
goed funktioneren van de gebruikte apparatuur. 
De manuskripten zijn getypt door Willie Bakhuizen en 
Marja Decae. Het grafische werk is grotendeels verzorgd 
door de Audiovisuele Dienst. 
Voor al deze steun ben ik iedereen zeer erkentelijk. 
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De mensheid wroet, met een onvoorstelbaar geduld en vin-
dingrijkheid, diep in de hem omringende natuur naar het 
ontstaan van het leven. Zelfs breekt men zich het hoofd 
over het probleem van het mogelijke bestaan van buiten-
aardse vormen van intelligentie, evenals men de invloed na-
gaat van de incubatiewarmte op de kunstmatige synthese van 
bepaalde sterolden in de zaadballen van ratten. Ogenschijn-
lijk ontsnapt er niets aan onze aandacht. Maar is dat wer-
kelijk zo? 
Saswitha (179) 
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SUMMARY 
The endogenous production of pregnenolone and testosterone in subcellular 
fractions of rat testis tissue was estimated. A medium containing co factors was used and 
the incubations were carried out for 120 min at 33 °C. Only mitochondrial fractions 
produced the estimated steroids. Seminiferous tubules and interstitial tissue were isolated 
from rat testis tissue using a wet dissection technique. Mitochondrial fractions were 
isolated from the homogenized isolated tissue compartments and production of 
pregnenolone and testosterone after incubation of these fractions was estimated. The 
interstitial mitochondrial fraction produced 1200-2600 pmoles per mg mitochondrial 
protein per 2 h which was at least 60 times higher than the production in similar fractions 
obtained from seminiferous tubules. Production in the mitochondrial fraction of whole 
testis tissue was 300-600 pmoles per mg protein per 2 h. 
Conversion of cholesterol to pregnenolone and isocaproic acid is an important 
rate-limiting step in steroid production 1 . The enzyme system (the so-called cholesterol 
side-chain cleaving enzyme) responsible for this conversion, consists of cytochrome P-450, 
a flavoprotein and a non-heme iron protein2 • It is generally considered that this enzyme 
system is located in mitochondria and that further metabolism of pregnenolone, e.g. to 
testosterone, occurs in the endoplasmic reticulum and cytosol2 • Information concerning 
the site and specificity of the metabolism of cholesterol to steroids in the testis has 
mainly been obtained from observations on the conversion of radioactive cholesterol to 
either radioactive steroids3 or radioactive isocaproic acid 3•4 . Although metabolism of a 
radioactive substrate may give valuable information about the p;esence of enzymes it does 
not give quantitative information about the production of endogenous steroids. Further-
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more, this type of study is complicated by the possibility that the radioactive precursor 
does not completely mix with the endogenous pool and therefore the results obtained 
may not reflect true endogenous conversions. 
We have therefore estimated the endogenous production of steroids by subcellular 
fractions from rat testis tissue. 
The results in Fig. l show the subcellular distribution of endogenous steroid 
production after fractionation of a homog~nate of totaJ rat testis tissue·. 
Testes from 3 Wistar rats of 8-10 weeks old were pooled and were homogenized 
with an automatic Potter homogenizer (B. Braun Melsungen) for 3 X 15 sat 1100 rev./ 
min. Nuclear fraction N; 500 X g for 10 min), nuclei-free fraction (E; 500 X g for 10 min, 
supernatant), heavy mitochondrial fraction (M; 3500 X g for 10 min), light mitochondrial 
fraction (L; 10 000 X g for 10 min), microsomal fraction (P; 105 000 X g for 60 min) and 
particle-free supernatant (S; 105 000 X g for 60 min, supernatant) were obtained by 
differential centrifugation. For determination of steroid production in a typical experiment 
7.9 mg protein of N fraction, 5.2 mg of E fraction, 5.6 mg of M fraction, 3.8 mg of 
L fraction, 7.3 mg of P fraction and 2.5 mg of S fraction were incubated for 120 min at 
33 °C in 95% 0 2 + 5% C02 atmosphere in a fortified medium (see legend Fig. 1). 
T~e results in Fig. 1 show the relative specific activity or concentration of DNA 
as a marker for the nuclear fraction, cytochrome c oxidase for mitochondrial fractions, 
carboxylest'etase for microsomal fraction and lactate -dehydrogenase for particle~ free 
supernatant. lt' was found that part of the lactate dehydrogenase activity remained in the 
mitochondrial fractions, even after repeated washing. The rate of production of steroids 
was measured as the increase in endogenous concentrations of testosterone and 
pregnenolone. RoUtinely pregnenolone and testosterone accounted for 80-90% of the 
steroids produced during 120 min incubation at 33 °C. Other steroids measured were 
progesterone and androstenedione (van der Vuss, G.J. and Ka1kman, M.L., unpublished 
results). Protein was measured by the method of LoWry et al. 5 using bovine serum 
albumin as a standard. The sum of production of pregnenolone and testosterone in N and 
E fraction is 101 nmoles/2 h. The relative contribution of the different fractions to the 
sum of production is 3.1% for N fraction, 27.4% forM fraction, 64.5% for L fraction, 
3.4% for P fraction and 0.4% for S fraction. The recovery is 98.8%. It is apparent that 
only mitochondrial fractions produced steroids in appreciable amounts. The production 
of testosterone (from pregnenolone) in the mitochondrial fractions may be due to 
microsomal contamination. These results are in agreement with experiments of Toren 
et a/3 , wholocated the cholesterol side-chain cleaving enzyme in the 6500 X g for 25 min 
pellet, using radioactive cholesterol as a substrate. 
Considering the different cell types in the testis it is still not clear whether only 
the interstitial tissue, which is supposed to produce the bulk of testicular steroids, is active 
in steroid biosynthesis, ~r whether the seminiferous tubules can also produce small amounts 
of steroids. Lacy and co-workers6 have suggested that Sertoli cells in the seminiferous 
tubules might convert choleSterol to steroids which are required for maintenance of 
spermato'genesis. Christerisen and Mason 7 , Hall et al. 8 and Bell et al. 9 have reported the 
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Fig. 1. Subcellular distribution of steroid production in rat testis tissue from endogenous precursors. 
Graphs show relative specific enzyme activities of marker enzymes and the relative specific rate of 
production of pregnenolone and testosterone in subcellular fractions of rat testis tissue. Subcellular 
fractions were isolated according to the method introduced by De Duve et al. 12 ; cytochrome c oxidase 
activity (EC 1.9.3.1) was measured according to the method of Schnaitman et a/. 13 and used as a 
marker for mitochondria; DNA according to the method of Burton14 and was used as a marker for 
nuclei; lactate dehydrogenase (EC 1.1.1.27) according to the method of Kornberg 15 ; carboxylesterase 
activity (EC 3.1.1.1) was measured with p-nitrophenyl acetates as a substrate and was used as a marker 
for microsomes; aliquots of the fractions were incubated for 120 min at 33 oC in a 95% 0 2 + 5% C0 2 
atmosphere in a medium containing sucrose (0.125 M), EDTA (0.5 mM), succinate (20.0 mM), 
NADPH (1.0 mM), glucose 6-phosphate (10.0 mM), glucose-6-phosphatase (3 K.U.), phosphate 
(25.0 mM), Ca2 + (0.7 mM), Mg2+ (5.0 mM) at pH 7.2 in 2.0 ml; pregnenolone and testosterone were 
extracted from the incubation medium with 3 X 5 ml ethyl acetate containing [16-3H]pregnenolone 
and [1,2- 3H]testosterone as internal standards and were estimated by gas-liquid chromatography 
using electron capture detection. Pregnenolone was measured by a modification of the method of De 
Jong et al. 16 and testosterone by the method of Brownie et al. 17 • 
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presence of enzyme activities in seminiferous tubules for the conversion of pregnenolone 
and progesterone to testosterone. The results of such experiments may greatly depend 
upon the purity of the isolated tissues and contamination of seminiferous tubules with 
only a small amount of interstitial tissue and may easily result in an apparent steroid 
biosynthetic activity. Hallet a/. 8 could not demonstrate a significant conversion of 
radioactive cholesterol to steroids by isolated intact seminiferous tubules. It has also been 
reported that isolated tubules incubated in vitro did not produce testosterone (Cooke 
et alw). 
In order to estimate the difference in biosynthetic activity between the different 
testis tissues, we have measured the production of endogenous pregnenolone and 
testosterone rather than the conversion of radioactive precursors in mitochondrial 
fractions from whole testis tissue, seminiferous tubules and interstitial tissue. 
For each experiment the testis of one Wistar rat, 10 weeks old, were decapsulated. 
2.7 g (Expt I, Table I and Fig. 2) and 3.1 g (Expt 2, Table I) testis tissue was divided in 
two parts 1.9 g (Expt I) and 2.2 g (Expt 2) was used for dissection into interstitial tissue 
and seminiferous tubules by a method introduced by Christensen and Mason 7 • The rest of 
the testis tissue remained undissected. From the loss of esterase activity and protein it 
was estimated that the loss of tissue during dissection was approximately 40-50%. Fig. 2 
shows the relative contribution of mitochondrial fractions from seminiferous tubules and 
interstitial tissue to endogenous steroid production in testis. The distribution of carboxylw 
esterase activity in the top panel supports the good separation between tubular and 
interstitial tissue (Rommerts, F.F.G., Van Doorn, L.G., Galjaard, H., Cooke, B.A. and 
Vander Molen, H.J., unpublished). Combined heavy and light mitochondrial fractions 
were obtained from these isolated tissues. Although we have used the presence of lactate 
dehydrogenase as a marker for the particlewfree supernatant, it has been reported by 
Machado de Domenech et a/. 11 that in the testis a different lactate dehydrogenase iso-
enzyme is located inside the mitochondria from primary spermatocytes. Therefore, the 
presence of lactate dehydrogenase activity in the mitochondrial fractions was considered 
specific for the presence of mitochondria from tubular origin and was used as a marker 
for contamination of mitochondria from interstitial tissue by mitochondria from tubules. 
The lower panel of Fig. 2 shows the distribution of the relative specific rate of production 
of pregnenolone and testosterone. The sensitivity of the techniques used for detection of 
the steroids permitted estimation of 1-3 pmoles testosterone18 and 6-10 pmoles 
pregnenolone 17. The endogenous amounts of steroids produced by mitochondrial fractions 
from interstitial tissue could easily be measured. Routinely, 0.25~0.40 mg of mitochondrial 
protein from interstitial tissue contained, after incubation, amounts in the order of 
20~25 pmoles pregnenolone and 500~700 pmoles testosterone, while 0.80~1.50 mg 
mitochondrial protein from the tubular compartment contained after incubation 15-20 
pmoles pregnenolone and 4~ 12 pmoles testosterone (Table 1). 
When expressed per mg mitochondrial protein per 2 h the production of 
pregnenolone and testosterone in the mitochondrial fraction of seminiferous tubules was 
at least 60 times lower, when compared with the production in the interstitial mitochondrial 
TABLE I 
ENDOGENOUS PRODUCTION OF PREGNENOLONE AND TESTOSTERONE BY MITOCHONDRIAL FRACTIONS FROM RAT 
TESTIS TISSUE. INTERSTITIAL TISSUE AND SEMINIFEROUS TUBULES 
Combined heavy and light mitochondrial fractions from total testis tissue, interstitial tissue and seminiferous tubules were incubated and 
steroids were estimated as described in the legend to Fig. 1. All results are mean values of duplicate estimations. 
Expt Source of Mitochondrial protein Pregnenolone Testosterone Total production of 
mitochondrial fraction (pmoles) (pmoles) pregnenolone and 
Total Protein per testosterone 
amount incubation Time of incubation Ti~e of incubation (pmoles/2 h/mg protein) 
(mg) (mg) (min) (min) 
0 120 0 120 
Total testis 10.3 1.47 11 25 3 410 286 
Interstitial tissue 2.5 0.40 6 20 0 483 1242 
Seminiferous tubules 11.9 1.28 2 21 2 12 23 
2 Total testis 5.7 0.86 12 29 2 481 576 
Interstitial tissue 1.8 0.26 8 24 2 663 2604 
Seminiferous tubules 5.8 0.68 2 14 
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4 18 
"' 
"' >
~ 
0 
~ 
-00 
w 
184 
carboxyl-
esterase 
lactate 
dehydro-
genase 
relative rote 
ol producrion 
4 
Relative 
spec. act. 
whole tissue 
50 
Relative 
100 
interstitium 
tubules 
4 
50 100 
::: bspecact :: f---------1 
0.5 0.5 L,__,6 
50 100 50 100 
5 
4 4 
of pregnenolone + 
testosterone 
50 100 
c,~ protein 
2 
50 100 
0
'0 recovered 
protein 
BBA REPORT 
whole 
homogenate 
mitochondrial 
fraction 
mitochondrial 
fraction 
Fig. 2. Intercellular distribution of endogenous production of pregnenolone and testosterone in rat 
testis tissue (Expt 1 fi:om Table 1). Top panel: relative specific activity of carboxylesterase in 
homogenates of whole testis and in homogenates of isolated seminiferous tubules and interstitial 
tissue; middle panel: relative specific activity of lactate dehydrogenase (EC 1.1.1.27) in isolated 
mitochondrial fractions from whole testis and from isolated seminiferous tubules and interstitial 
tissue; lower panel: relative specific rate of production of pregnenolone and testosterone, measured in 
mitochondrial fractions from whole testis tissue and from isolated seminiferous tubules and interstitial 
tissue. In this experiment heavy and light mitochondrial fractions were combined. See legend to Fig. 1 
for incubation conditions for steroid production and estimations of activity of lactate dehydrogenase 
and carboxylesterase. 
fraction. From the data in Table I it may appear that the production in the mitochondrial 
fractions isolated from interstitial tissue contributes 92-97% to the production of 
mitochondrial fractions isolated from total testis tissue, if losses of activity during the 
isolation procedure are comparable. In the light of these findings we conclUde that the 
mitochondrial fraction of interstitial tissue is the main source of steroids from endogenous 
precursors in rat testicular tissue. 
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Further investigation is required to establish if the small production of steroids 
in the tubular mitochondrial fraction is due to contamination by interstitial mitochondria; 
this contamination cannot be detected with the r"lrker enzymes used in the present 
investigation. It cannot be exclu~ed that the low rate of steroid production, if any, in the 
mitochondrial fraction from seminiferous tubules under our experimental conditions is 
caused by deprivation of extramitochondrial precursors, although Cooke et al. 10 could 
not show testosterone production in intact tubules. The observation of Hallet al. 8 that 
the tubular compartment does not convert exogenous radioactive cholesterol to steroids 
might reflect either the absence of enzyme activities or the restricted penetration of 
cholesterol into the seminiferous tubules, as shown by Parvin en et al. 18 . 
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SUMMARY 
The quantitative inter- and subcellular distribution of 3Jl-hydroxysteroid de-
hydrogenase (3jl-hydroxysteroid: NAD (P) + oxidoreductase, EC r. r. 1.51) has been 
studied in testis tissue of the rat. The specific activity in homogenates of isolated inter-
stitial tissue was 150-500 times higher than the specific activity in homogenates of 
seminiferous tubules. It was concluded that 95-98% of 3Jl-hydroxysteroid dehydro-
genase is located in the isolated interstitial tissue. 
Subcellular fractionation of testis homogenates and the distribution of marker 
enzymes indicated that mitochondria contribute 7-15% to total 3Jl-hydroxysteroid 
dehydrogenase in rat testis tissue. 
Nagarse (subtilipeptidase, EC 3-4-2!. 14) treatment or cyanoketone (2a-cyano-
4A', J7a-trimethyl- 17 jl-hydroxy-s-androsten-3-one) inhibited 3Jl-hydroxysteroid de-
hydrogenase activity in rat testis tissue. 
Measurements of steroid production from endogenous substrates in isolated 
mitochondrial fractions showed that addition of cyanoketone to incubation mixtures 
or pretreatment of homogenates of interstitial tissue with nagarse caused a acncumu-
lation of pregnenolone at the expense of testosterone. 
INTRODUCTION 
Testis tissue contains two different compartments: interstitial tissue, containing 
Leydig cells, connective tissue and blood vessels, and seminiferous tubules with 
Sertoli cells and cells in various stages of spermatogenesis. The steroidogenic proper-
ties of interstitial tissue have been clearly established [r-6]. Steroid production from 
endogenous substrates by seminiferous tubules either in vivo or in vitro remains un-
certain [2, 5, 6]. It has been suggested, however, that mitochondrial fractions of semi-
niferous tubules may convert [26-14C]cholesterol to isocaproic acid [7] and could 
therefore produce pregnenolone and testosterone [2]. Nevertheless, this enzyme ac-
tivity is very low when compared wi~h the same activity in analogous incubation 
studies with mitochondrial fractions from interstitial tissue. 
The conversion of radioactive pregnenolone to progesterone and androgens by 
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preparations of seminiferous tubules [8-II] indicate the presence of 3fl-hydroxy-
steroiddehydrogenasein this tissue compartment. However, no data are available for 
the quantitative intercellular distribution of this steroid dehydrogenase in testis tissues. 
With respect to subcellular distribution of 3fl-hydroxysteroid dehydrogenase 
in testis Shikita et al. [12] have shown that this enzyme activity is particle-bound, 
whereas the occurrence of this enzyme in the inner membrane fraction of mitochon~ 
dria, isolated from total testis tissue was recently reported [13]. 
The aim of the present study was to determine the quantitative distribution of 
3Jl-hydroxysteroid dehydrogenase between interstitial tissue and seminiferous tubules. 
It was also attempted to measure the contribution of the mitochondrial 3fl-hydroxy-
steroid dehydrogenase to the total enzyme activity. 
Finally the effect of inhibition of 3fl-hydroxysteroid dehydrogenase by cyano-
ketone or nagarse on mitochondrial steroid production from endogenous substrates 
was studied. 
MATERIALS AND METHODS 
Pregnenolone, progesterone and testosterone were obtained from Steraloids, 
Pawling, U.S.A. and were used without further purification. Cofactors were pur-
chased from Boehringer, Mannheim, Germany. Cyanoketone is a product of Stirling-
Winthrop, New York, U.S.A. Nagarse was obtained from Serva, Heidelberg, Ger-
many. p-Nitrophenyl acetate is a product of Koch-Light Lab., Coin brook, England. 
[r6-3H]Pregnenolone was obtained from CEN, Mol, Belgium. Other radioactive 
steroids and [r-14C]tyramine were obtained from Radiochemical Centre, Amersham, 
England. Radioactive steroids were purified until less than r% radioactive contami-
nants could be detected with paper chromatography. 
Male Wistar rats of 12-14 weeks old were killed by decapitation. Testes were 
removed and immediately chilled in ice-cold 0.25 M sucrose, containing I mM EDTA. 
After removing the tunica albuginea the weight of the testes was determined. 
In some experiments testis tissue was dissected into interstitial tissue and semini-
ferous tubules according to the method described by Christensen and Mason [4]. 
During the dissection procedure the tissue was covered with ice-cold 0.25 M sucrose, 
containing I mM EDTA. The dis~ected tissues were washed 2 times with the dissec-
tion medium. Tissues were homogenized at 4 oc in 0.25 M sucrose, containing r mM 
EDTA with an automatic Potter homogenizer (Braun Melsungen, Germany) for 
3 times 15 sat I 100 rev./min. Nuclear fractions (N, 500 x gav for ro-min pellet), nuclei-
free fractions (E, 500 x g, for 10-min supernatant), mitochondrial fractions (M, 
15 ooo x g" for Io-min pellet), microsomal fractions (P, I h, IDS ooo x g" pellet) and 
particle-free supernatant (S, 1 h, ros ooo x g, supernatant) were obtained by differen-
tial centrifugation. N, E. and M fractions were isolated using a Sorvall HB-4 swing-out 
rotor in a Sorvall RC 2-B centrifuge. Nand M fractions were washed twice with 0.25 
M sucrose, containing 1 mM EDTA. P and S fractions were obtained with a Beckmann 
so Ti rotor in a Beckmann L2-65B ultracentrifuge. 
Assay of enzyme activities 
Glucose-6-phosphate dehydrogenase activity (EC !.!.!.4) was determined ac-
cording to Glock and McLean [14] at 25 oc. 
3/i-Hydroxysteroid dehydrogenase (EC I.I.LSI) activity was determined rou-
tinely by following the conversion of o. I mM [I6-3 H]pregnenolone to [I6-3 H]proges-
terone at 33 'C in the presence of I mM NAD+ in 2S mM potassium phosphate 
buffer pH 7·3S or 9.0, o. I2S M sucrose, o.s mM EDTA. Incubation volume was r.o 
mi. Pregnenolone was added in 20 1tl ethanol to the incubation mixture. The reaction 
was stopped with 3 ml ethyl acetate, containing I20oo dpm [4-14C]pregnenolone and 
2000 dpm [4-14C]progesterone as internal standards. The incubation mixture was 
extracted 3 times with 3 ml ethyl acetate. The collected extracts were evaporated under 
N 2 and subjected to paper chromatography on Whatman No. 20 paper strips 
in a Bush All system (light petroleum (b.p. 60-90 'C)-methanol-water (10: 7= 3, by 
vol.). 
Detection of radioactive steroids on paper chromatograms was carried out 
with a Packard radiogramscanner (Model 7200). The spots corresponding with preg-
nenolone and progesterone were eluted separately with s ml ethanol. After evapora-
tion ofthe ethanol the residue was acetylated with an acetic anhydride-pyridine mix-
ture (I :I, vjv) for 30 min at 4S 'C, followed by evaporation of the reagents under N2 • 
After chromatography of the residue on paper in a Bush All system the spots corres-
ponding with progesterone and pregnenolone acetate were eluted with ethanol in 
counting vials. The ethanol was evaporated and radioactivity was counted in a modi-
fied Bray's solution [Is]. Incubation times and amounts of protein were chosen so that 
not more than IS% of the substrate was converted. No other metabolites than proges-
terone could be detected in this assay. In this assay the rate-limiting dehydrogenase 
activity was estimated since the isomerization js very rapid [r6, 17]. 
Monoamine oxidase (EC L4.3-4.) activity was determined by the method of 
McCaman et al. [I8], usmg [I-14C]tyramine as the substrate at 32 'C. 
Rotenone-insensitive NADPH-cytochrome c reductase (EC r.6.2.3) activity 
was measured in the presence of o.IS /1M rotenone by following the reduction of cyto-
chrome cat sso nm at 2S 'C [I9]. 
Cytochrome c oxidase (EC !.9-3-I) activity was assayed according to the method 
of Schnaitman et al. [20] at 32 'C. 
Adenylate kinase (EC 2. 7-4.3) was assayed by the method ofSottocasa et al. [21] 
at 2S 'C. 
Carboxyl esterase (EC 3.1.1.I) was measured with p-nitrophenyl acetate as 
substrate, by following the increase of extinction at 400 nm at 20 'C [22]. 
Glucose 6-phosphatase (EC 3.1.3.9) was assayed as described by De Duve 
et al. [23]. 
Steroid sulfatase (EC 3.1.6.2) was assayed essentially as described by Payne 
et al. [24] following the hydrolysis of [4-14C]dehydroepiandrosterone sulfate (J7-oxo-
s-andiOsten-3fl-yl sulfate) at 32 "C and pH 6.s. 
The endogenous production of steroids by mitochondrial fractions was es-
timated by incubating abquots of mitochondrial fractions, at 33 'C in a 0 2-C02 
(9S: s, vjv) atmosphere in a medium containing sucrose (O.I2S M), EDTA (o.s mM), 
succinate (20 mM), NADPH (r.o mM), glucose 6-phosphate (Io mM), glucose-6-
phosphate dehydrogenase (0.3 units), CaC12 (0.7 mM), MgC12 (s.o mM), Tris-HCl 
buffer (2s.o mM) at pH 7·3S in I mi. The reaction was stopped by adding 4 ml ethyl 
acetate containing IOOOOO dpm [I6-3 H]pregnenolone and I2oooo dpm [I,2-3H]tes-
tosterone as internal standards. The reaction mixture was extracted 3 times with 4 ml 
ethyl acetate. Pregnenolone was purified by paper and thin-layer chromatography 
and after oxidation to 4-pregnen-3,6,20-trione this compound was estimated using 
gas-liquid chromatography with electron capture detection. This method is essen-
tially a modification of the method of DeJong and Vander Molen [25] for estimation 
of dehydroepiandrosterone (3/3-hydroxy-4-androsten-17-one). Testosterone was de-
termined by the method of Brownie et al. [ 26] The smallest amount of pregnenolone 
and testosterone that could be measured was respectively 6-10 and 1-3 pmoles. 
Endogenous steroid production was calculted from the difference in the amount of 
pregnenolone or testosterone present in the incubations after 6o min incubation and at 
zero time. 
Cyanoketone was added to the incubation mixture in 20 rll ethanol. Protein 
was measured by the method of Lowry et al. [27] using bovine serum albumine as a 
standard. 
For gaschromatography either a Pye Unicam 104, Model 84 or an F and M 
gaschromatograph equipped with a 63Ni or 3H electron capture detector was used. 
Counting of radioactivity was done in either a Nuclear Chicago Mark I or a 
Packard 3375 liquid-scintillation counter to preciswn of 2% or less. 
RESULTS 
Assay of 3f3-hydroxysteroid dehydrogenase activity 
Insolubility of pregnenolone at concentrations higher than o. 1 rnM prevents the 
determination of the Michaelis-Menten constants of 3/3-hydroxysteroid dehydrogena-
se in homogenates of rat testis tissue since the Km is higher than the saturation concen-
tration. F01 the comparison of specific activities in various tissue fractions and in 
subcellular fractions o. r mM pregnenolone was used in all experiments communicated 
in this paper. 
The conversion of pregnenolone to progesterone reached a maximum at pH 
9.0. The ratio of the enzyme activity, assayed in the range pH 9.0-10.0 and at pH 7·35 
in homogenates of isolated tissues as well as subcellular fractions, is in the order of 
I.6. Sonication of aliquots of tissue homogenates before enzyme assay had no in-
fluence on enzyme activity (data not shown). 
Intercellular distribution of 3[3-hydroxysteroid dehydrogenase 
In Table I the results of a typical experiment are summarized. The specific 
activities of 3/3-hydroxysteroid dehydrogenase are compared with those of other par-
ticle-bound enzymes such as steroid sulfatase, carboxyl esterase and rotenone-insen-
sitive NADPH-cytochrome c reductase. 
Combined results of four experiments gave the following specific activities of 
3/3-hydroxysteroid dehydrogenase at pH 7·35 in homogenates: of undissected tissue 
0.20 ± o.o6 nmolesjmg protein per min (mean value ± S.D.), of interstitial tissue 
1.59 ± 0-40 and of seminiferous tubules 0.007 ± 0.004. The ratio of specific activity 
of the enzyme in homogenates of interstitial tissue and seminiferous tubules was 
260 ± 162. The ratio of specific activities measured in homogenates of interstitial 
tissue and of seminiferous tubules exceeded the value of the ratio of 25.3 for carboxyl 
esterase, which is a useful biochemical marker for interstitial tissue as recently shown 
by Rommerts et al. [22]. The ratio of specific activities of other microsomal enzymes 
TABLE I 
INTERCELLULAR DISTRIBUTION OF 3fi-HYDROXYSTEROID DEHYDROGENASE IN 
RAT TESTIS TISSUE 
Enzyme assays were performed as described in Materials and Methods. 
Two rat testes (2.83 g wet wt) were divided in two parts. 1.36 g remained undissected and 1.47 g was 
dissected into interstitial tissue and seminiferous tubules. Enzyme activities were determined in homo~ 
genates of the undissected testis tissue, of interstitial tissue and of seminiferous tubules. All results 
are mean values of triplicate determinations 
Enzyme Enzyme activity Ratio b/c 
(nmoles/mg protein per min) 
Total testis Interstitial Seminiferous 
tissue tissue tubules 
(a) (b) (c) 
3P-Hydroxysteroid dehydrogenase (pH 7 -35) 0.120 1.180 0.007 J68 
3P-Hydroxysteroid dehydrogenase (pH 9.0) 0.170 1.580 O.OIO 158 
Steroid sulfatase 0.016 0.081 0.013 6.2 
Carboxylesterase 240 1520 6o 25·3 
NADPH-cytochrome c reductase 3-0 6.9 3·3 2.1 
Protein (mgjfraction) 117·4 7.1 71.2 
as steroid sulfatase and rotenone-insensitive NADPH-cytochrome c reductase 
showed a less distinct difference between interstitial tissue and seminiferous tubules. 
Subcellular distribution of 3f3-hydroxysteroid dehydrogenase in homogenates of rat 
testjs tissue 
The results in Table II and Fig. 1 show the distribution of 3[3-hydroxysteroid 
dehydrogenase activity in subcellular fractions isolated from homogenates of total 
TABLE II 
SUBCELLULAR DISTRIBUTION OF 3fi-HYDROXYSTEROID DEHYDROGENASE AND 
SOME MARKER ENZYMES FOR SUBCELLULAR PARTICLES !N FRACTIONS ISOLATED 
FROM TESTIS TISSUE 
Enzyme assays were performed on subcellular fractions isolated from four pooled testes (6.35 g wet 
wt) as described in Materials and Methods. N, nuclear fraction; E, nuclei-free supernatant; M, mito~ 
chondrial fraction; P, microsomal fraction and S, I h, I05000Xgav supernatant. The enzyme activi~ 
ties present in the N + E fraction isolated from 4 testes are expressed as ,umolesjmin. All results are 
mean values of triplicate determinations. 
Enzyme Enzyme Relative distribution of enzyme Re~ 
activity activity in percent of the co very 
(,umoles/min) activity inN+ E fraction ( %) (%) 
in(N+E) N+E N M p s 
fraction 
3ft~Hydroxysteroid dehydrogenase (pH 7 .35) o.o66 roo 19·9 20.1 62.4 3·0 105·4 
3P~Hydroxysteroid dehydrogenase (pH g.o) 0.095 roo ] 8.2 16.s 55·1 4·7 94-5 
Cytochrome c oxidase 69.5 100 29.8 66.6 11.2 o.o 107.6 
Monoamine oxidase 0.41 100 35-4 48.2 u.s ].0 96.1 
Carboxyl esterase 145·7 100 15.2 13.9 59·4 8.9 97-4 
Steroid sulfatase 0.010 100 30.2 21.3 57-4 o.o 108.9 
NADPH-cytochrome creductase 0.82 100 23.4 22.2 51·4 8.7 105·7 
Glucose~6~phosphate dehydrogenase 6.18 100 12.7 4.8 4-4 72.8 94-7 
Protein (mg/4 testes) 435-4 100 34.0 15.0 13·7 33·1 95-8 
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Fig. 1. Subcellular distribution of 3.8-hydroxysteroid dehydrogenase in total testis tissue of the rat in 
relation to some marker enzymes. Abscissae: the percentage of the total protein content in each frac-
tion is presented as cummulative values. Ordinates: relative specific activity (percentage of total 
enzyme activity/percentage of total protein content) of various fractions. N, nuclear fraction; E, 
nuclei-free supernatant; M, mitochondrial fraction; P, microsomal fraction and S, I h, I 05 ooo X g~v 
supernatant. 
testis tissue in relation to known marker enzymes for subcellular particles and cytosol. 
The conversion of pregnenolone to progesterone occurred in all five fractions obtained 
by differential centrifugation. However, 3/l-hydroxysteroid dehydrogenase activity 
assayed at both pH 7-35 and 9.0 showed a distribution comparable with that of 
microsomal enzymes carboxyl esterase, steroid sulfatase and rotenone-insensitive 
NADPH-cytochrome c reductase. Glucose-6-phosphatase activity measured was 
extremely low in homogenates of rat testis tissue and could not be used as a marker 
for microsomes of rat testis, in contrast with a gluconeogenic organ like liver [23]. 
Because appreciable amounts of steroid sulfatase and NADPH-cytochrome c reduc-
tase are present in the seminiferous tubules (Table !), the subcellular distribution 
patterns of these two latter enzymes cannot be used as reliable markers to establish 
the subcellular localization of 3fl-hydroxysteroid dehydrogenase in interstitial tissue. 
Carboxyl esterase appears to be the most reliable marker. 
The ratio of enzyme activities of 3/l-hydroxysteroid dehydrogenase in micro-
somal and mitochondrial fractions was 2.7 ± o.6 (mean value ± S.D. from three 
fractionation studies), of carboxyl esterase 3.9 ± o.6 and of cytochrome c oxidase 
o. 1 r ± o.o6. When corrected for mutual contamination of the mitochondrial and 
microsomal fractions, it can be concluded that the contribution of mitochondria to 
total 3fl-hydroxysteroid dehydrogenase activity in rat testis tissue is 7-15%. 
The recovery of the activity of 3fl-hydroxysteroid dehydrogenase assayed at 
pH 7-35 and 9.0 is in the order of 100% (Table II) whereas addition of an aliquot of 
the particle-free supernatant to the particulate fractions did not influence the specific 
activity of 3/l-hydroxysteroid dehydrogenase (data not shown). 
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This observation strongly suggests that the enzyme activity measured in a se-
parate fraction is not dependent on the presence of any of the other fractions and does 
not support the conclusion of Shikita eta!. [12] that a stimulating factor for the par-
ticle-bound 3/l-hydroxysteroid dehydrogenase is present in the particle-free superna-
tant. 
FJfect of cyanoketone and nagarse on JfJ-hydroxysteroid dehydrogenase activity in 
homogenate of rat testis tissue 
Concentrations of 0.1 J1M cyanoketone, a potent inhibitor of 3fJ-hydroxy-
steroid dehydrogenase in other steroidogenic tissues [28, 29] almost completely inhi-
bited the conversion of pregnenolone to progesterone in incubation studies with o.s-
r.o mg protein of homogenates of total testis tissue and o.os-o.I mg protein of inter-
stitial tissue. On the other hand, the addition of the proteinase nagarse to the testis 
tissue homogenate (up to 0.20 mg/mg total tissue protein) inactivated only 80-85% of 
3f3-hydroxysteroid dehydrogenase activity (data not shown). 
In Table III the effect of nagarse pretreatment on the activity of 3fJ-hydroxy-
steroid dehydrogenase and some other enzymes present in the mitochondrial and 
miCrosomal fraction of isolated interstitial tissue is summarized. Preincubation of 
homogenates of isolated interstitial tissue with 0.22 mg nagarsejmg protein at 4 'C for 
30 min according to DeJong and Hiilsmann [30] caused an inactivation of 3/l-hydro-
xysteroid dehydrogenase measured in the mitochondrial fraction of approx. 88% and 
in the microsomal fraction of 98 %. At least 6% of total activity of both mitochondrial 
and microsomal fraction was unaffected by the nagarse pretreatment. 
The activity of cytochrome c oxidase, monoamine oxidase, carboxyl esterase 
and adenylate kinase was essentially not influenced by the pretreatment with nagarse. 
TABLE III 
INFLUENCE OF NAGARSE TREATMENT OF RAT INTERSTITIAL TISSUE HOMO-
GENATE ON THE ACTIVITY OF 3fi-HYDROXYSTEROID DEHYDROGENASE 
Four rat testes (5.71 g wet wt) were dissected into interstitial tissue and seminiferous tubules under 
0.25 M sucrose - I mM EDTA at o oc. The homogenate of interstitial tissue contained 4.6 mg 
protein/mi. Nagarse (2.5 mgl was added to an aliquot (2.4 ml) of this homogenate and subsequently 
stirred for 30 min at 4 "C before differential centrifugatiou to obtain mitochondrial and microsomal 
fractions as described under Materials and Methods. 
Fraction Enzyme Enzyme Activity (nmoles/min per fraction) 
Control Nagarse 
Mitochondrial 3,8-Hydroxysteroid dehydrogenase 3-25 0.38 
Cytochrome c oxidase 8o6 890 
Monoamine oxidase 14.6 14.1 
Adenylate kinase 286 243 
Carboxyl esterase 4108 5230 
Protein (mg/fraction) 2.6 2.7 
Microsomal 3,8-Hydroxysteroid dehydrogenase 4.85 0.10 
Cytochrome c oxidase 238 323 
Monoamine oxidase 4·76 4·93 
Carboxyl esterase 8290 9760 
Protein (rug/fraction) !.7 !.7 
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Effect of cyanoketone and nagarse on mitochondrial steroid production from endogenous 
precursors 
As previously shown by our laboratory [2] relatively crude mitochondrial 
fractions of rat testis tissue and of isolated interstitial tissue produce pregnenolone 
and testosterone. In order to obtain a simple parameter for the total endogenous 
steroid production by mitochondrial fractions, we have studied the effect of various 
concentrations of cyanoketone on the amount of pregnenolone and testosterone pro-
nmoles steroid 
formedlmg protein/60 min 
201 
1.5 
-- pregnenolone 
-- testosterone 
to 
~~~~:::::==""="'"' 
0 20 1.0 60 80 100 120 560 
[cyonoketonel in moles/1 ~109 
Fig. 2. Influence of cy&noketone on steroid production from endogenous substrate by the mitochon~ 
drial fraction from isolated interstitial tissue. Four testes (6. J o g wet wt) were dissected into interstitial 
tissue and seminiferous tubules in 0.25 M sucrose - I mM EDT A at o oc. Mitochondrial fraction 
was isolated from the interstitial tissue as described under Materials and Methods. Yield of mitochon-
drial protein: 6.3 mg. Mitochondrial protein (0.46 mg/ml) was incubated for 6o min at 33 oc with 
various amounts of cyanoketone. Results are mean value of duplicate incubations. See Materials 
and Methods for incubation conditions and assay of pregnenolone and testosterone. 
TABLE IV 
EFFECT OF NAGARSE TREATMENT OF HOMOGENATE OF INTERSTITIAL TISSUE ON 
STEROID PRODUCTION FROM ENDOGENOUS SUBSTRATE BY THE ISOLATED 
MITOCHONDRIAL FRACTION 
See Table III for details of nagarse treatment. 0.26 mg mitochondrial protein isolated from nagarse 
treated interstitial tissue homogenates and 0.26 rug of a control sample were incubated for 60 miP 
at 33 "C. The results of duplicate incubations are given. 
Mitochondrial fraction 
from 
Control homogenate 
Nagarse-treated homogenate 
Steroid production (pmoles/mg protein per 60 min) 
-----··---------- ·----
Pregnenolone Testosterone 
-----
960 1025 
940 945 
2250 !8 
3340 20 
·------
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duced by mitocbondrial fractions from isolated interstitial tissue during 6o min at 
33 oc. At concentrations of cyanoketone higher than o. r I'M only pregnenolone was 
produced and testosterone levels during incubation did not change (Fig. 2). Simpson 
eta!. [31] have previously shown that addition of cyanoketone to mitochondrial frac-
tions from rat adrenal tissue will cause accumulation of pregnenolone. 
After preincubation of homogenates of isolated interstitial tissue with 0.22 mg 
nagarsejmg protein at 4 oc for 30 min, mitochondrial fractions were obtained that 
produced large amounts of pregnenolone at the expense of testosterone (Table IV). In 
control experiments (homogenates of interstitial tissue incubated at 4 oc for 30 min 
without nagarse) pregnenolone and testosterone were produced in almost equal 
amounts. 
DISCUSSION 
The specific activity of 3,8-hydroxysteroid dehydrogenase in homogenates of 
isolated interstitial tissue is 150-500 times higher than the specific activity in homo-
genates of isolated seminiferous tubules. Assuming that ro% of rat testis protein is 
present in the interstitial compartment [4, 22]) the conclusion can be derived that 
approx. 97% of the total enzyme activity in testis is m the interstitial compartment 
and only 3% in the seminrferous tubules. The present finding of 3,8-hydroxysteroid 
dehydrogenase activity in interstitial tissue is in agreement with the observations of 
Bell et al. [r] and histochemical studies of Woods and Domm [32]. 
The occurrence of enzyme activities for conversion of radioactive pregnenolone 
by preparations of isolated seminiferous tubules of immature [II] and adult [8-ro] 
rats has been communicated. The present results do not exclude the possibility that 
pregnenolone can be converted to progesterone by preparations of isolated semini-
ferous tubules. The quantitative contribution of the seminiferous tubules to this 
enzyme activity would be small, however, and the very low specific activity measured 
in homogenates of seminiferous tubules may well reflect contamination of material 
from the interstitial tissue. 
When corrected for mutual contamination of the mitochondrial and micro-
somal fraction on basis of carboxyl esterase and cytochrome c oxidase (Tables II and 
III), it can be concluded that mitochondria are able to convert pregnenolone to pro-
gesterone. Their contribution to the total 3/3-hydroxysteroid dehydrogenase activity 
is 7-15%. 
In homogenates of testis tissue cyanoketone completely inhibits 3,8-hydroxy-
steroid dehydrogenase, whereas the proteinase nagarse reduces the activity of this 
steroid dehydrogenase to approx. 15% of the control value. This difference can be ex-
plained by the chemical nature of the inhibitor. Nagarse, because of its protein struc-
ture, cannot easily pass membranes [33-35] in contrast to cyanoketone, a lipophilic 
steroid. After pretreatment of homogenates of interstitial tissue with nagarse, fol-
lowed by isolation of washed subcellular fractions, 3,8-hydroxysteroid dehydrogenase 
activity in the microsomal fraction was almost completely abolished whereas approx. 
6% of the total activity in mitochondrial and microsomal fraction remained active 
(Table IV). 
Nagarse can only destroy dehydrogenase activity whrch is not shielded by in-
tact membranes. Therefore it may be expected that inactivation of mitochondrial ac-
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tivity must reflect either the presence of microsomal activity on the outside of intact 
mitochondria or the mitochondrial membranes might be disrupted, so that nagarse 
can invade the mitochondria. 
At present no evidence can be given for the intactness of the mitochondrial 
outer membrane. Therefore it can be concluded that at least 6% of testicular 3/3-
hydroxysteroid dehydrogenase, which is not inactivated after nagarse pretreatment, is 
inside the mitochondrial outer membrane. Localization of 3/3-hydroxysteroid dehy-
drogenase in the mitochondrial innermembrane fraction has been reported by Sulimo-
vici et al. [13]. They used submitochondrial fractions from mitochondria isolated from 
whole testis tissue. Assming that only ro% of testis mitotondria are deived from the 
interstitial tissue, their conclusions for total testis based on marker enzymes present 
in both interstitial tissue and seminiferous tubules compartment must be carefully in-
terpreted. 
Either pretreatment of testis tissue fractions with nagarse or cyanoketone does 
inactivate 3/3-hydroxysteroid dehydrogenase and inhibits metabolism of endogenous 
pregnenolone. Under such conditions the endogenous pregnenolone production in 
isolated mitochondrial fractions can be used as paramter for total steroid production. 
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Summary 
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Steroid production and enzyme activities were examined in preparations 
of whole testis tissue, isolated interstitial tissue and seminiferous tubules ob-
tained from adult rats with intact pituitaries receiving daily subcutaneous injec-
tions of 100 I.U. human chorionic gonadotropin for 5 days and from control 
animals. 
After human chorionic gonadotropin administration testosterone concen-
trations were increased in total homogenates of whole testis tissue, interstitial 
tissue and seminiferous tubules. The testosterone production from endogenous 
precursors was enhanced only in total homogenates of whole testis tissue and 
interstitial tissue obtained from testes of human chorionic gonadotropin-
treated rats. The production of testosterone in the corresponding homogenates 
of isolated seminiferous tubules was very low. 
The specific activity of 3iJ·hydroxysteroid dehydrogenase was increased in 
total homogenates of whole testis tissue, isolated interstitial tissue and semini-
ferous tubules. No effect was observed on the specific activities of marker 
enzymes such as cytochrome c oxidase, monoamine oxidase, steroid sulfatase 
and lactate dehydrogenase, whereas the specific activities of carboxyl esterase 
were decreased in homogenates of whole testis tissue and interstitial tissue. 
Total activity of monoamine oxidase was increased in homogenates of inter-
stitial tissue of testes from human chorionic gonadotropin treated rats. 
After the same prolonged human chorionic gonadotropin treatment the 
concentration of pregnenolone was increased in mitochondrial fractions of 
whole testis tissue, interstitial tissue and seminiferous tubules, and the amount 
of protein isolated in the mitochondrial fraction of interstitial tissue increased 
by 40%. 
Steroid production (estimated as pregnenolone) from endogenous precur· 
sors by mitochondrial fractions of whole testis tissue and interstitial tissue were 
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increased after human chorionic gonadotropin treatment, for whole testis from 
580 pmol/mg mitochondrial protein per h to 1420 pmol/mg per h; and for 
interstitial tissue from 2665 pmol/mg per h to 7050 pmolfmg per h. The 
production of pregnenolone in mitochondrial fractions obtained from isolated 
seminiferous tubules was very low and contributed hardly at all to the total 
pregnenolone production in mitochondrial fractions of whole testis tissue from 
normal rats as well as from human chorionic gonadotropin-treated rats. 
Introduction 
Luteinizing hormone plays an important role in the maintenance and 
stimulation of steroid biosynthesis in rat testis. Hypophysectomy of adult rats 
causes a decrease of testicular weight, a decreased concentration of testosterone 
in testis tissue and plasma [1,2], and a marked decrease of cytochrome P 4 50 
[3] and of enzyme activities related to steroid biosynthesis [3-5]. Administra-
tion of human chorionic gonadotropin to hypophysectomized rats prevents 
these effects of removal of tbe pituitary on testicular steroid biosynthesis 
[3,6,7]. 
It is also clearly established that prolonged human chorionic gonadotropin 
treatment of immature rats results in increased testicular weight and increased 
activity of enzymes involved in the biosynthesis of androgens [5,8]. For adult 
rats with intact pituitaries it has been reported that prolonged administration 
of human chorionic gonadotropin results in an increased testicular testosterone 
production in vivo [1], in an increased mitochondrial and microsomal cyto-
chrome P450 concentration [3,9] and in higher activities of 17a-hydroxylase 
(EC 1.14.1.7), steroid 17a,20~lyase and 5a-steroid reductase (EC 1.3.1.99) 
[3,9]. 
Mitochondrial conversion of cholesterol to pregnenolone appears to be a 
rate-limiting step in steroid biosynthesis in the ovary, adrenal and testis [10] 
and trophic stimulation of steroid production by adrenocorticotropin hormone 
or gonadotropins is thought to result in a stimulation of the mitochondrial 
activity for pregnenolone formation. Little information is available, however, 
on the effect of prolonged treatment with human chorionic gonadotropin of 
intact adult rats on the mitochondrial pregnenolone production. 
We have previously reported that production of steroids from endogenous 
precursors is a good parameter for steroid biosynthesis in cell-free preparations 
of rat testis [11,12]. Therefore, in the present experiments we have studied the 
effect of long-term human chorionic gonadotropin treatment on testicular 
steroid biosynthesis from endogenous precursors in tissue homogenates and in 
isolated mitochondrial fractions of whole testis tissue, interstitial tissue and 
seminiferous tubules. In addition, the effects of human chorionic gonadotropin 
treatment on testis 3,6-hydroxysteroid dehydrogenase (EC 1.1.1.51) and on the 
activities of cytochrome c oxidase (EC 1.9.3.1), monoamine oxidase (EC 
1.4.3.4), steroid sulfatase (EC 3.1.6.2), carboxyl esterase (EC 3.1.1.1) and 
lactate dehydrogenase (EC 1.1.1.27) and on the protein concentrations in dif-
ferent tissue compartments have been investigated. 
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Materials and Methods 
Human chorionic gonadotropin was obtained from Organon, Oss, Holland 
(Pregnyl, 500 I. U./flask). 
Pregnenolone, testosterone and progesterone were purchased from Stera-
loids, Pawling, U.S.A. and were used without further purification. 
Cyanoketone {2a-cyano-4,4' ,1 7a-trimethyl-1 7 {l-hydroxy-5-androsten-3-
one), an inhibitor of 3{l-hydroxysteroid dehydrogenase activity, is a product of 
Stirling-Winthrop, New York, U.S.A. [16-3 H]pregnenolone was obtained from 
CEN, Mol, Belgium. Other radioactive steroids and [1-1 4 C] tyramine were pur-
chased from The Radiochemical Centre, Amersham, England. Radioactive 
steroids were purified until less than 1% radioactive impurities could be de-
tected with paper chromatography. 
p-Nitrophenyl acetate is a product of Koch-Light Lab., Colnbrook, Eng-
land. Permablend II was obtained from Packard S.A., Zur.ich, Switzerland. 
Co-factors were obtained from Boehringer, Mannheim, Germany. 
Adult male Wistar rats substrain R-Amsterdam (14-16 weeks old, 200-
250 g) were used in this study. The animals were kept under controlled light 
(14 h light and 10 h darkness) and temperature (20-22°C) conditions. Labora-
tory chow and tap water were provided ad libitum. Daily subcutaneous injec-
tions of 100 I.U. human chorionic gonadotropin in 0.9% NaCl were given for a 
period of 5 days. Control animals received 0.2 ml vehicle only. The animals 
were killed by decapitation. Testes were removed and immediately chilled in 
ice-cold 0.25 M sucrose, containing 1 mM EDTA. After removing the tunica 
albuginea the weight of the testes was determined. Testis tissue was dissected 
into interstitial tissue and seminiferous tubules, and homogenates of testis tis-
sues and mitochondrial fractions of those tissues were prepared as described 
previously [12]. 
Assay of enzyme activities 
Lactate dehydrogenase was assayed according to Kornberg [13] at 25°C. 
Carboxyl esterase was assayed with p-nitrophenyl acetate as substrate, by 
following the increase of extinction at 400 nm at 20° C in 0.1 M Tris · HCl 
buffer, pH 8.0. 
The activities of 3{l-hydroxysteroid dehydrogenase, monoamine oxidase, 
cytochrome c oxidase and steroid sulfatase were assayed as described previous-
ly [12] . 
Estimation of steroid production 
The production of testosterone from endogenous substrates in tissue 
homogenates was estimated by incubating aliquots of homogenates of whole 
testis tissue (6-8 mg protein), of interstitial tissue (0.8-1.8 mg protein) or of 
seminiferous tubules (2.5-6 mg protein) at 33°C in an 0 2 /C02 (95 : 5, v/v) 
atmosphere in 2 ml medium, at pH 7.35, containing sucrose (0.125 M), EDTA 
(0.5 mM), sodium succinate (20 mM), NAD' (1.0 mM), NADPH (1.0 mM), 
glucose 6-phosphate (10 mM), glucose-6-phosphate dehydrogenase (0.3 unit) 
CaCl2 (0.7 mM), MgCl2 (5.0 mM), Tris · HCl (25 mM). The reaction was 
stopped by adding 3 ml ethyl acetate containing 120 000 dpm [1,2-3 H] testa-
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sterone as internal standard. The reaction mixture was extracted three times 
with 3 ml ethyl acetate and testosterone was purified with paper chromato-
graphy with a Bush A II system (light petroleum (b.p. 60-90°C)jmethanol/ 
water (10 : 7 : 3, by vol.) [14] ). Recovery of the added radioactive testos-
terone after extraction and purification was in the order of 80%. Corrections 
were applied for the losses to calculate the steroid contents of the original 
samples. 
The production of pregnenolone by mitochondrial fractions was measured 
as described previously [12] by incubating aliquots of mitochondrial fractions 
from whole testis tissue (1.0-1.5 mg mitochondrial protein), from interstitial 
tissue (0.3-0.5 mg protein) or from seminiferous tubules (1.0-2.0 mg pro-
tein). A solution (20 pi) of cyanoketone in ethanol was added to the incuba-
tion mixture to inhibit further conversion of pregnenolone. Final cyanoketone 
concentrations were 0.1 pM in incubation studies with mitochondrial fractions 
from testes of control animals and 0.25 pM in incubation studies with mito-
chondrial fractions from testes of human chorionic gonadotropin-treated rats. 
The reaction was stopped by adding 3 ml ethyl acetate containing 100 000 
dpm [16-3 H] pregnenolone as internal standard. The reaction mixture was ex-
tracted three times with 3 ml ethyl acetate. Pregnenolone was purified by paper 
chromatography with a Bush A II system. Recovery of the added radioactive 
pregnenolone after extraction and purification was in the order of 60%. Correc-
tions were applied for the losses to calculate the pregnenolone contents of the 
original samples. 
Those steroids that could theoretically interfere with the binding of tes-
tosterone or pregnenolone to the antisera (see below), were separated during 
paper chromatography using a Bush A II system. R, values measured for 
various steroids are: 17ct-hydroxypregnenolone, 0.0; 5-androstenediol, 0.0; 
17ct-hydroxyprogesterone, 0.11; testosterone, 0.14; dehydroepiandrosterone, 
0.26; 4-andro-androstenedione, 0.40; 5ct-dihydrotestosterone, 0.40; pregnenol-
one, 0.50; progesterone, 0.61; oestrone, 0.07; oestradiol, 0.0 and oestriol, 0.0. 
Testosterone cannot be separated from 17ct-hydroxyprogesterone in this 
system, but the last mentioned steroid does not interfere with the binding of 
testosterone [15]. It is unlikely that significant amounts of any of those 
steroids are present in the incubation mixture with mitochondrial fractions. 
The addition of cyanoketone prevents further conversion of pregnenolone by 
blocking 3{3-hydroxysteroid dehydrogenase activity [ 12] . Endogenous steroid 
production was calculated from the difference in the amount of pregnenolone 
or testosterone present in the incubation mixtures after 1 h and at zero time. 
Estimation of testosterone and pregnenolone 
Testosterone was estimated by a radioimmunoassay technique described 
by Verjans eta!. [15], which was essentially a modification of the method of 
Furuyama eta!. [16]. 
Pregnenolone was determined by a radioimmunoassay technique using an 
antiserum obtained from New Zealand white rabbits immunized against preg-
nenolone-3-hemisuccinate/bovine serum albumin. Three months after the initial 
immunization an antiserum was obtained, which was suitable for use in the 
radioimmunoassay. Pretreatment of this antiserum before use was exactly as 
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described for the antiserum against testosterone [15] . Estimations of pregne-
nolone with radioimmunoassay were performed in essentially the same way as 
the determination of testosterone in tissue samples [15]. 
The specificity of the antiserum was tested by comparing the ability of 
various steroids to displace [ 3 H] pregnenolone from the antibody and was ex-
pressed as percentage cross reaction, i.e. the amount of a certain steroid that 
displaces 50% of [3 H] pregnenolone relative to the amount of pregnenolone 
that displaces 50% of the [3 H] pregnenolone. The following data were ob-
tained: pregnenolone, 100%; cortisol, 29%; oestradiol-17~, 21%; progesterone 
12%; dehydroepiandrosterone, testosterone, cholesterol, 50<-dihydrotestos-
terone, 17-hydroxyprogesterone, 11{3-hydroxyprogesterone, corticosterone and 
cyanoketone, <1 %. For actual samples, specificity was also evaluated by com-
parison of the pregnenolone concentrations measured by the radioimmuno-
assay technique with results obtained by a method employing gas-liquid chro-
matography for estimation of pregnenolone. The latter method was essentially 
a modification of the method of DeJong and Vander Molen [17] for estima-
tion of dehydroepiandrosterone. Radioimmunological and gas-liquid chromato-
graphic results showed a good correlation (r = 0.961, n = 29). 
Sensitivity and precision of the present radioimmunological assay of preg-
nenolone were comparable with those of the assays described by DiPietro et al. 
[18] and Abraham and coworkers [19]. The smallest amounts of pregnenolone 
that could be detected in biological samples are in the order of 5-10 pmol. The 
precision of assays in this range was in the order of 20% (intra-assay variance). 
Protein was measured by the method of Lowry et al. [20] using bovine 
serum albumin as a standard. 
Counting of radioactivity was done in a scintillation fluid prepared by 
dissolving 80 g naphthalene and 5 g Permablend II in a mixture of 500 ml 
toluene and 500 ml methoxy ethanol. Radioactivity was estimated using an 
automated liquid scintillation system (Nuclear Chicago model Isocap/300 or a 
Packard 3375). Samples were counted to an accuracy of 2% or better. The 
significance of differences between results for different groups was calculated 
using a two-tailed Student's t-test [21]. 
Results 
The effect of prolonged human chorionic gonadotropin treatment on testis 
weight, protein and steroid concentration 
Values for testicular weight, the amounts of total and mitochondrial pro-
tein, testosterone concentrations in homogenates of testis tissues and preg-
nenolone concentrations in mitochondrial fractions for normal rats and for rats 
after prolonged subcutaneous administration of human chorionic gonadotropin 
are given in Table I. No significant effect of human chorionic gonadotropin 
treatment was observed in testicular weight and in amounts of protein of whole 
testis, isolated interstitial tissue and seminiferous tubules. Whereas the amounts 
of protein measured in mitochondrial fractions obtained from whole testis 
tissue and seminiferous tubules showed no difference after human chorionic 
gonadotropin treatment, the amount of protein, isolated in the mitochondrial 
fraction of interstitial tissue showed a 40% (P < 0.05) increase. 
TABLE I 
Testicular weight, protein concentrations in testis tissues and in mitochondrial fractions and concentrations of testosterone in tissue homogcnates and of pregnene~ 
lone in mitochondrial fractions of testis tissue from normal rats (control), and from rats treated with :1uman chorionic gonadotropin (HCG) (*MEANS± S.D.). 
Whole testis Interstitial tissue** 
n control HCG n control HCG 
Wet weight (g/2 testes) 9 2.65 ± 0.13 2.58 ± 0.13 
Protein (mg/2 testes) 9 214 ± 16 218 ± 18 6 12.1 ± 3.7 14.9 ± 3.8 
Testosterone (pmol{mg protein) 4 6.2 ± 2.8 38.4 ± 14.5 5 18.8 ± 11.3 68.8 ± 17.3 
Mitochondrial protein 
(mg/2 testes) 6 28.8 ± 3.9 27.8 ± 5.3 6 2.1 ± 0.4 3.0 ± 0.6 
Pregnenolone (pm.oljmg 
mitochondrial Protein) 6 29.3 ± 1.7 45,7 ±11.0 6 37.0 ± 15.1 116 ± 77 
* 100 I.U. human chorionic gonadotropin were administered subcutaneously each day for 5 days. 
** Values are not corrected for losses of protein during dissection. 
Seminiferous tubules** 
n control HCG 
6 84.4 ± 17.4 76.4 ± 14.4 
5 5.1 ± 2.9 16.4 ± 2.2 
6 9.4 ± 2.3 8.5 ± 1.1 
6 1.3 ± 0.8 5.1 ± 2.6 
.. 
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The concentrations of testosterone in homogenates of whole testis, inter-
stitial tissue and seminiferous tubules were significantly increased with factors 
of 6.1, 3.7 and 3.2, respectively (P < 0.05, P < 0.025 and P < 0.025) after 
human chorionic gonadotropin treatment. 
Pregnenolone concentrations in isolated mitochondrial fractions from 
whole testis tissue, interstitial tissue and seminiferous tubules were likewise 
increased with factors of 1.6, 3.1 and 3.9, respectively (P < 0.05, P < 0.10 and 
P< 0.05). 
The influence of prolonged human chorionic gonadotropin treatment on testos-
terone production and enzyme activities in. homogenates of rat testis tissues 
Data in Table II show that continuous administration of human chorionic 
gonadotropin to intact adult rats resulted in a 2 .4-fold increase in testosterone 
production from endogenous precursors in homogenates of whole testis tissue 
(P < 0.05) (production is expressed as pmoljmg protein per h or as nmol/2 
testes per h). 
Testosterone production in homogenates of interstitial tissue, expressed 
either per mg interstitial tissue or per amount of interstitial tissue obtained 
from two testes was significantly increased with factors of 2.0 and 2.4, respec-
tively (P < 0.05 and P < 0.05), whereas no significant increase was observed in 
incubations with material from seminiferous tubules. No corrections were made 
for losses of material during the dissection procedure and therefore the sum of 
the testosterone production in homogenates of interstitial tissue and semini-
ferous tubules is lower than the production in preparations of whole, undis-
sected tissue. In order to obtain an impression about the specificity of the 
trophic effect of human chorionic gonadotropin on testicular enzymes the 
activities of one of the enzymes involved in the formation of androgens from 
pregnenolone i.e. 3~-hydroxysteroid dehydrogenase and of some mitochon-
drial, microsomal and soluble enzymes not directly related to steroid biosyn-
thesis in rat testis have been studied (Table II). 
As a result of the human chorionic gonadotropin treatment a significant 
2.1-2.5-fold increase of the specific activity of 3~-hydroxysteroid dehydro-
genase ir, homogenates of whole testis tissue, interstitial tissue and seminiferous 
tubules was found (P < 0.001, P < 0.05 and P < 0.05, respectively). When 
expressed as total activities (in munits/2 testes) the increase of 3!3-hydroxy-
steroid dehydrogenase in whole testis tissue and interstitial tissue was 2.3- and 
2.6-fold, respectively (P < 0.001 and P < 0.025), whereas the total activity of 
this enzyme in isolated seminiferous tubules was very low, which is in agree-
ment with previous observations [12]. In contrast, human chorionic gonado-
tropin administration had no effect on the specific activity of mitochondrial 
enzymes, such as cytochrome c oxidase and monoan1ine oxidase, on the micro-
somal steroid sulfatase and on the soluble lactate dehydrogenase measured in 
homogenates of whole testis tissue and of dissected interstitial tissue and semi-
niferous tubules. Only the activity of monoamine oxidase (when expressed as 
munits per interstitial tissue obtained from two testes) showed a tendency to 
increase (P < 0.05). However, in homogenates of whole testis tissue and of 
interstitial tissue the specific activity of carboxyl esterase decreased significant-
ly after prolonged human chorionic gonadotropin treatment with a factor 0.6 
and 0.7, respectively (P< 0.05 andP< 0.05). 
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TABLE II 
TESTOSTERONE PRODUCTION IN VITRO AND ENZYME ACTIVITIES IN HOMOGENATES OF RAT 
(HCG)* (MEANS± S.D.) 
Whole testis 
n 
Testosterone production pmol/mg per h 4 
nmol/2 testes per h** 
Cytoc~rome c oxidase munitsjmg 4 
units/2 testes** 
Monoamine oxidase munitsjmg 4 
munits/2 testes** 
Carboxyl esterase units /mg 7 
units/2 testes** 
Steroid sulfatase }lunitsjmg 4 
munits/2 testes** 
3Jl-Hydroxysteroid dehydrogenase p.units/mg 9 
munits/2 testes** 
Lactate dehydrogenase units/mg 5 
units/2 testes** 
control 
112 ± 47 
23.7 ± 9.6 
155 ± 55 
31.6 ± 10.8 
0.84 ± 0.15 
174 ±29 
0.28 ± 0.09 
59.1 ± 21.4 
19.4 ± 3.9 
3.83± 0.77 
140 ± 25 
30.2 ± 5.5 
0.55 ± 0.11 
113 ± 19 
HCG 
267 ± 44 
60.2 ± 15.7 
123 ± 41 
26.3 ± 8.1 
1.05 ± 0.20 
218 ± 36 
0.16± 0.075 
35.7 ±17.8 
21.6 ± 4.4 
4.38 ± 0.87 
322 ± 60 
70.5 ± 13.1 
0.57 ± 0.11 
118 ± 20 
* 100 I. U. human chorionic gonadotropin were administered subcutaneously each day for 5 days. 
** Values are not corrected for losses of tissue during dissection. 
Pregnenolone production and activities of cytochrome c oxidase and mono-
amine oxidase. in isolated mitochondrial fractions 
The results in Table III show that the amount of pregnenolone formed 
from endogenous precursors in mitochondrial fractions, obtained from whole 
testis tissue was increased 2.4-fold (P < 0.025) after prolonged treatment with 
human chorionic gonadotropin. The production of pregnenolone in the pre-
sence of cyanoketone in mitochondrial fractions obtained from testes of 
human chorionic gonadotropin-treated and control animals is linear with time 
of incubation (Fig. 1). Therefore, the production of pregnenolone measured in 
TABLE III 
PREGNENOLONE PRODUCTION AND ENZYME ACTIVITIES IN ISOLATED MITOCHONDRIAL 
GONADOTROPIN (HCG)* (MEANS± S.D.) 
Whole testis 
n 
Pregnenolone production pmolfmg per h 5 
nmol/2 testes per h** 
Cytochrome c oxidase munits/mg 4 
units/2 testes** 
Monoamine oxidase munits/mg 
munits/2 testes** 
control 
580. ± 165 
16.0 ± 4.5 
680 ± 231 
19.1 ± 
n.d. 
n.d. 
3.6 
HCG 
1420 ± 390 
38.3 ± 6.9 
612 ± 170 
18.1 ± 1.0 
n.d. 
n.d. 
* 100 I.U. human chorionic gonadotropin were administered subcuteaneously each day for 5 days. 
** Values not corrected for losses of protein during dissection and fractionation. 
n.d., Not determined. 
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TABLE II (Continued) 
TESTIS TISSUES AFTER PROLONGED TREATMENT WITH HUMAN CHORIONIC GONADOTROPIN 
Interstitial tissue Seminiferous tubules 
n control HCG n control HCG 
5 1041 ± 228 2081 ± 628 5 2.1 ± 1.7 6.8 ± 4.5 
13.6 ± 3.1 33.1 ± 3.8 0.20 ± 0.18 0.57 ± 0.49 
5 206 ± 71 235 ± 36 5 182 ± 97 159 ± 44 
2.51 ± 1.00 3.61 ± 1.42 15.4 ± 7.9 12.7 3.4 
4 3.02 ± 1.15 4.15 ± 0.28 4 0.82 ± 0.15 0.84 ± 0.10 
35.8 ± 12 .. 3 61.2 ± 11.5 71.7 ± 15.2 73.5 ± 5.4 
4 1.25 ± 0.05 0.82 ± 0.16 4 0.061 ± 0.009 0.056 ± 0.005 
16.6 ± 1.0 13.5 ± 2.8 5.77 ± 1.81 4.75 ± 1.10 
4 56.0 ± 11.2 60.8 ± 7.5 4 16.2 ± 3.4 17.4 ± 4.3 
0.69 ± 0.20 1.01 ± 0.18 1.48 ± 0.47 1.42 ± 0.38 
4 1030 ± 140 2200 ± 420 4 8 ± 2 20 ± 6 
12.8 ± 1.8 33.9 ± 6.1 0.72 ± 0.19 1.78 ± 0.77 
5 0.17 ± 0.08 0.18 ± 0.04 5 0.56 ± 0.10 0.55 ± 0.08 
2.13 ± 1.09 3.02 ± 0.84 50.2 ± 17.7 44.3 ± 13.4 
vitro after 60 min of incubation may be expected to give a reliable reflection of 
the effect of human chorionic gonadotropin treatment on pregnenolone syn-
thesis. Mitochondrial fractions isolated from interstitial tissue from testes of 
human chorionic gonadotropin -treated rats showed an increased production of 
pregnenolone with a factor 2.6 (P < 0.025). Production of pregnenolone by 
mitochondrial fractions from seminiferous tubules was slightly increased after 
prolonged human chorionic gonadotropin treatment in vivo (0.10 > P > 0.05) 
but the production was very low when compared with the in vitro production 
of pregnenolone by mitochondrial fractions from the interstitial compartment 
FRACTIONS OF RAT TESTIS TISSUES AFTER PROLONGED TREATMENT WITH HUMAN CHORIONIC 
Interstitial tissue Seminiferou'S tubules 
n control HCG n control HCG 
5 2665 ± '1000 7050 ± 2850 6 17.5 ± 15.0 37.5 ± 21.2 
6.1 ± 3.5 20.7 ± 6.9 0.16 ± 0.13 0.32 ± 0.12 
6 391 ± 117 342 ± 130 6 551 ± 133 520 ± 251 
0.83 ± 0.25 0.99 ± 0.34 5.42 ± 2.56 4.48 ± 2.39 
6 4.72 ± 1.29 6.19 ± 0.92 6 2.86 ± 0.54 3.08 ± 0.54 
11.5 ± 3.6 18.5 ± 4.1 26.2 6.9 25.8 ± 5.5 
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Fig. 1. Ti.me course of the production of pregnenolone from endogenous precursors by mitochondrial 
fractions of whole testis tissue. -----------•. incubations with mitochondrial protein from testes of intact 
adult rats treated with 100 I.U. human chorionic gonadotropin subcutaneously each day for 5 days. 
o--o, incubations with mitochondrial protein from testes of control rats. Results of duplicate 
incubations are given. See Materials and Methods for incubation conditions and assay of pregnenolone. 
of the same testes. No significant effect of human chorionic gonadotropin was 
observed on the specific activities of cytochrome c oxidase and monoamine 
oxidase assayed in the mitochondrial fractions. In contrast, the total amount of 
monoamine oxidase in the mitochondrial fractions obtained from interstitial 
tissue was increased by 60% after human chorionic gonadotropin treatment (P 
< 0.05). 
Discussion 
The present results show that prolonged treatment with human chorionic 
gonadotropin of adult rats with intact pituitaries results in an increased testos-
terone production from endogenous substrates in homogenates of whole testis 
tissue. These in vitro results are compatible with in vivo data published by De 
Jong et a!. [22], who observed after prolonged human chorionic gonadotropin 
treatment of intact adult rats an increase of the testicular production rate of 
testosterone from 10.7 ± 7.3 nmol/2 testes per h to 137 ± 57 nmol/2 testes 
per h. Although the production of testosterone in vitro is of the same order of 
magnitude (23.7 ± 9.6 nmol/2 testes per h for control rats and 60.2 ± 15.7 
nmol/2 testes per h for human chorionic gonadotropin-treated animals) as the 
in vivo production, the lower percentage increase after human chorionic gona-
dotropin treatment in the in vitro studies may be caused by the difference in 
strain of animals used or a partial loss of stimulating factors(s) during homo-
genization of the testicular preparations. 
Assuming that 10% of rat testis protein is present in the interstitial com-
partment [23,24], it can be .concluded that for these in vitro experiments the 
contribution of interstitial testosterone production to the production in whole 
testis tissue is approx. 98%. With respect to the apparently very small testos-
terone production in homogenates and pregnenolone production in isolated 
mitochondrial fractions obtained from seminiferous tubules it cannot be ex-
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eluded that cell type(s) in the spermatogenic compartment of the testis pro-
duce this small amount of steroids, but on the other hand this apparent tubular 
production may well reflect contamination with material from the interstitial 
tissue. 
The in vitro results with isolated interstitial tissue preparations indicate 
that the increased testicular steroid production is caused by stimulation of the 
steroid production in the interstitial compartment. In that respect the present 
results are compatible with results concerning in vitro stimulation by lutein-
izing hormone of testosterone biosynthesis in isolated interstitial tissue and 
seminiferous tubules, obtained from hypophysectomized rats [25]. Hall and 
Eik-Nes [ 6] have reported that long-term treatment of intact rabbits with 
human chorionic gonadotropin had no effect on the conversion of radioactive 
cholesterol into testosterone by testis homogenates. However, such observa-
tions may be caused by poor mixing of the added radioactively labelled com-
pound with the endogenous cholesterol pools. This difficulty does not apply if 
steroid production from endogenous precursors is measured as in the present 
study. Prolonged treatment with human chorionic gonadotropin does increase 
the total activity of 3iJ-hydroxysteroid dehydrogenase in rat testis tissue. This 
increase can be explained by the increase of enzyme activity present in the 
interstitial compartment. This increased specific activity of 3iJ-hydroxysteroid 
dehydrogenase and the lack of increase of the specific activities of other par-
ticle-bound enzymes, not directly related to steroid biosynthesis, indicate a 
specific effect of human chorionic gonadotropin. The present results do not 
support the suggestion of Shikita and Hall [26] that the activity of 3iJ-hy-
droxysteroid dehydrogenase in testes of rats older than 22 days is already 
maximally stimulated by the endogenous circulating gonadotropins and cannot 
be further increased by added human chorionic gonadotropin. Moreover, Purvis 
et a!. [ 3] have recently reported an increase in activity of the microsomal 
cytochrome P., 0 -dependent enzymes 17cx-hydroxylase and steroid C1 7 •2 0 -
lyase after long-term treatment with human chorionic gonadotropin. 
Human chorionic gonadotropin treatment resulted in a 2-3 times higher 
pregnenolone production from endogenous precursors in testicular mitochon-
drial fractions in the presence of cyanoketone, in fractions obtained from 
whole testis tissue as well as from isolated interstitial tissue. This observation 
strongly suggests that the enhanced androgen biosynthesis may be caused by 
stimulation of the mitochondrial pregnenolone production. 
The increased pregnenolone production in isolated mitochondrial frac-
tions might reflect (1) an increased amount of Leydig cell mitochondria, as-
suming that Leydig cells are the steroid producing cells in the interstitial tissue; 
(2) an increased concentration of components of the cholesterol side-chain 
cleaving complex per mitochondrion; (3) an accumulation of precursors for 
pregnenolone synthesis (e.g. cholesterol) in the isolated mitochondrial fraction, 
caused by an activation of the supply of these precursors and ( 4) a combination 
of the above mentioned phenomena. The significant increase of the amount of 
protein measured in the mitochondrial fraction from the interstitial tissue and 
of the mitochondrial enzyme monoamine oxidase in total homogenates and in 
mitochondrial fractions from this tissue compartment may indicate that human 
chorionic gonadotropin increases the amount of interstitial tissue mitochon-
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dria. An increase of some components of the cholesterol side-chain cleaving 
complex has also been reported [9,27]. 
Little is known about the effect of long-term human chorionic gonado-
tropin treatment on cholesterol pools in testes of intact adult rats. Ying et al. 
[28] have shown that the biosynthesis of cholesterol is accelerated after one 
week of human chorionic gonadotropin treatment, whereas Van der Molen et 
al. [29] have reported that for the strain of rats used in our studies no differ-
ence can be observed in cholesterol and cholesterol esters concentrations in 
homogenates of whole testis and isolated interstitial tissue before and after 
human chorionic gonadotropin treatment. In contrast with the adrenal gland, 
in which organ most of the cholesterol is esterified and accumulated in lipid 
droplets [ 30], in testicular interstitial tissue less than 5% of cholesterol is 
esterified [29] and the free cholesterol is mainly recovered in mitochondrial 
and microsomal fractions after tissue fractionation (Van der Vusse, unpub-
lished results). Therefore the hypothesis of de-esterification of cholesterol 
esters in lipid droplets and a subsequent translocation of cholesterol from these 
droplets into the mitochondria appears less likely as mechanism of action of 
human chorionic gonadotropin on testicular steroid biosynthesis. A possible 
effect of gonadotropins on cholesterol uptake by Leydig cells and on an intra-
cellular and intramitochondrial shift of cholesterol remains to be investigated. 
From the present data it is evident that endogenous steroid production by 
isolated testis mitochondria can be employed as a useful parameter for trophic 
stimulation of testicular steroid production in vivo. 
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Summary 
An attempt has been made to correlate the rapid effect of luteinizing 
hormone on testicular steroid production in vivo with testicular steroid concen-
trations and in vitro steroid production rates in testis tissue preparations. 
Within 20 min after intravenous administration of 25 11g luteinizing hor-
mone, increases were observed in testosterone concentrations in testicular 
venous plasma and in whole testis tissue and in pregnenolone concentrations in 
isolated testis mitochondrial fractions. Testosterone production by whole testis 
homogenates and pregnenolone production by isolated mitochondrial fractio'l.s 
were significantly increased within 5 min after in vivo administration of luteir.-
izing hormone. 
Injection of cycloheximide 10 min prior to luteinizing hormone prevented 
the stimulating effect of luteinizing hormone on steroid levels in testicular 
venous plasma and testis tissue and on steroid production rates by preparations 
of rat testis tissue. Cycloheximide treatment of control animals did not signifi-
cantly alter testosterone concentrations and testosterone production rates in 
vitro, although mitochondrial pregnenolone concentrations and production 
rates were decreased. 
Testosterone production by whole testis homogenates as well as the preg-
nenolone production by isolated mitochondrial fractions obtained from lutein-
izing hormone treated testes and control glands showed a biphasic time curve. 
A period (5-1 0 min) of high steroid production was followed by a period of 
lower steroid production. 
Addition of 25 11g luteinizing hormone or 10-8 -·10-5 M adenosine 3':5'-
monophosphate (cyclic AMP) to the incubation medium had no effect on 
pregnenolone production by isolated mitochondrial fractions. 
I 
I 
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Administration of luteinizing hormone in vivo markedly enhanced the 
stimulating effect of Ca2 + on testosterone production by whole testis homage-
nates and on pregnenolone production by isolated mitochondrial fractions. 
Introduction 
Testicular steroid production can be stimulated by luteinizing hormone in 
vivo as well as in vitro [1-3]. The action of luteinizing hormone is thought to 
be mediated by intracellular cyclic AMP [ 4] and protein synthesis or activation 
of protein factor(s) seems to be involved. This has also been suggested for the 
adrenal gland [5], ovary [6] and the testis [7], but the precise molecular 
mechanism of the stimulation of the steroid biosynthetic pathway is poorly 
understood. Mitochondrial conversion of cholesterol to pregnenolone appears 
to be a rate-limiting step in steroid biosynthesis [2] and stimulation of steroid 
production by gonadotropins may be caused by a stimulation of the mitochon-
drial activity for pregnenolone synthesis. 
Several authors [1,8] have shown, that rapid changes in gonadotropin 
levels in blood cause a rapid response in testicular steroid production in vivo. In 
this respect we report on the short-term effect of intravenously administered 
luteinizing hormone in intact adult male rats on testosterone production in 
vivo, as well as on testosterone concentrations in whole testis tissue and preg-
nenolone concentrations in isolated mitochondrial fractions. In order to study 
the molecular mechanism of hormone-activated steroid biosynthesis, we have 
tried to correlate the in vitro steroid production in cell-free preparations of rat 
testes with the in vivo biosynthesis. We have previously shown [9,10,11] that 
pregnenolone and testosterone production from endogenous precursors is a 
good parameter for rat testicular steroid biosynthesis. Therefore, we have stud-
ied the in vitro testosterone production by whole testis tissue homogenates and 
pregnenolone production by isolated mitochondrial fractions from rat testis 
after in vivo luteinizing hormone treatment. The possible involvement of pro .. 
tein synthesis was studied by investigating the effect of cycloheximide adminis-
tered prior to luteinizing hormone on testosterone production in vivo and on 
testosterone and pregnenolone production in vitro. It has been reported that 
Ca2 + can activate the conversion of radioactive cholesterol by testis mitochon-
drial fractions [12] as well as pregnenolone synthesis by mitochondrial frac-
tions isolated from adrenal glands [13,14]. However, no data are available on 
the possible role of Ca2 • in trophic hormone stimulated pregnenolone forma-
tion. In the present study the effect of luteinizing hormone treatment in vivo 
on Ca2 + stimulated mitochondrial pregnenolone production in vitro was investi-
gated. 
Materials and Methods 
Luteinizing hormone (ovine NIH-LH-S18, 1.03 units/mg) was a gift from 
the National Institute of Health, Bethesda, Md., U.S.A. Cycloheximide was 
purchased from Boehringer Mannheim, Germany. The phosphodiesterase in· 
hibitor 3-isobutyl-1·methylxanthine was obtained from Aldrich Chemic il Com· 
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pany Inc., Milwaukee, U.S.A. Steroids, cofactors and other chemicals were 
purchased as previously described [9]. Sodium pentobarbital is a product of 
Abbott S.A., Saint Remy sur Avry, France. 
Adult male Wistar rats substrain R-Amsterdam (14-16 weeks old) were 
used in this study. Luteinizing hormone dissolved in 0.2 ml 0.9% NaCl, contain-
ing 0.2% bovine serum albumin, was administered into the Vena iliaca. Blood 
from the testicular vein was obtained under sodium pentobarbital anaesthesia 
as described by DeJong et al. [8]. Blood was collected in heparinized tubes for 
20 min after intravenous injection of 25 fJ.g luteinizing hormone or of 0.2 ml 
NaCl/albumin solution only. Blood samples were centrifuged after collection 
and the plasma was stored at -20° C until analysed. 
When the short-term effect of gonadotropin administration on testicular 
steroid production in vitro was studied, rats were anaesthetized with sodium 
pentobarbital. After opening the scrotum and underlying tissue, one testis was 
removed and was immediately chilled in 0.25 M sucrose, containing 1 mM 
EDTA at 0°C (zero control testis). Subsequently, the animals were injected 
into the Vena iliaca either with 25 fJ.g luteinizing hormone or with NaCl/al-
bumin solution only. The second testis was then removed 5-30 min after 
injection with the luteinizing hormone (LH-treaced testis) or the vehicle (con-
trol testis). The homogenation procedure and isolation of subcellular fractions 
from testis tissue were performed in ice-cold 0.25 M sucrose, containing 1 mM 
EDTA as described previously [9]. When used, 1 mg cycloheximide dissolved 
in 0.2 ml NaCl/albumin solution was administered intravenously 10 min prior 
to injection of luteinizing hormone. The activity of 3[3-hydroxysteroid dehy· 
drogenase (EC 1.1.1.51) was assayed as described previously [9]. 
Testosterone production from endogenous precursors was estimated by 
incubating 4-8 mg protein of whole testis tissue homogenates at 33° C in a 
0 2 /C02 (95 : 5, v/v) atmosphere in 2-ml medium at pH 7.35 containing 
sucrose (0.125 M), EDTA (0.5 mM), sodium succinate (20 mM), NAD• (1.0 
mM), NADPH (1.0 mM), glucose 6-phosphate (10 mM), glucose-6-phosphate 
dehydrogenase (0.3 unit), CaCl2 (0.7 mM), MgCl2 (5.0 mM), Tris/HCl (25 
mM). Pregnenolone production from endogenous precursors in mitochondrial 
fractions was estimated by incubating 0.8-1.8 mg mitochondrial protein in 
2 ml incubation medium as described for testosterone production (see above). 
NAn• was omitted and 0.1 JJ.M cyanoketone (2a<-cyano-4,4', 17 a<-trimethyl-
17[3-hydroxy-5-androsten-3-one) was added to inhibit further conversion of 
pregnenolone [9]. The production was calculated from the differmce in the 
amount of testosterone or pregnenolone in the incubation mixtures after in-
cubation and at zero time. 
Testosterone in plasma and in tissue samples was estimated with a radio-
immunoassay technique described by Verjans et al. [15]. Pregnenolone was 
determined by a radioimmunoassay technique described by Vari der Vusse et 
al. [10]. 
The significance of differences between results for different groups was 
calculated using a two-tailed Student's t-test [16]. Protein was measured by the 
method of Lowry et al. [ 1 7] using bovine serum albumin as a standard. 
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TABLE I 
CONCENTRATIONS OF TESTOSTERONE IN TESTICULAR VENOUS PLASMA OF INTACT MALE 
RATS AFTER INTRAVENOUS ADMINISTRATION OF LUTEINIZING HORMONE AND CYCLO~ 
HEXIMIDE 
The treatment consisted of 25 J.Lg luteinizing hormone administered intravenously immediately before 
collection of testicular venous blood for 20 min. 1 mg cycloheximide was injected intravenously 10 mL-1 
prior to the administration of 0.2 ml NaCl/albumin solution or 25 p.g luteinizing hormone. The number of 
experiments is given in parentheses. Figures are mean values± S.D. 
Treatment 
N aCl/albumin solution ( 4) 
1 mg cycloheximide+ NaCl/albumin solution (3) 
25 }.lg luteinizing hormone (4) 
1 mg cycloheximide+ 25 J.Lg luteinizing hormone (2) 
Results 
Testosterone (pmol/ml) 
350 ± 100 
300 ± 90 
830 ± 190 
320 
Testosterone concentration in testicular venous plasma 
Table I shows that the testosterone concentration in plasma obtained 
from testicular venous blood collected for 20 min after administration of 25 /lg 
luteinizing hormone was enhanced 2.4 times (P < 0.01). Cycloheximide in-
jected prior to luteinizing hormone abolished the increase of testosterone con-
centration in testicular venous plasma. Cycloheximide had no effect on the 
basal levels of testosterone in testicular venous plasma. 
Concentration of testosterone in whole testis homogenates and pregnenolone 
concentration in isolated mitochondrial fractions 
Fig. lA shows that within 20 min after the administration of 25 fJ.g 
pmol testosterone/ mg protein pmol pregnenolone/ mg mitochondrial protein 
50 
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time after administration (min) time oHm administration (min) 
Fig, 1. (A) Concentration of testosterone in whole tissue homogenates of testes removed at various times 
after intravenous administration of luteinizing hormone or of NaCl/alLumin solution (means of at least 
four experiments ±S.E.M.). (B) Concentration of pregnenolone in isolated mitochondrial fractions ob· 
tained from testes removed at various times after intravenous administration of luteinizing hormone or 
NaCl/albumin solution (means ±S.E.M.). L>--------6, after injection of 0.2 ml NaCl/albumin solution; 
•---e, after injection of 25 }J.g luteinizing hormone. 
32 
luteinizing hormone, testosterone concentrations in whole testis tissue homo-
genates increased from 4 to 32 pmol per mg protein (P < 0.001). Pregnenolone 
concentrations in mitochondrial fractions obtained from zero control and con-
trol testes were about 10 pmol per mg mitochondrial protein (Fig. lB). Within 
10 and 20 min after intravenous administration of luteinizing hormone mito-
chondrial pregnenolone concentrations were significantly increased to 25 and 
50 pmol per mg mitochondrial protein respectively (P < 0.001). 
Production of testosterone and pregnenolone in vitro 
Testosterone production by homogenates obtained from zero control 
testes and testes removed 5, 10 and 20 min after intravenous administration of 
NaCl/albumin solution were about 20 pmol testosterone per mg protein per 30 
min, whereas 5, 10 and 20 min after administration of luteinizing hormone, 
testosterone production increased to 39, 66 and 78 pmol testosterone per mg 
protein per 30 min respectively (P < 0.05, P < 0.025 and P < 0.001 respective-
ly) (Fig. 2A). 
Fig. 2B shows the stimulatory effect of intravenous administration of 
luteinizing hormone on pregnenolone production by mitochondrial fractions 
isolated from testes removed 5, 10, 20 and 30 min after luteinizing hormone 
administration. Pregnenolone productions by mitochondrial fractions isolated 
from zero control and control testes were about 150 pmol pregnenolone per 
mg mitochondrial protein per 30 min. When testes were removed 20 min after 
luteinizing hormone injection, mitochondrial pregnenolone production was sig-
nificantly enhanced to 400 pmol per mg mitochondrial protein per 30 min (P < 
0.001 ). When testes were removed 30 min after luteinizing hormone injection, 
the increase of mitochondrial pregnenolone production was smaller. 
In order to obtain an impression about the amount of exogenous lutein-
izing hormone that is needed in vivo to cause a stimulation of in vitro testoster-
one production by whole tissue homogenates 25 ng, 250 ng, 2.5 11g, 25 11g and 
prnol testosterone/ mg protein, 30 min. pmol pregnenolone/ mg mitochondrial protein, 30 min. 
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Fig. 2. (A) Production of testosterone by whole tissue homogenates of testes removed various times after 
intravenous administration of luteinizing hormone or of NaCl/albumin solution (means of at least four 
experiments ±S.E.M.). (B) Production of pregnenolone by isolated mitochondrial fractions obtained from 
testes removed various times after intravenous administration of luteinizing hormone or of NaCl/albumin 
solution (means ±S.E.M.). ~:.---~::,, after injection of 0.2 ml NaCI/albumin solution; e--------o, after 
injection of 25 /.lg luteinizing hormone. 
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250 Jlg luteinizing hormone were administered and testes were removed after 
20 min. It appeared that under these conditions at least more than 250 ng 
luteinizing hormone in vivo was required to stimulate testosterone production 
in vitro (data not shown). 
Testosterone and pregnenolone production in vitro as a function of time of 
incubation 
Fig. 3A reflects that testosterone formation from endogenous precursors 
by whole testis homogenates versus incubation time showed a biphasic pattern. 
An initial phase of high testosterone production lasting 10 min was followed by 
a slower rate of production. The production of pregnenolone from endogenous 
precursors by mitochondrial fractions showed a similar time curve (Fig. 3B). 
This biphasic pattern was more pronounced in incubation experiments with 
preparations from luteinizing hormone-treated testes than in experiments with 
control testes. 
Activity of 3{3-hydroxysteroid dehydrogenase in whole tissue homogenates 
The specific activities of 3{3-hydroxysteroid dehydrogenase in homage-
nates of zero control and control testes were 0.13 ± 0.03 and 0.12 ± 0.01 mU 
per mg protein (mean value ±S.D., n = 4). In homogenates of luteinizing hor-
mone-treated testes, the same specific activity was found: 0.12 ± 0.02 mU per 
mg protein (testes were removed 20 min after injection of luteinizing hormone 
or NaCl/albumin solution). 
Effect of cycloheximide administration in vivo on steroid concentrations and 
on steroid production in vitro 
Cycloheximide injection prior to luteinizing hormone prevented the 
luteinizing hormone stimulation of testicular testosterone concentration and 
prnol teslosterorte / mg protein pmol pregner.olone / mg mitochondrial protein 
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Fig. a. (A) Production of testosterone by. whole testis tissue homogenates as a function of the time of 
incubation. [j,------6, homogenates of control testes; e--------e, homogenates of testes removed 20 min 
after intravenous administration of 25 !J,g luteinizing hormone. (BfProduction of pregnenolone by isoM 
lated mitochondrial fractions as a function of the time of incubation . .6---L'>, mitochondrial fractions 
obtained from control testes; .____.,mitochondrial fractions obtained from testes, removed 20 min 
after intravenous administration of 25 J.Lg luteinizing hormone. 
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TABLE II 
STEROID CONCENTRATION AND IN VITRO STEROID PRODUCTION IN RAT TESTIS PREPARA-
TIONS AFTER IN VIVO ADMINISTRATION OF CYCLOHEXIMIDE AND LUTEINIZING HORMONE 
Number of experiments (n) is given in parentheses. Figures are mean values± S.D. 
Treatment Steroid concentration Steroid production 
Whole tissue Mitochondrial Whole tissue Mitochondrial 
homogenate fraction homogenate fraction 
(pmol testos- (pmol pregneno- (pmol testos- (pmol pregneno-
terone/mg lone/mg mito- teronejmg lone {mg mito-
protein) chondrial protein, 30 min) chondrial 
protein) protein, 30 min) 
NaCl/albumin *solution (4) 3.2 ± 1.1 (7) 8.3 ± 1.4 (5)18±4 (6) 167 ± 27 
Cycloheximide**+ 
NaCl/albumin 
solution (4) 1.7±0.7 (5) 2.8 ± 2.0 (4)16±6 (5) 126 ± 26 
Luteinizing hormone*** (4) 32 ±4 (5) 50 ±4 (4)78±8 (4) 397 ± 84 
Cycloheximide+ 
luteinizing hormone t (4) 3.3 ± 1.8 (3) 3.4 ± 1.2 (4)23±9 (3) 142 ± 10 
* 0.2 ml 0.9% NaCI, containing 0.2% bovine serUm albumin was injected intravenoush: 30 min 
before removing the testis. 
* * 1 mg cycloheximide in NaCl-albumin solution was injected intravenously. Testes were removed 30 
min after injection. 
* ** 25 }J.g luteinizing hormone was injected i.v. 20 min before removing the testes. 
t 1 mg cycloheximide was injected i.v. 10 min prior to administration of 25 }J.g luteinizing hormone 
20 min after luteinizing hormone administration testes were removed. 
testosterone production by whole testis homogenates (Table II). Moreover, 
cycloheximide administration prior to luteinizing hormone injection inhibited 
the increases of mitochondrial pregnenolone concentration and pregnenolone 
production which were observed after administration of luteinizing hormone 
alone (Table II). Administration of cycloheximide to control animals did not 
significantly alter testosterone concentration and production in vivro. However, 
cycloheximide injection of control animals resulted in a decreased preg-
nenolone concentration in mitochondrial fractions (P < 0.001) and pregnenol-
one production by mitochondrial fractions decreased from 167 to 126 pmol 
pregnenolone per mg protein per 30 min (P < 0.05). A<;ldition of 1 mg cyclo-
heximide to the incubation mixture did not inhibit the production of testoster-
one by whole testis homogenates and of pregnenolone by mitochondrial frac-
tions from control and luteinizing hormone treated testes (data not shown). 
Effect of Ca'• concentration on testosterone and pregnenolone synthesis in 
vitro 
The incubation studies mentioned above were performed in a medium 
with 0.7 mM Ca'•. Fig. 4 shows the effect of variation of Ca2 • concentration in 
the incubation medium on testosterone production by whole testis homage-
nates. An increase of Ca2 • concentration in the range from 0 to 1 mM resulted 
in a striking activation of testosterone production. The stimulation was de-
creased at Ca'• concentrations of 50 mM and higher. 
Fig. 5 shows the influence of Ca'• concentration in mitochondrial preg-
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pmol pregnenolone/ mg mitochondriol protein, 30 min. 
pmol le<tmlerooe / mg protein, 30 min. 
wo 1000 
(! l 5 10 
Fig. 4. The effect of ca2+ on the production of testosterone by whole testis tissue homogenates. 
6~, homogenates of control testes; •~. homogenates of testes, removed 20 min after intra~ 
venous administration of 25 JJ,g luteinizing hormone. 
Fig. 5. The effect of Ca2 + on the production of pregnenolone by isolated mitochondrial fractions. 
6~, mitochondrial fractions obtained from control testes; e----e, mitochondrial fractions 
obtained from testes, removed 20 min after intravenous administration of 25 jig luteinizing hormone. 
nenolone production. The increase of Ca2 + concentrations from 0 to 1 mM also 
caused an increase of mitochondrial pregnenolone synthesis. At 25 mM Ca2 • a 
maximal production rate was achieved; at higher Ca2 + concentrations the pro-
duction rate decreased (not shown). In the absence of Ca2 +, mitochondrial 
fractions of control testes produced 36 ± 10 whereas mitochondrial fractions of 
luteinizing hormone-treated testes produced 76 ± 36 pmol pregnenolone per 
mg mitochondrial protein, 30 min (mean values ±S.D., n = 3). Under the ex-
perimental conditions used in the present study, changes in low Ca'+ concentra-
tions had a more pronounced effect on steroid production in preparations fron, 
luteinizing hormone treated testes as compared to the production by control 
testes (Figs 4 and 5 ). 
Influence of luteinizing hormone and cyclic AMP in vitro on mitochondrial 
pregnenolone synthesis 
The presence of 12.5 and 25 /lg luteinizing hormone in the incubation 
medium had no effect on the production of pregnenolone from endogenous 
precursors by mitochondrial fractions (data not shown). With our incubation 
conditions, 10-8 -10-5 M cyclic AMP in the presence of 0.2 mM 3-isobutyl-1-
methylxanthine, an inhibitor of phosphodiesterase activity (EC 3.1.4.1), had 
no influence on pregnenolone production by isolated mitochondrial fractions 
of rat restis (data not shown). 
Discussion 
The present results show a good correlation between the effects of lutein-
izing hormone injected intravenously on steroid production in vivo and m vitro. 
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The results (Table I) also confirm that the testosterone concentration in rat 
testicular venous plasma is a good parameter for steroid secretion by the rat 
testis. A rapid increase of the testosterone concentration in venous plasma was 
observed after injection of luteinizing hormone, which is compatible with pre-
vious observations of Eik-Nes [1] and of De Jong et a!. [8]. The effect of 
luteinizing hormone administered in vivo is reflected already after 5 min by an 
increase in the in vitro testosterone production by whole testis homogenates 
(Fig. 2A). The increased pregnenolone production by isolated mitochondrial 
fractions after in vivo luteinizing hormone treatment (Fig. 2B) appears a logical 
cause for this increase in testosterone production. This is in accordance with 
the theory that gonadotropins stimulate steroid biosynthesis at a step prior to 
the conversion of pregnenolone [2]. 
The biphasic time curve of steroid production by whole testis tissue 
homogenates (Fig. 3A) as well as by mitochondrial fractions (Fig. 3B) may 
reflect the involvement of a mitochondrial substance which is required for 
steroid production and which is rapidly depleted (within 5-10 min) during 
incubation in vitro. Luteinizing hormone treatment may enhance the in vivo 
accumulation of this factor. A similar. time-curve of steroid production has 
been observed for pregnenolone production by isolated mitochondrial fractions 
from the rat adrenal gland [13,14] and ovary [6]. 
After luteinizing hormone treatment, the concentrations as well as the 
production rates of mitochondrial pregnenolone were increased (Figs 1B and 
2B). This observation makes it unlikely that activation of testicular steroid 
production by trophic hormones is only caused by an increased efflux of 
pregnenolone from the mitochondrion, thus relieving feedback inhibition of 
the cholesterol side chain-cleaving enzyme complex by pregnenolone as was 
proposed by Koritz and Kumar for the adrenal gland [18]. 
In the present experiments, after short-term luteinizing hormone adminis-
tration, no effect was observed on 3{3-hydroxysteroid dehydrogenase activity. 
This is in contrast to the effect of long-term human chorionic gonadotropin 
administration [10] which caused a 2-fold increase of 3{3-hydroxysteroid dehy-
drogenase activity. This may reflect that the rapid effect of luteinizing hor-
mone on testis st<eroidogenesis does not involve an increase of the synthesis of 
enzymes involved in testosterone formation. It is generally accepted that cyclic 
AMP is required as an intracellular messenger for gonadotropin stimulation of 
testicular steroid biosynthesis [ 4]. Recently, Cooke eta!. [19] have reported 
that the cyclic AMP concentration in rat testis tissue is about 10-7 M. Lutein-
izing hormone treatment increases the cyclic AMP concentration in isolated 
testicular interstitial tissue [19]. From the present results it appears that phy-
siological concentrations of cyclic AMP had no direct effect on mitochondrial 
pregnenolone production. Also, luteinizing hormone, when added directly to 
mitochondrial incubation mixtures, did not affect mitochondrial pregnenolone 
production. Although Sulimovici and Lunenfeld [20] have reported that 
luteinizing hormone in vitro can stimulate rat testis mitochondrial adenylcy-
clase, the present results do not support the suggestion that mitochondrial 
cyclic AMP formation plays a role in the regulation of mitochondrial steroid 
production. 
Pretreatment of the animals with cycloheximide in vivo prevented the 
37 
effect of luteinizing hormone on activation of steroid production in vivo and in 
vitro (Tables I and II). This may indicate that extra-mitochondrial protein 
synthesis is involved in the molecular action of trophic hormones on the mito· 
chondrial pregnenolone production. 
Effects of protein synthesis inhibitors have been reported on steroid pro-
duction by superfused adrenal cells [21] and testicular interstitial tissue [7] 
and in adrenal mitochondria [ 22] and on the mitochondrial cholesterol side-
chain cleavage activity from luteinized rat ovaries [6]. These results have been 
interpreted in terms of a cytoplasmic protein which is rapidly turning over and 
which may be involved in the interaction between cholesterol and mitochon-
drial cytochrome P-450. 
Testosterone production by whole testis tissue homogenates and preg-
nenolone production by mitochondrial fractions are stimulated by Ca2 • in vitro 
(Figs 4 and 5 ). After luteinizing hormone treatment in vivo the testosterone 
and pregnenolone production rates in the absence of Ca2 • were increased when 
compared with steroid production by relevant control samples. In the presence 
of low Ca2 • concentrations the activating effect of this cation is more pro-
nounced in preparations of luteinizing hormone treated testes, than in prepara-
tions of control testes. These results could indicate that luteinizing hormone 
stimulates mitochondrial pregnenolone production via a compound that en-
hances the mitochondrial sensitivity to Ca2 • or increases cellular Ca'• concen-
trations, which may facilitate the uptake of Ca2 • by the mitochondria. On the 
other hand it cannot be excluded that cellular Ca2 • plays a permissive role in 
the regulation of testicular steroidogenesis. The mechanism of the Ca2 • in 
stimulating pregnenolone production is not known. Recently, Simpson et al. 
[13] have reported that pregnenolone synthesis in rat adrenal mitochondria 
can be activated by Ca2•, which also alters the spin state of mitochondrial 
cytochrome P450, probably caused by a change in conformation of mitochon-
dria. The possible relationship between a cytoplasmic protein factor that may 
be involved in the trophic stimulation of steroid production and Ca2 • -induced 
mitochondrial pregnenolone production also remains to be elucidated. 
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